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ABSTRACT

DESIGN RULES FOR THE NUCLEATION, GROWTH, AND ENCAPSULATION OF
GOLD NANOPARTICLES WITH APPLICATIONS TO CANCER IMAGING
by
Matthew A. Wall

Advisors:
Professors Moritz F. Kircher & Charles Michael Drain

Surface-enhanced Raman scattering (SERS) nanoparticles are exciting candidates for
high-precision cancer imaging due to their highly specific spectral signature (Raman
“fingerprint”) and propensity for passive targeting of cancerous tissues. However, the
signal intensity of currently available SERS nanoparticles is insufficient for cancer
imaging via passive targeting in most solid tumors. The overarching aim of this body of
work is to develop a new generation of SERS nanoparticles with sufficiently low limits of
detection to enable robust detection of various solid tumors in vivo.
The optimization of SERS nanoparticle constructs requires significant advances to
the theoretical and experimental understanding of metal nanoparticle syntheses and the
methods of their encapsulation. In particular, the requirement that the Raman-active
molecules adsorb to the metal nanoparticle for maximum surface enhancement
necessitates nucleation, growth and encapsulation methods that maximize the potential
for metal-molecule binding. This poses a substantial roadblock to overcoming the current
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limitations of SERS nanoparticle intensity, because metal nanoparticle syntheses rely
upon surface-passivating surfactants or polymers to enable morphological control.
Moreover, metal nanoparticles typically require priming of their surface with silicate or
polymer layers to ensure successful encapsulation under high ionic strength (e.g., from
the presence of Raman-active molecules and counterions). These challenges make the
optimization of SERS nanoparticles a case study in the theoretical and experimental
frontiers of nanoparticle engineering.
The following advancements will be presented in this dissertation: i) a new,
generalized thermodynamic theory of crystal nucleation (chapter 2); ii) a new,
generalized theory of shape-controlled crystal growth (chapter 3); iii) a theoretical and
experimental description of encapsulation including a novel method for chelator-free
radiolabeling (chapter 4); and iv) the in vivo results of the new generation of SERS
nanoparticles in state-of-the-art orthotopic and transgenic mouse models. The generality
of these findings extend beyond the scope of cancer imaging. Accordingly, context will
be provided in each chapter for the potential impact of the work.
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CHAPTER 1
Introduction
1.1 Introduction
Cancer is the second leading cause of death in the United States and its burden
continues to increase (1). The complexity and heterogeneity of cancer requires that it be
battled on every front, including research into preventative measures, early detection,
proper diagnosis, improved resection, drug development and therapeutic monitoring, and
prevention of recurrence (1-4). Success in these endeavors is often limited by the extent
to which we can image pre-cancerous and cancerous tissue (5).
Ideal imaging techniques would demonstrate sufficient sensitivity and specificity
to detect cancer on the scales of both solid tumors and single cells in vivo (6). The
development of such sensitive techniques is exceptionally difficult, and has only recently
become feasible as a result of innumerable researchers making revolutionary
advancements across many generations. Given that there are tens to hundreds of trillions
of cells in the average adult human body, searching for individual rogue cells must be
done strategically, rather than by brute force (7). To that end, contrast agents have proved
invaluable in the detection of cancer (5, 8-10).
The basic requirements of a contrast agent are that they accumulate in the region
of interest (e.g., cancer), and have a detectable signal for an imaging instrument, which is
often developed in parallel. For example, if a tissue of interest is known to exhibit
particularly high glucose metabolism, then contrast agents for that tissue can be created
by modifying glucose molecules to become detectable by specific instruments.
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Substituting the 2’ hydroxyl of glucose with a radioactive isotope of fluorine (18F), for
example, yields fluorodeoxyglucose – a molecule that accumulates in tissues with high
glucose metabolism and can be detected via positron emission tomography (PET) (9).
Arguably, the greatest challenge in contrast agent development is the dearth of biological
properties sufficiently unique to a tissue or cell type to enable selective targeting in vivo
(11).
One biological property that can be exploited in many cancers is the enhanced
permeability and retention (EPR) effect. The EPR effect is a phenomenon typically
attributed to porous vasculature (i.e., enhanced permeability) and impaired lymphatic
drainage (i.e., enhanced retention) that allows macromolecules and nanoparticles to
passively accumulate in cancerous tissue (12). Recent studies suggest that other, more
active processes (e.g., macropinocytosis) may contribute to the mechanism of the EPR
effect, but a comprehensive explanation remains elusive (6). Because the EPR effect is
most pronounced for materials with nanoscale dimensions, nanoparticles have become
widely investigated as potential contrast agents for cancer imaging (13-16).

Nanoparticles offer many routes to instrumental detection (17-21). Radioisotopes
can be directly incorporated into nanoparticle structures or attached to nanoscale
platforms via molecular chelators (22-25). Materials with high electron density or
superparamagnetic properties can be used to provide computed tomography (CT) or
magnetic resonance (MR) contrast, respectively (26-30). Semiconductor nanoparticles
(i.e., quantum dots) can provide fluorescence contrast at tunable wavelengths by control
of their composition (31, 32). Thus, nanoparticles have the necessary properties to serve
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as a new generation of contrast agents, so long as they accumulate with sufficient
concentrations in regions of interest to provide detectable signals.
One class of nanoparticle contrast agents – surface-enhanced Raman scattering
(SERS) nanoparticles – has become an especially interesting candidate for intraoperative
imaging (4, 33-35). SERS nanoparticles exhibit highly specific “fingerprint” spectra that
are unambiguously identifiable by Raman detectors (33, 36-38). Furthermore, the
“background” Raman spectrum of biological tissue is extremely weak compared to SERS
nanoparticle signals, such that very high signal-to-noise ratios (SNR) are achievable (4,
34, 39). The intravenous injection of SERS nanoparticles has been shown to enable
accurate delineation of glioblastoma for high-precision intraoperative guidance during
cancer resection (4). The nanoparticles used in that study did not demonstrate the same
success outside of the brain, however, raising questions as to whether or not SERS
nanoparticles could be broadly applied as effective contrast agents (40).

The overarching motivation of this body of work is the following hypothesis: If
the sensitivity of SERS nanoprobes is sufficiently high, then they can be detected in
cancerous tissues throughout the body. The basis of this hypothesis is that SERS
nanoparticles are expected to accumulate in all solid tumors known to exhibit the EPR
effect, which are not restricted to the brain (12, 15). The likely explanation for the
absence of SERS contrast in these tissues is that the accumulated concentration of
nanoparticles remains below the limit of Raman detection (41). Indeed, it is well
established that the overwhelming majority of injected nanoparticles are filtered out of
circulation by the reticuloendothelial system, so it is plausible that the SERS
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nanoparticles are present at very low concentrations in tumors where their signal has not
been detected (42). Increasing the SERS intensity per particle sufficiently could
hypothetically make that same small concentration of nanoparticles detectable by a
Raman scanner.
In order to identify methods by which the intensity of SERS nanoparticles can be
substantially increased, we must first review the fundamentals of Raman scattering.

1.2 Fundamental principles of Raman scattering
Oscillating electric fields induce oscillations in the electron clouds of molecules,
referred to as induced dipoles (43). These oscillating electron clouds in turn generate
light. The light so generated is referred to as scattered light, and the intensity of the
scattered light is dependent upon the amplitude of the dipole oscillation (i.e. the
amplitude of the electron cloud oscillation) (44).
The electric field vector, Eσ, of a photon is expressed in terms of a maximum
amplitude, Eσ0, an oscillating frequency, ν0, and time, t:

When a photon approaches a molecule from a direction, σ, the amplitude, Pρ, of the
resulting induced dipole in the direction ρ is proportional to Eσ(45):
𝑃⃑

𝜌=

𝛼𝜌𝜎𝐸⃑

𝜎

The proportionality relationship is defined by the polarizability, αρσ, which depends upon
the relative orientations of the incident electric field and induced dipole. Thus, αρσ is a
tensor of proportionality constants. The polarizability tensor is a function of the normal
coordinates (i.e., relative positions of the atoms in a molecule), Qk, of the molecule and
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the magnitude of αρ will vary for certain normal modes as the molecule vibrates (44, 45).
Since the polarizability is a function of the normal coordinates, it can be expressed as a
Taylor series about the equilibrium value of αρσ. As a simplification, which holds well for
relatively small nuclear displacements, the Taylor series can be approximated by the first
two terms(45):

The normal mode coordinate Qk has a corresponding vibrational frequency, νk, such that
it varies over time according to:
𝑄𝑘 = 𝑄𝑘0cos(2𝜋𝜈𝑘𝑡)
Combining all of the equations above reveals that the time-dependent expression for the
induced dipole is given by:

Applying the trigonometric identity cos(a)cos(b) = (1/2)[cos(a + b) + cos(a – b)] yields
the classic form of the induced dipole expression(43-45):

This equation demonstrates that incident photons will induce a dipole in a
molecule’s electron cloud which can oscillate, and therefore produce scattered light, at
three frequencies: ν0, ν0 – νk, and ν0 + νk. Oscillation at the first of these frequencies
generates elastically, or Rayleigh, scattered light, while oscillation at either of the shifted
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frequencies produces inelastically, or Raman, scattered light. The lower-frequency
inelastic scattering is referred to as Stokes scattering and the higher-frequency inelastic
scattering is called Anti-Stokes scattering (45).
The intensity, IR, of Raman scattered light is expressed as a function of the
incident laser intensity, IL, the speed of light, c, the angular frequency of the kth normal
vibrational mode, ωk = 2πνk, and the polarizability tensor (46):

1.3 Strategies for increasing the intensity of Raman scattering
The intensity of Raman scattering can be increased by either increasing the total number
of scattering events or increasing the percentage of total scattering events that generate
Raman photons. The total number of scattering events is proportional to the intensity of
the incident electromagnetic field (e.g., the incident laser intensity), such that larger fields
yield more scattering events. Control of Raman scattering efficiency, however, is a more
subtle matter.
The Raman scattering efficiency will be greatest near an electronic resonance
(45). Conceptually, this occurs because the lifetime of the “virtual” excited state that
precedes emission of scattered light is significantly increased at excitation frequencies.
Because of this longer excitation, the initial and final nuclear coordinates (i.e., relative
atomic positions within the molecule) become further displaced than they would have for
a non-resonant molecule (i.e. the nuclei have more time to move before the virtual state
relaxes). This large change in nuclear coordinates results in a shift in the favored
vibrational state to which the virtual excited state relaxes, as described by the
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FranckCondon principle. Thus, molecules with an electronic resonance at an incident
laser wavelength will yield more intense Raman scattering than molecules without
electronic resonances at the incident wavelength.
In order to achieve enhancements to Raman scattering exceeding a few orders of
magnitude, the local electromagnetic field and polarizability tensor must be dramatically
increased (47). In order for this to occur, molecules would have to electronically couple
to a system that has very high polarizability. The prototypical example this phenomenon
is surface-enhanced Raman scattering by noble metal nanoparticles (37, 48-50).

The

high polarizability of noble metals originates in their electron structure. The electron
density in noble metals is so large that their Hamiltonian is dominated by electronelectron repulsion, driving the electrons to align in a lattice (51). When part of the
electron lattice is exposed to an incident electric field, a force is exerted on the electrons
that displaces them from their local equilibrium positions (52). This displacement
propagates throughout the electron lattice in a fashion analogous to phonons moving
through a crystal lattice (53). The collective oscillation of electrons is called a plasmon.
When the dimensions of a noble metal nanoparticle are smaller than the
wavelength of an incident photon, the plasmons generated rapidly propagate from one
end of the nanoparticle to the other. The net effect of this concerted motion is an
oscillating surface charge, called a localized surface plasmon (LSP), which generates
very large electromagnetic fields at the nanoparticle surface (52). The optical extinction
of the nanoparticle exhibits a maximum at the plasmon resonance frequency, which is a
sensitive function of the nanoparticles shape and size (52, 53). Accordingly, noble metal
nanoparticles can be rationally synthesized such that they act as optical antennas for a
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given frequency of light (e.g., near-infrared light), effectively concentrating incident
electromagnetic fields from laser sources onto their surfaces (54, 55).
When molecules adsorb to noble metal nanoparticles, their Raman scattering
exhibits resonances at the molecular electronic transition, the metal-molecule
chargetransfer transition, and the localized surface plasmon resonance (46, 47, 50). The
conceptual explanation for the large Raman intensity at molecular electronic and charge
transfer transitions is the increased Raman scattering efficiency that occurs for
longerlived excited state lifetimes. The surface plasmon resonance yields increased
intensity of Raman scattering by greatly increasing the number of scattering events (i.e.,
the surface electromagnetic field is increased). When all three of these resonances
overlap, the largest possible enhancement to Raman scattering is achieved (50). Thus,
Raman-active molecules with electronic transitions at the incident laser wavelength
should be combined with nanoparticles that have been optimized for electric field
enhancement in order to generate optimal metal-molecule interfaces.
The final step toward maximizing the intensity of Raman scattering is to optimize
the number of dye molecules at the surface of the nanoparticle. Synthetic methods that
passivate the nanoparticle surface will inhibit metal-molecule coupling, thus preventing
the optimal surface concentration of resonant dye molecules from be achieved. In other
words, if the synthetic methods used to control nanoparticle growth or encapsulation
block surface binding sites for resonant dye molecules, the optimal Raman intensity
cannot be achieved. Accordingly, metal nanoparticle syntheses that employ surfactants or
polymers, and encapsulation procedures that require surface primers (i.e., surface
coatings that render a substrate more amenable to encapsulation) are undesirable.

8

Because the existing shape-controlled metal nanoparticle syntheses require the use of
surfactant or polymer “shape-directing agents,” a new approach to controlling the
morphology of nanoparticles is required for the development of optimized SERS
nanoparticles (56, 57).

1.4 Concluding remarks
The subsequent chapters and appendices present literature summaries and novel
theoretical and experimental findings on nanoparticle nucleation, growth, and
encapsulation. The intention of this work is to review the contemporary understanding
and practices of these fields, highlight their strengths and weaknesses, and provide new
solutions to overcome their critical limitations. The theoretical and experimental
advances presented in this dissertation enabled the development of a new generation of
SERS nanoparticles with unprecedented limits of detection (6, 58). The utility of these
nanoparticles for in vivo cancer imaging has been evaluated in state-of-the-art orthotopic
and transgenic cancer models (6). The published results of this study can be found in
reference 6 of this chapter.
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CHAPTER 2
Nucleation in Solution
2.0 List of variables and constants
G................................................................................................................Gibbs free energy
Qr...............................................................................................................Reaction quotient
Keq........................................................................................................Equilibrium constant
dG........................................................................Infinitesimal change in Gibbs free energy
R.........................................................................................................Universal gas constant
T...........................................................................................................Absolute temperature
Ccryst......................................................................Concentration of crystalline growth units
Csolv..........................................................................Concentration of solvated growth units
a(Ccryst)...........................................................................Activity of crystalline growth units
a(Csolv)...............................................................................Activity of solvated growth units
Ceq...................................................................................Solubility of solvated growth units
NA...........................................................................................................Avogadro’s number
κ...........................................................................................................Boltzmann’s constant
σ.................................................................................................Specific surface free energy
A.........................................................................................................................Surface area
V................................................................................................................................Volume
Gvol......................................................................Volume contribution to Gibbs free energy
Gsurf......................................................................Surface contribution to Gibbs free energy
μ...............................................................................................................Chemical potential
P................................................................................................................................Pressure
N.................................................................................................Molar amount of substance
U....................................................................................................................Internal energy
S................................................................................................................................Entropy
Δμ..................................................................................................................Supersaturation
ξ..............................................................................................................Reaction coordinate
Ω.........................................................................Volume of a single crystalline growth unit
n...................................................................Number of growth units in a crystal or nucleus
r...............................................................................Radius of a spherical crystal or nucleus
n*...........................................................................................................Critical nucleus size
r*.....................................................................................................................Critical radius
W(n)..............................................................Work of formation to create nucleus of size n
W(n*)..............................................................................................Critical nucleation work
C0...........................................................................................Concentration nucleation sites
Cn....................................................................Equilibrium concentration nuclei with size n
J.....................................................................................................................Nucleation rate
Z...................................................................................................................Zeldovich factor
J.....................................................................................................................Nucleation rate
β.................................................................................................Monomer impingement rate
D...............................................................................................................Diffusion constant
x.................Stoichiometric coefficient of crystal precipitate in balanced chemical reaction
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E..............................................................................................................Reduction potential
E0..............................................................................................Standard reduction potential
F...............................................................................................................Faraday’s constant
2.1 Introduction
In this chapter, the essential concepts of classical nucleation theory (CNT) will be
developed and applied to the study of gold nanoparticles (sections 2.2 – 2.11). It will be
observed that the nucleation of gold nanoparticles is forbidden according to CNT (section
2.11). A generalized nucleation theory (GNT) will be presented that corrects a critical
oversight in CNT (sections 2.12 – 2.21). In particular, the GNT presented here models the
nucleation of crystals from arbitrary reactants, in contrast to CNT, which cannot account
for crystal formation as the result of a chemical reaction. A prototypical gold nanoparticle
synthesis will be analyzed in the context of the GNT and the experimental observations
will be explained by the new theory (sections 2.18 – 2.21).

2.2 Background
The laws of thermodynamics describe the evolution of systems in terms of energy
(1-3). In chemistry, the concept of free energy, particularly Gibbs free energy, G, is
essential to the study of how systems will change over time. Free energy is a measure of
the amount of energy that a system has available to transfer to another system. In the
particular case that the system is held to constant temperature and pressure, the free
energy is referred to as Gibbs free energy (3).
A system evolves as a result of thermodynamic driving forces (4, 5). The
thermodynamic driving force of a chemical reaction or phase transformation is the
minimization of free energy. That is, as a system changes states, it will tend toward the
state of lowest energy. According to the principle of detailed balance, this state is
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achieved when all reversible processes are in equilibrium (6, 7). The thermodynamic
driving force can be quantitatively expressed in terms of a reaction quotient and
equilibrium constant (1-3). For the general chemical equilibrium characterized by the
equation:
𝑎𝐴 + 𝑏𝐵 + ⋯ ⇌ 𝑥𝑋 + 𝑦𝑌 + ⋯
The reaction quotient is equal to:
𝑄𝑟 =

{𝑋}𝑥 {𝑌}𝑦 …
{𝐴}𝑎 {𝐵}𝑏 …

Where the lowercase letters a, b, x, and y are the stoichiometric coefficients
corresponding to the chemical species A, B, X, and Y involved in the equilibrium reaction,
and the angular brackets denote the chemical activity of the species. When all species
exist in their equilibrium proportions, the reaction quotient is referred to as the
equilibrium constant, Keq:
𝐾𝑒𝑞 =

𝑥 {𝑌} 𝑦
{𝑋}𝑒𝑞
𝑒𝑞 …

{𝐴}𝑎𝑒𝑞 {𝐵}𝑏𝑒𝑞 …

In order to predict the most energetically favorable evolution of a system it is
necessary to have a measure of how far a reaction is from equilibrium. The measure used
by chemists is the infinitesimal change in free energy, dG, with respect to an infinitesimal
change in the chemical composition of the system:
𝐾𝑒𝑞
𝑑𝐺𝑚𝑜𝑙𝑎𝑟 = −𝑅𝑇𝑙𝑛 ( )
𝑄𝑟
The subscript molar indicates that the change in free energy is given on the molar scale
(i.e., the units of reactants and products are moles). When the value of dG is negative,
there is a driving force to increase the concentration of products, and when it is positive,
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there is a driving force to decrease the concentration of products. Thus, when dG is
negative there is a thermodynamic driving force to produce more products.

2.3 Driving Force for Crystallization
When a crystalline substance is placed into a solvent, a driving force is
established for the crystalline substance to reach equilibrium with its solvated state (3, 812). If we denote the concentration of the crystalline substance by Ccryst and the
concentration of the solvated substance by Csolv, then the phase equilibration reaction is
given by:
𝐶𝑐𝑟𝑦𝑠𝑡 ⇌ 𝐶𝑠𝑜𝑙𝑣
This reaction is characterized by the reaction quotient, Qr, of the form:
𝑄𝑟 =

𝑎(𝐶𝑠𝑜𝑙𝑣 )
𝑎(𝐶𝑐𝑟𝑦𝑠𝑡 )

In this expression, a(Csolv) and a(Ccryst) are the activities of the solvated and crystalline
substance. When determining the activity, we treat all crystalline growth units as fully
coordinated (i.e., they have no broken bonds) such that they are in their most stable state.
This is an approximation because the surface growth units are not fully coordinated. In
CNT, this approximation is corrected by adding a surface energy term at the end of the
derivation. The activity of the crystalline growth units thus equals 1 by definition (i.e.,
they are in the most stable state), and the activity of the solvated substance is assumed to
equal its concentration (11, 13). This assumption tends to be a good approximation
because the concentrations encountered in typical crystallization studies are small enough
to exhibit ideal behavior (10, 13). The reaction quotient is therefore described by the
equation:
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𝑄𝑟 = 𝐶𝑠𝑜𝑙𝑣
At equilibrium, the reaction quotient is equal to the equilibrium constant, Keq, and the
solvated substance takes its equilibrium concentration, Ceq, called the solubility:
𝐾𝑒𝑞 = 𝐶𝑒𝑞
The thermodynamic driving force for crystal dissolution is given by substituting
the values for Qr and Keq into the equation for the infinitesimal change in free energy on
the molar scale, dGmolar:
𝑑𝐺𝑚𝑜𝑙𝑎𝑟 ≈ 𝑅𝑇𝑙𝑛 (

𝑑𝐺𝑚𝑜𝑙𝑎𝑟 ≈ 𝑅𝑇𝑙𝑛 (

𝑄𝑟
)
𝐾𝑒𝑞

𝐶𝑠𝑜𝑙𝑣
)
𝐶𝑒𝑞

We say that the right-hand and left-hand sides of these expressions are almost equal
because we are still neglecting the surface energy contributions.
When considering the formation of crystals, the solvated growth units will be
treated as reactants and the crystalline growth units will be products. Accordingly, the
expression for the change in free energy will be the opposite of the expression for
dissolution of crystals:
𝐶𝑠𝑜𝑙𝑣
𝑑𝐺𝑓𝑜𝑟𝑚𝑎𝑡𝑖𝑜𝑛 ≈ −𝑅𝑇𝑙𝑛 (
)
𝐶𝑒𝑞
Note that the expressions for the change in free energy derived thus far are on the
molar scale. This is counterintuitive considering that we are considering infinitesimal
changes. In practice, we are actually describing the infinitesimal change in free energy
with respect to a single reaction and then scaling that change by Avogadro’s number, NA.
The change in free energy on the scale of a single reaction dissolution or formation
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reaction is given by replacing the universal gas constant, R, with Boltzmann’s constant, κ
= R/NA:
𝐶𝑠𝑜𝑙𝑣
𝑑𝐺𝑑𝑖𝑠𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 ≈ 𝜅𝑇𝑙𝑛 (
)
𝐶𝑒𝑞
𝐶𝑠𝑜𝑙𝑣
𝑑𝐺𝑓𝑜𝑟𝑚𝑎𝑡𝑖𝑜𝑛 ≈ −𝜅𝑇𝑙𝑛 (
)
𝐶𝑒𝑞
Before we can apply these expressions to crystallization processes, we have to correct for
the approximation that all crystalline growth units are fully coordinated. We define the
quantity σ to be the specific surface free energy (i.e., the excess free energy per unit
surface area) such that addition of the term d(σA) makes the following equations exact:
𝐶𝑠𝑜𝑙𝑣
𝑑𝐺𝑑𝑖𝑠𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 = 𝜅𝑇𝑙𝑛 (
) + 𝑑(𝜎𝐴)
𝐶𝑒𝑞
𝑑𝐺𝑓𝑜𝑟𝑚𝑎𝑡𝑖𝑜𝑛 = −𝜅𝑇𝑙𝑛 (

𝐶𝑠𝑜𝑙𝑣
) + 𝑑(𝜎𝐴)
𝐶𝑒𝑞

In order to develop an intuition for the nucleation of crystals, we must further evaluate
these free energy terms.

2.4 Free Energy of Crystallization System
The total free energy of the system, G, is the sum of the free energy of all
components within the system. We express the total free energy as the sum of the free
energy of the crystalline substance, Gcryst, the solvated substance, Gsolv, and all other
contributions not involved in the crystallization process, ΣGi:

𝐺 = 𝐺𝑐𝑟𝑦𝑠𝑡 + 𝐺𝑠𝑜𝑙𝑣 + ∑ 𝐺𝑖
𝑖
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The free energy of the crystal will vary depending upon its shape and size (8, 9). In fact,
changes in geometry will change the value of Gcryst even if the number of atoms remains
constant (14-17). This variability comes from the surface energy of the crystal. As shown
in section 2.3, we describe the total free energy of the crystalline substance as the sum of
a volume free energy (i.e., perfect coordination assumption) and a surface free energy:
𝐺𝑐𝑟𝑦𝑠𝑡 = 𝐺𝑣𝑜𝑙 + 𝐺𝑠𝑢𝑟𝑓
𝐺𝑠𝑢𝑟𝑓 = 𝜎𝐴
𝐺 = 𝐺𝑣𝑜𝑙 + 𝜎𝐴 + 𝐺𝑠𝑜𝑙𝑣 + ∑ 𝐺𝑖
𝑖

The free energy of substances undergoing phase transitions or chemical reactions
is described in terms of chemical potential. The chemical potential, μi, of a substance, i, is
equal to the change in free energy that results from exclusively changing the amount, Ni,
of that substance (2, 18):
𝜇𝑖 = (

𝜕𝐺
)
𝜕𝑁𝑖 𝑇,𝑃,𝑁

𝑗≠𝑖

The subscripts T, P, and Nj≠i, mean that the temperature, pressure, and concentration of
all other substances are constant when defining μi.
The chemical potentials of crystalline and solvated growth units have an
important relationship in nucleation theory. In order to illustrate this, we recall that the
first law of thermodynamics relates the internal energy, U, the temperature, T, the
entropy, S, the pressure, P, the volume, V, the chemical potentials of species i, μi, and the
amount of species i, Ni, the specific surface free energy, σ, and the crystalline surface
area, A, using exact differentials as:
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𝑑𝑈 = 𝑇𝑑𝑆 − 𝑃𝑑𝑉 + ∑ 𝜇𝑖 𝑑𝑁𝑖 + 𝑑(𝜎𝐴)
𝑖

Rearrangement of this equation yields:
𝑇𝑑𝑆 = 𝑑𝑈 + 𝑃𝑑𝑉 − ∑ 𝜇𝑖 𝑑𝑁𝑖 − 𝑑(𝜎𝐴)
𝑖

Substitution of the identities d(TS) = TdS + SdT and d(PV) = PdV + VdP gives:
𝑑(𝑇𝑆) − 𝑆𝑑𝑇 = 𝑑𝑈 + 𝑑(𝑃𝑉) − 𝑉𝑑𝑃 − ∑ 𝜇𝑖 𝑑𝑁𝑖 − 𝑑(𝜎𝐴)
𝑖

𝑉𝑑𝑃 − 𝑆𝑑𝑇 + ∑ 𝜇𝑖 𝑑𝑁𝑖 + 𝑑(𝜎𝐴) = 𝑑𝑈 + 𝑑(𝑃𝑉) − 𝑑(𝑇𝑆)
𝑖

𝑑(𝑈 − 𝑇𝑆 + 𝑃𝑉) = 𝑉𝑑𝑃 − 𝑆𝑑𝑇 + ∑ 𝜇𝑖 𝑑𝑁𝑖 + 𝑑(𝜎𝐴)
𝑖

The definition of Gibbs free energy, G, is G = U – TS + PV. Substitution of this
identity gives:
𝑑𝐺 = 𝑉𝑑𝑃 − 𝑆𝑑𝑇 + ∑ 𝜇𝑖 𝑑𝑁𝑖 + 𝑑(𝜎𝐴)
𝑖

Now, consider a closed system at constant temperature and pressure containing
growth units that either exist in solvated or crystalline form. If we consider the phase
transition between solvated and crystalline states where the amount of all other chemical
species remains constant, then we have:
𝑑𝐺 = 𝜇𝑐𝑟𝑦𝑠𝑡 𝑑𝑁𝑐𝑟𝑦𝑠𝑡 + 𝜇𝑠𝑜𝑙𝑣 𝑑𝑁𝑠𝑜𝑙𝑣 + 𝑑(𝜎𝐴)
Because the system is closed, the total amount of growth units remains constant.
Accordingly, we have:
𝑑𝑁𝑠𝑜𝑙𝑣 = −𝑑𝑁𝑐𝑟𝑦𝑠𝑡
𝑑𝐺 = 𝜇𝑐𝑟𝑦𝑠𝑡 𝑑𝑁𝑐𝑟𝑦𝑠𝑡 − 𝜇𝑠𝑜𝑙𝑣 𝑑𝑁𝑐𝑟𝑦𝑠𝑡 + 𝑑(𝜎𝐴)
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𝑑𝐺 = −(𝜇𝑠𝑜𝑙𝑣 − 𝜇𝑐𝑟𝑦𝑠𝑡 )𝑑𝑁𝑐𝑟𝑦𝑠𝑡 + 𝑑(𝜎𝐴)
The expression in parentheses is called the supersaturation, and is usually denoted by the
shorthand Δμ:
Δ𝜇 ≡ 𝜇𝑠𝑜𝑙𝑣 − 𝜇𝑐𝑟𝑦𝑠𝑡
Recall from section 2.3 that the infinitesimal change in free energy of solvated
growth units going to crystalline growth units is given by:
𝑑𝐺𝑓𝑜𝑟𝑚𝑎𝑡𝑖𝑜𝑛 = −𝜅𝑇𝑙𝑛 (

𝐶𝑠𝑜𝑙𝑣
) + 𝑑(𝜎𝐴)
𝐶𝑒𝑞

Hence, the supersaturation on the scale of a growth unit is defined as:
Δ𝜇 = 𝜅𝑇𝑙𝑛 (

𝐶𝑠𝑜𝑙𝑣
)
𝐶𝑒𝑞

The change in free energy per growth unit to move from solvated to crystalline form is
therefore given by:
𝑑𝐺 = −Δ𝜇 + 𝑑(𝜎𝐴)

2.5 The Reaction Coordinate
In order to use these free energy equations, we must evaluate them at specific
“points” during the reaction. That is, we must plug in numbers for how much solvated
substance exists, how much crystalline substance exits, etc. We do this by considering the
reaction, or phase transition in this case, to begin with a certain composition (e.g., all
reactants) and proceed in a specific direction (e.g., toward product formation). Notice,
however, that there is no dependence on time in the equations. Instead, we follow the
reaction coordinate. The reaction coordinate, ξ, gives the progress along the reaction
pathway, and thus defines the amount and phase of all substances present. In a plot of the

23

reaction (e.g., from reactants to products) the reaction coordinates would be the points on
the line.
When studying nucleation processes, we consider the beginning state to be the
reaction coordinate wherein all of the substance exists in its solvated form. That is,
nucleation moves from solvated toward crystalline. We express the change in free energy
with respect to the change in reaction coordinate, dG/dξ, as:
𝑑𝑁𝑐𝑟𝑦𝑠𝑡
𝑑𝐺
𝑑𝐴
=−
∆𝜇 + 𝜎
𝑑𝜉
𝑑𝜉
𝑑𝜉

Note that the specific surface free energy is treated as a constant in CNT (8).

2.6 The Gibbs-Thomson Equation

The change in free energy during nucleation has been shown to be the sum of a
volume and a surface term. When the concentration of the solvated substance is greater
than its solubility (i.e., its equilibrium concentration), the supersaturation becomes greater
than zero, and the volume term is negative. As the size of the nucleus increases, the
volume term increases proportionately to the radius cubed, whereas the surface term
increase is proportional to the square of the radius. For small sizes, the positive surface
term tends to be larger than the negative volume term, because most of the growth units
are situated at the surface. As the size becomes large, however, the negative volume term
dominates. Accordingly, the growth of a nucleus requires an increase in free energy until
a critical radius, r*, is reached, after which increasing the nucleus size decreases free
energy. The critical radius is found by expressing the change in free energy as a function
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of radius, then finding the radius that makes the change in free energy equal zero (i.e., the
critical radius occurs at a maximum in free energy):
𝜕𝐺
𝜕𝐴
= −∆𝜇 + 𝜎
𝜕𝑛
𝜕𝑛
Let V equal the nucleus volume and Ω be the volume of a single growth unit
within the crystalline substance. Then the number of growth units in the crystal is given
by:
𝑛=

𝑉
Ω

In CNT, the nucleus is assumed to be spherical. The corresponding expressions for
volume, surface area, and their derivatives are:

𝑉=

4 3
𝜋𝑟
3

𝐴 = 4𝜋𝑟 2
𝑑𝑉
= 4𝜋𝑟 2
𝑑𝑟
𝑑𝐴
= 8𝜋𝑟
𝑑𝑟
Thus, the change in free energy as a function of nucleus radius is:
𝜕𝐺
𝑑𝑉 Δ𝜇
𝑑𝐴
=−
+𝜎
𝜕𝑟
𝑑𝑟 Ω
𝑑𝑟
𝜕𝐺
4𝜋𝑟 2
=−
Δ𝜇 + 8𝜋𝑟𝜎
𝜕𝑟
Ω
The critical radius is found by setting the change in free energy to zero:
0=−

4𝜋𝑟 2
Δ𝜇 + 8𝜋𝑟𝜎
Ω
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4𝜋𝑟 2
Δ𝜇 = 8𝜋𝑟𝜎
Ω
Solving for the radius yields the famous Gibbs-Thomson equation (8):
𝑟∗ =

2𝜎Ω
Δ𝜇

The power of this equation is that it clearly relates the critical nucleus size with the
specific surface free energy and the supersaturation in a simple, intuitive form that is easy
to remember. As with all of CNT, the Gibbs-Thomson equation remains a staple for
researchers in crystal growth not because of its accuracy – it can fail from a quantitative
standpoint – but because it informs experimental design and analysis with an ostensibly
reasonable approximation (19). The Gibbs-Thomson equation shows that nucleation can
be favored by either decreasing the specific surface free energy, σ, or increasing the
supersaturation of solvated growth units, Δμ.

2.7 Nucleation Work
While the Gibbs-Thomson equation is a hallmark of nucleation theory, it is
simply a consequence of a more fundamental concept: the nucleation work. The
nucleation work is the amount of free energy required to produce a nucleus with n
crystalline growth units from n solvated growth units (10). We can calculate this amount
of free energy by integrating our expression for the infinitesimal change in free energy
per growth unit. Let m be a dummy variable representing the number of growth units in
the nucleus:
𝑛

𝑊(𝑛) = ∫
0

𝑑𝐺
𝑑𝑚
𝑑𝑚

𝑛

𝑊(𝑛) = ∫ [−∆𝜇 + 𝜎
0

𝜕𝐴
] 𝑑𝑚
𝜕𝑚
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𝑊(𝑛) = [−𝑚∆𝜇 + 𝜎𝐴(𝑚)]|𝑛0
𝑊(𝑛) = −𝑛∆𝜇 + 𝜎𝐴(𝑛)
We can arrive at an explicit equation by assuming that the nucleus is spherical and
using the corresponding expression for the surface area and radius:
𝐴(𝑟) = 4𝜋𝑟 2
1

3𝑛Ω 3
𝑟=(
)
4𝜋
2
3𝑛Ω 3
𝐴(𝑛) = 4𝜋 (
)
4𝜋
Substituting this into the expression for W(n) gives:
1

2

𝑊(𝑛) = −𝑛∆𝜇 + (36𝜋Ω2 )3 𝜎𝑛3
This is the classical expression for nucleation work in CNT. As in the Gibbs-Thomson
equation, we can define a critical nucleus by setting the derivative of W(n) with respect to
n equal to zero:
1
1
𝜕𝑊(𝑛)
2
= −∆𝜇 + (36𝜋Ω2 )3 𝜎𝑛−3
𝜕𝑛
3

3∆𝜇

1

1

= 𝑛 −3

2(36𝜋Ω2 )3 𝜎
1

2(36𝜋Ω2 )3 𝜎
𝑛∗ = [
]
3∆𝜇
𝑛∗ =

3

32𝜋𝜎 3 Ω2
3∆𝜇 3

The work of formation for a nucleus with n* growth units is determined by simply
plugging n* into W(n):
2

1
2 32𝜋𝜎 3 Ω2 3
32𝜋𝜎 3 Ω2
3 𝜎Ω3 (
(36𝜋)
𝑊(𝑛∗ ) = − (
)
∆𝜇
+
)
3∆𝜇 3
3∆𝜇 3
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𝑊(𝑛∗ ) = −

𝑊(𝑛

32𝜋𝜎 3 Ω2 3 32𝜋𝜎 3 Ω2
+ (
)
3∆𝜇 2
2
3∆𝜇 2
∗)

1 32𝜋𝜎 3 Ω2
= (
)
2
3∆𝜇 2

∆𝜇
𝑊(𝑛∗ ) = ( ) 𝑛∗
2
The relationship between W(n), n*, W(n*), and Δμ is illustrated for the wellknown test case of barium sulfate (BaSO4) in Fig. 2.1. The study of BaSO4 is frequently
encountered in classic texts on CNT because its physical parameters (solubility, lattice
parameter, etc.) are well known and the crystallization of BaSO4 in oil pipelines has been
an important industrial concern (10, 20).
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Fig. 2.1 | Nucleation work diagram of BaSO4. The work required to form a nucleus,
W(n), is plotted versus the number of growth units, n, in the nucleus for various
supersaturations, Δμ. The critical nucleation work, W(n*), and critical nucleus, n*, are the
values of W(n) and n evaluated at the maximum of the W(n) curve.
2.8 The Nucleation Theorem
Although the principles of CNT are straightforward from a theoretical
perspective, complications arise when trying to apply them to experiment. The greatest
difficulty, historically, was the inability to determine whether or not nucleation was
occurring freely in solution, called homogeneous nucleation, or on an existing surface,
called heterogeneous nucleation (10). The reason why this was so problematic is that
different theoretical models are used to describe heterogeneous and homogeneous
nucleation, so it was not possible to experimentally validate or optimize CNT without
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knowing which model to apply(13). The nucleation theorem was developed to relate
W(n*), n*, and Δμ without the need to know which type of nucleation was occurring(2123).

The nucleation theorem holds that because the only dependence on
supersaturation in the nucleation work expression comes from the volume term, - nΔμ,
the partial derivative of W(n*) with respect to Δμ will identify the critical nucleus:
𝜕𝑊(𝑛∗ )
= −𝑛∗
𝜕∆𝜇
Experiments relating nucleation rates to supersaturation can be performed to determine
n* (10, 13, 24).

2.9 Ensembles of Nuclei
The concepts of nucleation work and critical nucleus size have been developed on
the scale of a single nucleus, however experiments typically require consideration of an
ensemble of nuclei. Classically, the concentration of nuclei comprising n growth units,
Cn, is approximated by the equilibrium concentration of nuclei under ideal conditions
(10). Although nucleation occurs under non-equilibrium conditions, more formal
mathematical treatments reveal that the assumption of an equilibrium distribution is a
good approximation. In particular, the steady-state concentration of critical nuclei is 1/2
the equilibrium concentration of critical nuclei (25). Because the parameters of CNT
cannot be experimentally resolved with sufficient precision for a factor of 1/2 to be
significant (14), most treatments do not include it.
The equilibrium concentration of nuclei is given by the formula (10):
𝐶𝑛 = 𝐶0 𝑒

(−

𝑊(𝑛)
)
𝜅𝑇
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The Arrhenius form of this expression comes from the Boltzmann statistics used to model
ideal mixtures of nuclei at equilibrium. The prefactor, C0, is easily mistaken to be the
concentration of growth units in solution, but that is incorrect to many orders of
magnitude (13). Instead, C0 is the concentration of nucleation sites, defined as the
locations where it is possible for nucleation to occur. In solution, homogeneous
nucleation is assumed to be possible everywhere, thus C0 is given by:
𝐶0 =

1
Ω

The concentration of critical nuclei, Cn*, on the ensemble scale is therefore given by:
𝐶

𝑛∗

1 (−𝑊(𝑛
𝜅𝑇
= 𝑒
Ω

∗)

)

2.10 Nucleation Rate

The development of a widely accepted rate equation took several decades, but
ultimately became the cornerstone of CNT (20, 26-29). The nucleation rate, J, is defined
as the rate at which stable nuclei (i.e., nuclei that will not redissolve) appear. Because
steady-state assumptions are used in CNT, the rate of nucleation equals the rate at which
the critical nucleus grows (i.e., the rate that clusters of size n* grow to size n*+1) (10).
This rate is given by the difference between a forward and backward growth rate:
𝐽 = 𝐽𝑛+∗ − 𝐽𝑛−∗+1
In practice, it is exceptionally difficult to accurately describe the backward
reaction in a simple analytic form (14). Instead, a scaling factor, Z, is added to the
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forward reaction rate that decreases it by an amount representative of the expected
backward reaction rate.
𝐽 = 𝑍𝐽𝑛+∗
The scaling parameter, called the Zeldovich factor, accounts for dissolution of nuclei with
sizes greater than n* that occurs due to random thermal fluctuations (i.e., kT energy is
sufficient to overcome the activation energy barrier to dissolution) (14, 29). The equation
for Z is:

𝑍 = √−

1 𝜕 2 𝑊(𝑛)
|
2𝜋𝜅𝑇 𝜕𝑛
𝑛=𝑛∗

For spherical nuclei, the Zeldovich factor is thus given by:
𝑍=

∆𝜇 2
3

8𝜋√𝜅𝑇Ω𝜎 2
𝑍=

∆𝜇 2
1

(64𝜋 2 𝜅𝑇Ω2 𝜎 3 )2

The Zeldovich factor typically ranges in value from 0.01 to 1 (13). In order to
arrive at an expression for the nucleation rate, we must derive an equation for the forward
growth rate of critical nuclei (i.e., 𝐽𝑛+∗ ). In CNT, the forward growth rate equals the rate of
monomer impingement, β*, per critical nucleus times the concentration of critical nuclei,
Cn :
𝐽 = 𝑍𝛽 ∗ 𝐶𝑛∗
𝑍𝛽 ∗ (−𝑊(𝑛
𝜅𝑇
𝐽=
𝑒
Ω

∗)

)

The rate of monomer impingement has two different forms, depending on whether
the growth reaction is diffusion-limited or reaction-limited (10). Both forms of β* are
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functions of the critical nucleus, n*, the volume per growth unit, Ω, the diffusion
coefficient of the solvated growth units, D, and the concentration of the solvated growth
units, Csolv. The diffusion-limited term is:
1

1

1

2

∗
𝛽𝐷𝐿
= (48𝜋 2 Ω)3 𝐷𝐶𝑠𝑜𝑙𝑣 𝑛∗ 3

The reaction-limited term is given by:
∗
𝛽𝑅𝐿
= (6𝜋 2 Ω)3 𝐷𝐶𝑠𝑜𝑙𝑣 𝑛∗ 3

Thus, the diffusion-limited (DL) and reaction-limited (RL) nucleation rates in CNT are
given by:
1

1

3 2

𝐽𝐷𝐿

𝑍(48𝜋 2 Ω)3 𝐷𝐶𝑠𝑜𝑙𝑣 𝑛∗ 3 −(16𝜋𝜎2 Ω )
=
𝑒 3∆𝜇 𝜅𝑇
Ω

𝐽𝑅𝐿

𝑍(6𝜋 2 Ω)3 𝐷𝐶𝑠𝑜𝑙𝑣 𝑛∗ 3 −(16𝜋𝜎2 Ω )
=
𝑒 3∆𝜇 𝜅𝑇
Ω

1

2

3 2

Note that we have included the explicit expression for the nucleation work derived in
section 2.7:
1 32𝜋𝜎 3 Ω2
𝑊(𝑛∗ ) = (
)
2
3∆𝜇 2
2.11 Testing the Classical Nucleation Theory
Now that we have an explicit expression for the nucleation rate, we can plug in
tabulated experimental data in order to test the accuracy of CNT for a common
application. As a test case, we will examine the rate of gold nanoparticle nucleation from
the ascorbic acid-mediated reduction of tetrachloroauric acid, which occurs rapidly at
room temperature (30, 31). Table 2.1 lists the values of various parameters calculated by
inputting literature values into the equations of the preceding sections. Although there is
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no available data for the diffusion coefficient of gold atoms in water, the value of 1 x 10-5
cm2/s is a common approximation for an atomic or molecular diffusion constant in water.

Parameter
Specific surface free
energy
Growth unit volume
Solubility

Symbol
σ

Diffusion coefficient
Zeldovich factor
Thermal energy

D
Z
κT

Solvated growth unit
concentration
Supersaturation
Critical nucleus
Critical radius
Critical nucleation
work
Nucleation rate (DL)

Csolv

Nucleation rate (RL)

JRL

Ω
Ceq

Δμ
n*
r*
W(n*)
JDL

Value (units)
1.51 (J/m2)

Reference
Galanakis et al
2002(32)
1.70 x 10-2 (nm3)
Davey et al 1925(33)
-16
3.59 x 10 (M)
Calculated from
approximation in
Kashchiev et al
2003(13)
-5
2
1.0 x 10 (cm /s)
Approximated here
0 ≤ Z ≤ 0.2488 (unitless) Calculated here
4.11 x 10-21 (J)
IUPAC Gold
Book(34)
-4
0 ≤ Csolv ≤ 1.50 x 10
Experimental
(M)
Approximation
0 ≤ Δμ ≤ 27.3 (κT)
Calculated here
≥ 23 (atoms)
Calculated here
≥ 0.453 (nm)
Calculated here
≥ 318.8 (κT)
Calculated here
0 ≤ J ≤ 7.68 x 10-132
(nuclei L-1 s-1)
0 ≤ J ≤ 1.09 x 10-131
(nuclei L-1 s-1)

Calculated here
Calculated here

Table 2.1. Classical nucleation theory (CNT) parameter values for the nucleation of gold.
The values that have been calculated here correspond to a standard tetrachloroauric acid
(AuCl4-) reduction by ascorbic acid.

The nucleation work diagram for gold is shown in Fig. 2.2. Calculation of the
critical work reveals that it exceeds 300 κT! Such a large activation energy barrier forbids
nucleation on an experimental time scale (13). Indeed, the calculated nucleation rates are
on the order of 10-131 nuclei per liter per second. In reality, the ascorbic acid reduction of
tetrachloroauric acid proceeds rapidly upon mixture of the reactants, so why does CNT
predict that nucleation is forbidden? The remainder of this chapter explores the critical
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oversight in CNT that must be corrected in order to explain how gold nanoparticle
nucleation is allowable.

Fig. 2.2 | Classical nucleation theory nucleation work plot for gold. The plot of W(n)
predicted from CNT is shown as the black curve. The critical nucleation work, W(n*),
greatly exceeds 80 κT, which means that gold nucleation is forbidden according to CNT.
The large value of W(n*) results from the high surface energy of gold.
2.12 The Oversight of Classical Nucleation Theory
In CNT, it is assumed that solvated growth units exist in solution and can form
nuclei simply by ordering into a cluster. In other words, the nucleation event involves
only a phase transition. Oftentimes, however, solvated growth units are not present at the
beginning of a nucleation reaction (35-37). Instead, a growth unit precursor (e.g.,
tetrachloroauric acid) exists in solution that must be converted into an active growth unit
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form (e.g., solvated gold atoms) that subsequently becomes incorporated into nuclei.
Moreover, some growth unit precursors react directly with nuclei to deposit growth units,
as when the disproportionation of gold halides occurs on the surface of a gold cluster. In
this case, the crystalline growth unit does not have an equivalent solvated form (e.g., the
solvated monomers are gold chloride, not gold atoms).
The chemical reaction responsible for generating growth units from precursors
liberates free energy that can be used to overcome the energy barrier to nucleation.
Accordingly, the nucleation work expression must be modified to include this
contribution. As a general rule, the total free energy change of a nucleation reaction can
be determined from the balanced chemical reaction, with the addition of a surface energy
term.

2.13 Generalized Expression for Nucleation Work
Consider a general nucleation reaction wherein a precipitate, X, nucleates from a
given set of reactants:
𝑎𝐴 + 𝑏𝐵 + ⋯ ⇌ 𝑥𝑋 + 𝑦𝑌 + ⋯
Recall from section 2.2 that the reaction quotient, Qr, equilibrium constant, Keq, and
infinitesimal change in free energy, dG, of this chemical reaction (in Joules per mole) are
given by the expressions:
𝑄𝑟 =

𝐾𝑒𝑞 =

{𝑋}𝑥 {𝑌}𝑦 …
{𝐴}𝑎 {𝐵}𝑏 …
𝑥 {𝑌} 𝑦
{𝑋}𝑒𝑞
𝑒𝑞 …

{𝐴}𝑎𝑒𝑞 {𝐵}𝑏𝑒𝑞 …

𝐾𝑒𝑞
𝑑𝐺𝑚𝑜𝑙𝑎𝑟 = −𝑅𝑇𝑙𝑛 ( ) + 𝑑(𝜎𝐴)
𝑄𝑟
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The average change in free energy of a single reaction is given by:
𝐾𝑒𝑞
𝑑𝐺 = −𝜅𝑇𝑙𝑛 ( ) + 𝑑(𝜎𝐴)
𝑄𝑟
In order to obtain the average free energy change per growth unit generated, we
must remember to also divide by the volume term by the stoichiometric coefficient, x, of
the precipitate:
𝑑𝐺𝑟𝑥𝑛 = −

𝐾𝑒𝑞
𝜅𝑇
𝑙𝑛 ( ) + 𝑑(𝜎𝐴)
𝑥
𝑄𝑟

This formula gives the average free energy liberated during the generation of a single
growth unit of the precipitated phase (e.g., in the crystalline phase). The generalized
nucleation work, W(n)GNT, is obtained by integrating the infinitesimal free energy change.
Following section 2.7, let m be the dummy variable for the number of growth
units in a nucleus:
𝑛

𝑊(𝑛)𝐺𝑁𝑇 = ∫

0

𝑛

𝑊(𝑛)𝐺𝑁𝑇 = ∫ [−
0

𝑊(𝑛)𝐺𝑁𝑇

𝑑𝐺𝑟𝑥𝑛
𝑑𝑚
𝑑𝑚

𝐾𝑒𝑞
𝜅𝑇
𝜕𝐴
𝑙𝑛 ( ) + 𝜎 ] 𝑑𝑚
𝑥
𝑄𝑟
𝜕𝑛

𝑛
𝐾𝑒𝑞
𝑚𝜅𝑇
= [−
𝑙𝑛 ( ) + 𝜎𝐴]|
𝑥
𝑄𝑟
0

𝑊(𝑛)𝐺𝑁𝑇 = −
𝑊(𝑛)𝐺𝑁𝑇 = −

𝐾𝑒𝑞
𝑛𝜅𝑇
𝑙𝑛 ( ) + 𝜎𝐴(𝑛)
𝑥
𝑄𝑟

1
2
𝐾𝑒𝑞
𝑛𝜅𝑇
𝑙𝑛 ( ) + (36𝜋Ω2 )3 𝜎𝑛3
𝑥
𝑄𝑟

From this formula, we can generalize all of the essential equations of CNT presented in
the previous sections.
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As in interesting test case, we can apply this expression for the change in free
energy to the classical phase transition modeled in CNT:
𝐶𝑠𝑜𝑙𝑣 ⇌ 𝐶𝑐𝑟𝑦𝑠𝑡
This reaction is characterized by the reaction quotient, Qr, of the form:
𝑄𝑟 =

𝑎(𝐶𝑐𝑟𝑦𝑠𝑡 )
𝑎(𝐶𝑠𝑜𝑙𝑣 )

Assuming ideal conditions, we therefore have:
𝑄𝑟 =

1
𝐶𝑠𝑜𝑙𝑣

𝐾𝑒𝑞 =

1
𝐶𝑒𝑞

Thus, application of the general expression for free energy change per growth unit
yields the classical result when applied to a phase transition:
𝐶𝑠𝑜𝑙𝑣
𝑑𝐺𝑝ℎ𝑎𝑠𝑒 = −𝜅𝑇𝑙𝑛 (
) + 𝑑(𝜎𝐴)
𝐶 𝑒𝑞
𝑑𝐺𝑝ℎ𝑎𝑠𝑒 = −∆𝜇 + 𝑑(𝜎𝐴)
The generalized framework presented here and in subsequent sections reduces to the
equations of CNT when the nucleation reaction is a pure phase transition.

2.14 The Generalized Critical Nucleus and Critical Work of Nucleation
Setting the derivative of our new nucleation work expression equal to zero and
solving for the nucleus size generalizes the critical nucleus, n*, expression of CNT:
1
1
𝐾𝑒𝑞
𝜕𝑊(𝑛)𝐺𝑁𝑇
𝜅𝑇
2
= − 𝑙𝑛 ( ) + (36𝜋Ω2 )3 𝜎𝑛−3
𝜕𝑛
𝑥
𝑄𝑟
3

0=−

1
1
𝐾𝑒𝑞
𝜅𝑇
2
𝑙𝑛 ( ) + (36𝜋Ω2 )3 𝜎𝑛−3
𝑥
𝑄𝑟
3
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3

1
(36𝜋Ω2 )3

2
𝜎
∗
𝑛𝐺𝑁𝑇
=[
]
𝐾𝑒𝑞
3 𝜅𝑇
𝑥 𝑙𝑛 ( 𝑄𝑟 )
∗
𝑛𝐺𝑁𝑇
=

32𝜋Ω2 𝜎 3
𝐾𝑒𝑞 3
𝜅𝑇
3 [ 𝑥 𝑙𝑛 ( 𝑄 )]
𝑟

Rewriting this expression in terms of a critical radius, we obtain the generalized GibbsThomson equation:
∗
𝑟𝐺𝑁𝑇
=

2𝜎Ω
𝐾𝑒𝑞
𝜅𝑇
𝑥 𝑙𝑛 ( 𝑄𝑟 )

In contrast to the critical nucleus expression from CNT, the generalized
expression for n* depends strongly upon the driving force of the chemical reaction.
Substituting the critical nucleus into the nucleation work expression yields the
generalized critical nucleation work:
𝑊(𝑛∗ )𝐺𝑁𝑇 = −

𝑊(𝑛∗ )𝐺𝑁𝑇 = −

∗
2
1
𝐾𝑒𝑞
𝑛𝐺𝑁𝑇
𝜅𝑇
∗
3
𝑙𝑛 ( ) + (36𝜋Ω2 )3 𝜎𝑛𝐺𝑁𝑇
𝑥
𝑄𝑟
1
(36𝜋Ω2 )3

3

1
(36𝜋Ω2 )3

2

1
𝐾𝑒𝑞 2
𝜅𝑇
𝜎
2
𝜎
𝑙𝑛 ( ) [
] + (36𝜋Ω2 )3 𝜎 [
]
𝐾𝑒𝑞
𝐾𝑒𝑞
𝑥
𝑄𝑟 3 𝜅𝑇
3 𝜅𝑇
𝑥 𝑙𝑛 ( 𝑄𝑟 )
𝑥 𝑙𝑛 ( 𝑄𝑟 )

𝑊(𝑛∗ )𝐺𝑁𝑇 = −

𝑊(𝑛

32𝜋Ω2 𝜎 3
𝐾𝑒𝑞
𝜅𝑇
3 [ 𝑥 𝑙𝑛 ( 𝑄 )]
𝑟
∗)

𝐺𝑁𝑇

=

2+

48𝜋Ω2 𝜎 3
𝐾𝑒𝑞 2
𝜅𝑇
3 [ 𝑥 𝑙𝑛 ( 𝑄 )]
𝑟

16𝜋Ω2 𝜎 3
𝐾𝑒𝑞 2
𝜅𝑇
3 [ 𝑥 𝑙𝑛 ( 𝑄 )]
𝑟

𝐾𝑒𝑞
1 𝜅𝑇
∗
𝑊(𝑛∗ )𝐺𝑁𝑇 = [ 𝑙𝑛 ( )] 𝑛𝐺𝑁𝑇
2 𝑥
𝑄𝑟

39

The generalized expression W(n*)GNT reveals that a nucleation reaction forbidden
by CNT can be achieved by careful choice of the reactants. Consider, for example, the
nucleation of gold nanoparticles that we showed is forbidden by CNT in section 2.11.
The reason why the nucleation reaction will not proceed, according to CNT, is that the
critical nucleation work is very high – over 300 κT. This high energetic barrier is an
artifact of the CNT assumption that nucleation can be modeled by a phase transition,
wherein the “reactants” are solvated gold atoms, and the work of nucleation is the change
in free energy between the initial state of solvated gold atoms and the final “product”
state of gold nuclei. According to our generalized expression, however, if we choose
reactants that produce gold via a very exothermic reaction, the nucleation work becomes
negligible. This concept is not restricted to a particular material or reaction, as can be
seen in the following theorem:
Theorem 2.1. The nucleation of any material can be made to proceed without a
nucleation work barrier (i.e., the critical nucleation work is less than or equal to zero) by
incorporation of sufficiently exothermic reaction steps.
Proof: The work of nucleation is a state function, such that the nucleation work done
between an initial state I and a final state F is independent of the path between I and F:
𝑊(𝐼 → 𝐹) = 𝑊(𝐹) − 𝑊(𝐼)
Consider a system with initial state M wherein the maximum value of n equals 1
(i.e., there exist no nuclei in solution). Let N* be the state of the system corresponding to
the maximum free energy, such that the free energy of the critical nucleation state is less
than or equal to N*. The work to move from state M to state N* is finite and given by:
𝑊(𝑀 → 𝑁 ∗ ) = 𝑊(𝑁 ∗ ) − 𝑊(𝑀)
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Because the change in free energy is finite, there always exists some value P that
satisfies:
𝑊(𝑁 ∗ ) − 𝑊(𝑀) < 𝑃
Now, suppose there exists a system at state I that can evolve to the state M via
sufficiently exothermic steps such that W(M) – W(I) < -P. Then the work to form the
maximum free energy state of the system from the initial state I is given by:
𝑊(𝐼 → 𝑁 ∗ ) = 𝑊(𝑁 ∗ ) − 𝑊(𝐼)
Accordingly, we know that:
𝑊(𝑁 ∗ ) < 𝑊(𝑀) + 𝑃
𝑊(𝐼) > 𝑃 + 𝑊(𝑀)
Thus, it follows that:
𝑊(𝐼 → 𝑁 ∗ ) < [𝑊(𝑀) + 𝑃] − [𝑃 + 𝑊(𝑀)]
𝑊(𝐼 → 𝑁 ∗ ) < 0
Because the free energy of the critical nucleation state is less than or equal to the
maximum free energy state, the critical nucleation work is less than zero.

2.15 The Generalized Nucleation Theorem
A generalization of the nucleation theorem is straightforward given that the
surface term of the nucleation work shows no dependence on the driving force of the
nucleation reaction:
𝑊(𝑛

∗)

𝐺𝑁𝑇

∗
2
1
𝐾𝑒𝑞
𝑛𝐺𝑁𝑇
𝜅𝑇
∗
3
=−
𝑙𝑛 ( ) + (36𝜋Ω2 )3 𝜎𝑛𝐺𝑁𝑇
𝑥
𝑄𝑟

𝑊(𝑛∗ )𝐺𝑁𝑇
∗
= −𝑛𝐺𝑁𝑇
𝐾𝑒𝑞
𝜅𝑇
𝜕 [ 𝑥 𝑙𝑛 ( 𝑄 )]
𝑟
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The generalized nucleation theorem assumes its familiar form from CNT when
the nucleation reaction is a simple phase transition because (κT/x)ln(Keq/Qr) = Δμ for
phase transitions.

2.16 Nucleation Rate
The nucleation rate in CNT is given by the product of the Zeldovich factor, Z, the
impingement rate, β, and the concentration of nuclei, Cn, all evaluated at the critical
nucleus size, n*:
𝐽 = 𝑍𝛽 ∗ 𝐶𝑛∗
In order to correct this formula for the influence of a chemical reaction driving
nucleation, we can analyze the three terms of the right hand side individually. We begin
with the Zeldovich factor:
𝑍 = √−

1 𝜕 2 𝑊(𝑛)
|
2𝜋𝜅𝑇 𝜕𝑛
𝑛=𝑛∗

Recall that the work of nucleation is given by:
𝑊(𝑛)𝐺𝑁𝑇

2
1
𝐾𝑒𝑞
𝑛𝐺𝑁𝑇 𝜅𝑇
2
3
3
=−
ln ( ) + (36𝜋Ω ) 𝜎𝑛𝐺𝑁𝑇
𝑥
𝑄𝑟

The first derivative of the nucleation work with respect to nucleus size is:
1
1
𝐾𝑒𝑞
∂𝑊(𝑛)𝐺𝑁𝑇
𝜅𝑇
2
−
2
3
3
= − ln ( ) + (36𝜋Ω ) 𝜎𝑛𝐺𝑁𝑇
𝜕𝑛
𝑥
𝑄𝑟
3

The second derivative with respect to nucleus size, evaluated at the critical nucleus, is
thus:
4
1
∂2 𝑊(𝑛)𝐺𝑁𝑇
2
−
∗
2 )3
3
(36𝜋Ω
|
=
−
𝜎𝑛
𝐺𝑁𝑇
𝜕𝑛2
9
𝑛=𝑛∗
Substituting this result into the Zeldovich factor expression yields:
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𝑍𝐺𝑁𝑇 = √−

4
1
1
2
−
∗
3]
[− (36𝜋Ω2 )3 𝜎𝑛𝐺𝑁𝑇
2𝜋𝜅𝑇 9

1

𝑍𝐺𝑁𝑇

1 √ 1 (36𝜋Ω2 )3 𝜎
= 2
9𝜋𝜅𝑇
1
𝑛∗ 3

𝑍𝐺𝑁𝑇 =

𝐾𝑒𝑞 2
𝜅𝑇
[ 𝑥 ln ( 𝑄 )]
𝑟

1

[64𝜋 2 𝜅𝑇Ω2 𝜎 3 ]2

The Zeldovich factor is thus corrected by performing the substitution:
∆𝜇 ↦

𝐾𝑒𝑞
𝜅𝑇
ln ( )
𝑥
𝑄𝑟

Correction of the impingement rate is straightforward. Because the mechanism of
nucleus growth is still considered to be monomer growth unit addition to a critical
cluster, the diffusion-limited and reaction-limited impingement rates are given by the
same equations as in CNT, but with the proper expression for the critical nucleus of a
chemically driven reaction:
1

1

1

2

∗
∗
3
𝛽𝐷𝐿,𝐺𝑁𝑇
= (48𝜋 2 Ω)3 𝐷𝐶𝑠𝑜𝑙𝑣 𝑛𝐺𝑁𝑇
∗
∗
3
𝛽𝐷𝐿,𝐺𝑁𝑇
= (6𝜋 2 Ω)3 𝐷𝐶𝑠𝑜𝑙𝑣 𝑛𝐺𝑁𝑇

∗
𝑛𝐺𝑁𝑇
={

1
2(36𝜋Ω2 )3 𝜎

𝐾𝑒𝑞
𝜅𝑇
3 [ 𝑥 ln ( 𝑄 )]
𝑟

∗
𝛽𝐷𝐿,𝐺𝑁𝑇
=

3

}

8𝜋𝐷𝐶𝑠𝑜𝑙𝑣 Ω𝜎
𝐾𝑒𝑞
𝜅𝑇
ln
(
𝑥
𝑄𝑟 )
1

∗
𝛽𝑅𝐿,𝐺𝑁𝑇
=

8(36𝜋 4 Ω5 )3 𝐷𝐶𝑠𝑜𝑙𝑣 𝜎 2
𝐾𝑒𝑞 2
𝜅𝑇
3 [ 𝑥 ln ( 𝑄 )]
𝑟
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Because Boltzmann statistics are still used to determine the ensemble distribution
of nucleus sizes, we arrive at the same equilibrium expression for Cn as in CNT. The
concentration of critical nuclei is, therefore, approximated by:

𝐶𝑛∗ =

1
𝑒
Ω

−

1
16𝜋𝜎3 Ω2
3 𝜅𝑇
𝐾𝑒𝑞 2
)] }
[
ln(
{ 𝑥
𝑄𝑟

The nucleation rate expressions for diffusion-limited and reaction-limited growth
are thus given by:
∗
𝐽𝐷𝐿,𝐺𝑁𝑇 = 𝑍𝐺𝑁𝑇 𝛽𝐷𝐿,𝐺𝑁𝑇
𝐶𝑛∗
∗
𝐽𝑅𝐿,𝐺𝑁𝑇 = 𝑍𝐺𝑁𝑇 𝛽𝑅𝐿,𝐺𝑁𝑇
𝐶𝑛∗

𝐽𝐷𝐿,𝐺𝑁𝑇 =

𝐾𝑒𝑞
𝜅𝑇
8𝜋 [ 𝑥 ln ( 𝑄 )] 𝐷𝐶𝑠𝑜𝑙𝑣 𝜎
𝑟

𝑒

1
[64𝜋 2 𝜅𝑇Ω2 𝜎 3 ]2

4

𝐽𝑅𝐿,𝐺𝑁𝑇 =

−

8(36𝜋 Ω

1
2 )3

𝐷𝐶𝑠𝑜𝑙𝑣 𝜎
1

3[64𝜋 2 𝜅𝑇Ω2 𝜎 3 ]2

−

2

𝑒

1
16𝜋𝜎3 Ω2
3 𝜅𝑇
𝐾𝑒𝑞 2
{[ 𝑥 ln( 𝑄𝑟 )] }

1
16𝜋𝜎3 Ω2
3 𝜅𝑇
𝐾𝑒𝑞 2
)] }
[
ln(
{ 𝑥
𝑄𝑟

We emphasize that a fundamental assumption of the rate equation in CNT, and
consequently our generalization of this equation, is that a critical nucleation work barrier
greater than zero exists. This assumption will fail when the free energy of nuclei (i.e., the
products) is less than the free energy of the reactants for all nuclei sizes. In this case, the
critical nucleus size is theoretically equal to 1, and the Zeldovich factor becomes
irrelevant (i.e., Z is only defined when W(n) is concave down at n*) (14) and the
following forms of JDL,GNT and JRL,GNT should be used:
𝑐𝑜𝑛𝑐𝑎𝑣𝑒 𝑢𝑝
∗
𝐽𝐷𝐿,𝐺𝑁𝑇
= 𝛽𝐷𝐿,𝐺𝑁𝑇
𝐶𝑠𝑜𝑙𝑣
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𝑐𝑜𝑛𝑐𝑎𝑣𝑒 𝑢𝑝

𝐽𝑅𝐿,𝐺𝑁𝑇

∗
= 𝛽𝑅𝐿,𝐺𝑁𝑇
𝐶𝑠𝑜𝑙𝑣
1

𝑐𝑜𝑛𝑐𝑎𝑣𝑒 𝑢𝑝
2
𝐽𝐷𝐿,𝐺𝑁𝑇
= (48𝜋 2 Ω)3 𝐷𝐶𝑠𝑜𝑙𝑣
1

𝑐𝑜𝑛𝑐𝑎𝑣𝑒 𝑢𝑝
2
𝐽𝑅𝐿,𝐺𝑁𝑇
= (6𝜋 2 Ω)3 𝐷𝐶𝑠𝑜𝑙𝑣

2.17 Testing the General Nucleation Theory
The predictions of our generalized nucleation theory can be compared to those of
CNT by evaluating the same test case of tetrachloroauric acid reduction by ascorbic acid.
In order to determine the nucleation rate, we must first obtain explicit expressions for the
reaction quotient and equilibrium constant. Then we can calculate the thermodynamic
driving force as a function of the reaction coordinate and identify the critical nucleus and
nucleation work. The nucleation rate can be predicted once these expressions are known.

2.18 Reaction Quotient of Ascorbic Acid Reduction of Tetrachloroauric Acid
We begin the test case evaluation by determining the reaction quotient, Qr,
expression. The balanced chemical reaction is:
3𝐶6 𝐻 8 𝑂6 + 2𝐴𝑢𝐶𝑙4− ⇌ 3𝐶6 𝐻 6 𝑂6 + 6𝐻 + + 2𝐴𝑢0 + 8𝐶𝑙 −
Hence, the reaction quotient is given by the expression:
𝑄𝑟 =

[𝐶6 𝐻6 𝑂6 ]3𝜉 [𝐻 + ]6𝜉 [𝐶𝑙 − ]8𝜉
[𝐶6 𝐻 8 𝑂6 ]3𝜉 [𝐴𝑢𝐶𝑙4− ]2𝜉

When the reaction quotient is evaluated at equilibrium, we obtain the equilibrium
constant, Keq:

𝐾𝑒𝑞

[𝐶6 𝐻 6 𝑂6 ]3𝑒𝑞 [𝐻 + ]6𝑒𝑞 [𝐶𝑙 − ]8𝑒𝑞
=
[𝐶6 𝐻8 𝑂6 ]3𝑒𝑞 [𝐴𝑢𝐶𝑙4− ]2𝑒𝑞
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Ultimately, we want to evaluate the reaction quotient as a function of the fewest
number of variables possible. This is important because it is often not possible or
practical to measure all of the species involved in a reaction. Accordingly, we define the
following identities:
∆𝜉 [𝐶6 𝐻 8 𝑂6 ] = [𝐶6 𝐻8 𝑂6 ]0 − [𝐶6 𝐻 8 𝑂6 ]𝜉
∆𝜉 [𝐴𝑢𝐶𝑙4− ] = [𝐴𝑢𝐶𝑙4− ]0 − [𝐴𝑢𝐶𝑙4− ]𝜉
[𝐴𝑢𝐶𝑙4− ]0 =

2
[𝐶 𝐻 𝑂 ]
3 6 8 60

If we assume that the intermediate disproportionation step is rapid with respect to
reduction of AuCl4-, the following identities hold true:
∆𝜉 [𝐴𝑢𝐶𝑙4− ] =

2
∆ [𝐶 𝐻 𝑂 ]
3 𝜉 6 8 6

[𝐶6 𝐻 8 𝑂6 ]𝜉 = [𝐶6 𝐻 8 𝑂6 ]0 − ∆𝜉 [𝐶6 𝐻8 𝑂6 ]
[𝐴𝑢𝐶𝑙4− ]𝜉 =

2
{[𝐶 𝐻 𝑂 ] − ∆𝜉 [𝐶6 𝐻 8 𝑂6 ]}
3 6 8 60

[𝐶6 𝐻 6 𝑂6 ]𝜉 = ∆𝜉 [𝐶6 𝐻8 𝑂6 ]
[𝐻 + ]𝜉 = 2∆𝜉 [𝐶6 𝐻 8 𝑂6 ]
8
[𝐶𝑙 − ]𝜉 = ∆𝜉 [𝐶6 𝐻8 𝑂6 ]
3
We can therefore write the reaction quotient as a function of the initial
concentration of ascorbic acid and the change in the ascorbic acid concentration:

𝑄𝑟 =

17
8 8
(2)6 ( ) (∆𝜉 [𝐶6 𝐻 8 𝑂6 ])
3

5
4
(9) {[𝐶6 𝐻8 𝑂6 ]0 − ∆𝜉 [𝐶6 𝐻 8 𝑂6 ]}
𝜉
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2.19 Calculation of the Equilibrium Constant
In order to calculate the equilibrium constant from electrochemical data we must
turn to the Nernst equation (38):
𝐸 = 𝐸0 −

𝑅𝑇
𝑙𝑛(𝑄𝑟 )
𝑛𝐹

The Nernst equation relates reduction potential, E, to the standard reduction potential, E0,
the number of electrons transferred, n, Faraday’s constant, F, and the reaction quotient,
Qr. At equilibrium, the Nernst equation can be rearranged to give:
𝑛𝐹𝐸 0 = 𝑅𝑇𝑙𝑛(𝐾𝑒𝑞 )
The equilibrium constant can therefore be expressed in terms of the standard reduction
potential as:
𝐾𝑒𝑞 = 𝑒

𝑛𝐹𝐸 0
𝑅𝑇

Thus, we can determine the equilibrium constant from knowledge of electrochemical
reactions.
The standard reduction potentials of the half-cell reactions relevant to our test
case are:
3{𝐶6 𝐻 8 𝑂6 → 𝐶6 𝐻6 𝑂6 + 2𝐻 + + 2𝑒 − }

E0 = -0.166

3{𝐴𝑢𝐶𝑙4− + 2𝑒 − → 𝐴𝑢𝐶𝑙2− + 2𝐶𝑙 − }

E0 = +0.926

2{𝐴𝑢𝐶𝑙2− + 𝑒 − → 𝐴𝑢0 + 2𝐶𝑙 − }

E0 = +1.154

1{𝐴𝑢𝐶𝑙2− + 2𝐶𝑙 − → 𝐴𝑢𝐶𝑙4− + 2𝑒 − }

E0 = -0.926

The expressions for the reaction quotient and equilibrium constant are:

𝑄𝑟 =

[𝐶6 𝐻6 𝑂6 ]3𝜉 [𝐻 + ]6𝜉 [𝐶𝑙 − ]8𝜉
[𝐶6 𝐻 8 𝑂6 ]3𝜉 [𝐴𝑢𝐶𝑙4− ]2𝜉
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𝐾𝑒𝑞

[𝐶6 𝐻 6 𝑂6 ]3𝑒𝑞 [𝐻 + ]6𝑒𝑞 [𝐶𝑙 − ]8𝑒𝑞
=
[𝐶6 𝐻8 𝑂6 ]3𝑒𝑞 [𝐴𝑢𝐶𝑙4− ]2𝑒𝑞

The principle of detailed balance states that at equilibrium, all intermediate
chemical reactions must also be in equilibrium. We can therefore study the overall
equilibrium constant in terms of the equilibrium constants of AuCl4- reduction and AuCl2disproportionation. For the initial reduction reaction, we have:
3{𝐶6 𝐻 8 𝑂6 → 𝐶6 𝐻6 𝑂6 + 2𝐻 + + 2𝑒 − }

E0 = - 0.252

3{𝐴𝑢𝐶𝑙4− + 2𝑒 − → 𝐴𝑢𝐶𝑙2− + 2𝐶𝑙 − }

E0 = +0.926

3𝐶6 𝐻 8 𝑂6 + 3𝐴𝑢𝐶𝑙4− → 3𝐶6 𝐻 6 𝑂6 + 6𝐻3 𝑂+ + 3𝐴𝑢𝐶𝑙2− + 6𝐶𝑙 −

E0 = +0.674

𝐾𝑒𝑞,𝑟𝑒𝑑 =

[𝐶6 𝐻6 𝑂6 ]3𝑒𝑞 [𝐻 + ]6𝑒𝑞 [𝐴𝑢𝐶𝑙2− ]3𝑒𝑞 [𝐶𝑙 − ]6𝑒𝑞
[𝐶6 𝐻8 𝑂6 ]3𝑒𝑞 [𝐴𝑢𝐶𝑙4− ]3𝑒𝑞
𝐾𝑒𝑞,𝑟𝑒𝑑 = 𝑒

6∗96485∗0.674
2477.7

𝐾𝑒𝑞,𝑟𝑒𝑑 = 2.467 × 1068

The half-cell reactions relevant to the disproportionation reaction are:
2{𝐴𝑢𝐶𝑙2− + 𝑒 − → 𝐴𝑢0 + 2𝐶𝑙 − }

E0 = +1.154

1{𝐴𝑢𝐶𝑙2− + 2𝐶𝑙 − → 𝐴𝑢𝐶𝑙4− + 2𝑒 − }

E0 = - 0.926

3𝐴𝑢𝐶𝑙2− → 𝐴𝑢𝐶𝑙4− + 2𝐴𝑢0 + 2𝐶𝑙 −

E0 = +0.228

𝐾𝑒𝑞,𝑑𝑖𝑠𝑝 =

[𝐴𝑢𝐶𝑙4− ]𝑒𝑞 [𝐶𝑙 − ]2𝑒𝑞
[𝐴𝑢𝐶𝑙2− ]3𝑒𝑞

𝐾𝑒𝑞,𝑑𝑖𝑠𝑝 = 𝑒

2∗96485∗0.228
2477.7

𝐾𝑒𝑞,𝑑𝑖𝑠𝑝 = 5.151 × 107

48

Combining the two equilibrium constants yields the overall expression for the
equilibrium constant of the reaction:
𝐾𝑒𝑞 = 𝐾𝑒𝑞,𝑟𝑒𝑑 𝐾𝑒𝑞,𝑑𝑖𝑠𝑝
𝐾𝑒𝑞 =

[𝐶6 𝐻6 𝑂6 ]3𝑒𝑞 [𝐻 + ]6𝑒𝑞 [𝐴𝑢𝐶𝑙2− ]3𝑒𝑞 [𝐶𝑙 − ]6𝑒𝑞 [𝐴𝑢𝐶𝑙4− ]𝑒𝑞 [𝐶𝑙 − ]2𝑒𝑞
×
[𝐶6 𝐻8 𝑂6 ]3𝑒𝑞 [𝐴𝑢𝐶𝑙4− ]3𝑒𝑞
[𝐴𝑢𝐶𝑙2− ]3𝑒𝑞
𝐾𝑒𝑞 =

[𝐶6 𝐻 6 𝑂6 ]3𝑒𝑞 [𝐻 + ]6𝑒𝑞 [𝐶𝑙 − ]8𝑒𝑞
[𝐶6 𝐻8 𝑂6 ]3𝑒𝑞 [𝐴𝑢𝐶𝑙4− ]2𝑒𝑞

𝐾𝑒𝑞 = (2.467 × 1068 ) × (5.151 × 107 )
𝐾𝑒𝑞 = 1.271 × 1076
2.20 Calculation of the Change in Free Energy
In order to arrive at the free energy change per growth unit generated, we begin
with the general expression for the molar change in free energy, dGmolar. The contribution
of surface energy will be separately added at the end of the derivation.
𝐾𝑒𝑞
𝑑𝐺𝑚𝑜𝑙𝑎𝑟 = −𝑅𝑇𝑙𝑛 ( )
𝑄𝑟
𝑑𝐺𝑚𝑜𝑙𝑎𝑟 = −𝑅𝑇𝑙𝑛 {

(6.765 × 1084 )[𝐶6 𝐻8 𝑂6 ]3𝜉 [𝐴𝑢𝐶𝑙4− ]2𝜉
[𝐶6 𝐻 6 𝑂6 ]3𝜉 [𝐻 + ]6𝜉 [𝐶𝑙 − ]8𝜉

}

Assuming that disproportionation is rapid, we can express the change in free energy as a
function of the ascorbic acid concentration (section 2.18):

𝑑𝐺𝑚𝑜𝑙𝑎𝑟 = −𝑅𝑇𝑙𝑛 {

5
9
8 8
(1.271 × 1076 ) ( ) (26 ) ( ) {[𝐶6 𝐻 8 𝑂6 ]0 − ∆𝜉 [𝐶6 𝐻8 𝑂6 ]}
4
3
𝜉
17

(∆𝜉 [𝐶6 𝐻8 𝑂6 ])

}
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𝑑𝐺𝑚𝑜𝑙𝑎𝑟 = −𝑅𝑇𝑙𝑛 {

(4.680 × 1081 ){[𝐶6 𝐻8 𝑂6 ]0 − ∆𝜉 [𝐶6 𝐻8 𝑂6 ]}

5
𝜉

17

(∆𝜉 [𝐶6 𝐻8 𝑂6 ])

𝑑𝐺𝑚𝑜𝑙𝑎𝑟 = −𝑅𝑇𝑙𝑛[(4.680 × 1081 )] − 𝑅𝑇𝑙𝑛 {

𝑑𝐺𝑚𝑜𝑙𝑎𝑟 = −188.1𝑅𝑇 − 𝑅𝑇𝑙𝑛 {

}

{[𝐶6 𝐻8 𝑂6 ]0 − ∆𝜉 [𝐶6 𝐻 8 𝑂6 ]}
17

(∆𝜉 [𝐶6 𝐻8 𝑂6 ])

{[𝐶6 𝐻8 𝑂6 ]0 − ∆𝜉 [𝐶6 𝐻 8 𝑂6 ]}
17

(∆𝜉 [𝐶6 𝐻8 𝑂6 ])

5
𝜉

}

5
𝜉

}

2.21 Scaling the Reaction Coordinate
The expression for the change in free energy derived in the preceding section is a
function of the reaction coordinate. In order to determine the amount of free energy
liberated per growth unit, we must first know which reaction coordinates to evaluate.
We begin by considering a volume of the solution that is sufficiently small such that, on
average, only one nucleus forms within it throughout the entire course of the reaction. We
call this volume the nucleation cell and can calculate it from knowledge of the
concentration of nuclei at the end of the reaction. Typical nucleation reactions for gold
nanoparticles yield approximately 60 nanomoles of nuclei per liter of solution (i.e., 60
nM), as determined from ultraviolet-visible (UV-Vis) spectroscopy (37, 39). Therefore
the volume of the nucleation cell is:

𝑉𝑐𝑒𝑙𝑙

1𝐿
109 𝑛𝑎𝑛𝑜𝑚𝑜𝑙𝑒𝑠 𝑛𝑢𝑐𝑙𝑒𝑖
𝑚𝑜𝑙𝑒 𝑛𝑢𝑐𝑙𝑒𝑖
=
×
×
60 𝑛𝑎𝑛𝑜𝑚𝑜𝑙𝑒𝑠 𝑛𝑢𝑐𝑙𝑒𝑖
𝑚𝑜𝑙𝑒𝑠 𝑛𝑢𝑐𝑙𝑒𝑖
6.022 × 1023 𝑛𝑢𝑐𝑙𝑒𝑖
𝑉 𝑐𝑒𝑙𝑙 = 2.768 × 10−17 𝐿

We can approximate the number of ascorbic acid molecules within the nucleation
cell by multiplying its volume by the concentration of ascorbic acid. Typical
concentrations of ascorbic acid and tetrachloroauric acid in a nucleation reaction are
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approximately 2.25 x 10-4 M and 1.50 x 10-4 M, respectively (30). The initial number of
ascorbic acid molecules in the nucleation cell is therefore:

𝑁𝐶6 𝐻8 𝑂6

2.25 × 10−4 𝑚𝑜𝑙𝑒𝑠
6.022 × 1023 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠
2.768 × 10−17 𝐿
=(
)×(
)×(
)
𝐿
𝑚𝑜𝑙𝑒
𝑛𝑢𝑐𝑙𝑒𝑎𝑡𝑖𝑜𝑛 𝑐𝑒𝑙𝑙
𝑁𝐶6 𝐻8 𝑂6 = 4,168

𝑁

𝐴𝑢𝐶𝑙4−

𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠
𝑛𝑢𝑐𝑙𝑒𝑎𝑡𝑖𝑜𝑛 𝑐𝑒𝑙𝑙

1.50 × 10−4 𝑚𝑜𝑙𝑒𝑠
6.022 × 1023 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠
2.768 × 10−17 𝐿
=(
)×(
)×(
)
𝐿
𝑚𝑜𝑙𝑒
𝑛𝑢𝑐𝑙𝑒𝑎𝑡𝑖𝑜𝑛 𝑐𝑒𝑙𝑙
𝑁𝐴𝑢𝐶𝑙4− = 2,500

𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠
𝑛𝑢𝑐𝑙𝑒𝑎𝑡𝑖𝑜𝑛 𝑐𝑒𝑙𝑙

Because one gold atom is produced for each molecule of tetrachloroauric acid
reduced, we know that the average nucleation event will generate a particle comprising
2,500 gold atoms. The reaction coordinate can therefore be expressed as proceeding from
0% to 100% complete in increments of 100/2,500 = 0.04%.
Scaling the free energy change per mole to the average free energy change per
growth unit generated, dGgrowth unit = -(nκT/x)ln(Keq/Qr), yields:

−

𝐾𝑒𝑞
𝑛𝜅𝑇
ln ( )
𝑥
𝑄𝑟

𝐽𝑜𝑢𝑙𝑒𝑠
𝜅𝑇
)×(
)
𝑚𝑜𝑙𝑒 𝑔𝑟𝑜𝑤𝑡ℎ 𝑢𝑛𝑖𝑡 𝑔𝑒𝑛𝑒𝑟𝑎𝑡𝑒𝑑
4.114 × 10−21 𝐽𝑜𝑢𝑙𝑒𝑠
𝑚𝑜𝑙𝑒 𝑔𝑟𝑜𝑤𝑡ℎ 𝑢𝑛𝑖𝑡 𝑔𝑒𝑛𝑒𝑟𝑎𝑡𝑒𝑑
×(
)
6.022 × 1023 𝑔𝑟𝑜𝑤𝑡ℎ 𝑢𝑛𝑖𝑡𝑠 𝑔𝑒𝑛𝑒𝑟𝑎𝑡𝑒𝑑
= 𝑑𝐺𝑚𝑜𝑙𝑎𝑟 (

−

𝐾𝑒𝑞
𝑛𝜅𝑇
1
𝐽𝑜𝑢𝑙𝑒𝑠
ln ( ) = (
) × ∆𝐺 (
)
𝑥
𝑄𝑟
2477.7
𝑚𝑜𝑙𝑒 𝑔𝑟𝑜𝑤𝑡ℎ 𝑢𝑛𝑖𝑡 𝑔𝑒𝑛𝑒𝑟𝑎𝑡𝑒𝑑
5

{[𝐶6 𝐻 8 𝑂6 ]0 − ∆𝜉 [𝐶6 𝐻8 𝑂6 ]}
𝐾𝑒𝑞
𝑛𝜅𝑇
188.1
1
𝜉
−
ln ( ) = −𝑅𝑇 (
+
𝑙𝑛 {
})
17
𝑥
𝑄𝑟
2477.7 2477.7
(∆ [𝐶 𝐻 𝑂 ])
𝜉

6

8 6
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We calculate the nucleation work corresponding to this reaction by substituting
our formula for –(nκT/x)ln(Keq/Qr) into the expression for W(n)GNT. A plot of the
nucleation work as a function of the nucleus size, n, is given in Fig. 2.3, and the critical
values and predicted nucleation rates are listed in Table 2.2. The reduction reaction
responsible for generating the gold atoms is shown to be sufficiently exothermic to
compensate for the gold nuclei’s large free energy of formation. In contrast to the
equations of CNT, our generalized nucleation theory correctly predicts that gold
nucleation should occur rapidly at room temperature.

Parameter
Specific surface free
energy
Growth unit volume
Solubility

Symbol
σ

Value (units)
1.51 (J/m2)

Ω
Ceq

1.70 x 10-2 (nm3)
3.59 x 10-16 (M)

Diffusion coefficient
Zeldovich factor
Thermal energy

D
Z
κT

1.0 x 10-5 (cm2/s)
0 ≤ Z ≤ 1 (unitless)
4.11 x 10-21 (J)

Solvated growth unit
concentration
Supersaturation
Critical nucleus
Critical radius
Critical nucleation
work
Nucleation rate (DL)

Csolv

0 ≤ Csolv ≤ 1.50 x 10-4
(M)
0 ≤ Δμ ≤ 27.3 (κT)
2 (atoms)
≥ 0.201 (nm)
-258.8 (κT)

Δμ
n*
r*
W(n*)

Reference
Galanakis et al 2002
(32)
Davey et al 1925 (33)
Calculated from
approximation in
Kashchiev et al 2003
(13)
Approximated here
Calculated here
IUPAC Gold Book
(34)
Experimental
Approximation
Calculated here
Calculated here
Calculated here
Calculated here

0 ≤ J ≤ 3.72 x 107
Calculated here†
-1 -1
(nuclei L s )
Nucleation rate (RL) JRL
0 ≤ J ≤ 2.34 x 107
Calculated here†
-1 -1
(nuclei L s )
Table 2.2. Generalized nucleation theory (GNT) parameter values for the nucleation of
gold. The values that have been calculated here correspond to a standard tetrachloroauric
acid (AuCl4-) reduction by ascorbic acid.
†
These rates are reported for the concave up nucleation rate equations because the critical
nucleation work is negative.
JDL
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Fig. 2.3 | Generalized nucleation theory nucleation work plot for gold. The plot of
W(n) predicted from GNT is shown as the black curve. The critical nucleation work,
W(n*), is negative, which means that gold nucleation proceeds without a nucleation work
barrier.
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CHAPTER 3
Crystal Growth
3.1 Introduction
Precise control of nanoparticle shape is critical to their performance in catalytic
(1, 2), sensing (3, 4), and biomedical applications (5, 6). Although synthetic protocols
have been developed for a wide variety of morphologies, the mechanisms and design
rules of shape-controlled growth remain poorly understood (7). The prevailing
assumption is that surfactants, polymers, or other small adsorbates are responsible for the
ultimate nanoparticle shape by preferentially blocking certain facets such that their
growth is inhibited (Appendix 1) (7-9). In this chapter, we report the development of a
shape controlled synthesis of gold nanoparticles free of shape-directing agents, and thus
not explained by the most widely accepted growth mechanism. Of particular interest is
the formation of gold nanorods, which is the prototypical shape thought to require the
presence of surfactants (9-11). In order to better understand our observations, we
developed a mathematical framework that unifies the fundamental principles of classical
and modern crystal growth theories (12-16). We demonstrate the practical application of
this quantitative framework by investigating the growth mechanism of surfactant-free
nanoparticles. The origin of anisotropic growth is predicted to be re-entrant grooves
catalyzing nucleation of monolayers on the fast-growing facets. Although grooved
structures are known to exist on gold nanoplates, we report for the first time that reentrant grooves are consistently observed at the ends of gold nanorods, thus corroborating
our proposed mechanism. The unified crystal growth theory is neither restricted to a

57

particular growth unit or size range, and will open new avenues in the study and design of
crystal growth.
3.2 Overview of Theoretical Framework
Here we present a theoretical framework describing crystal growth originating
from seed crystals exhibiting well-defined facets. Growth is assumed to begin with
nucleation of a two-dimensional (2D) island and proceed by step flow (i.e. lateral growth)
of the nucleus into a partial monolayer. The step flow is fueled by the incorporation of
monomer growth units that adsorb onto the step and diffuse to binding sites. The
completion of a net monolayer occurs when the 2D nucleus spreads a distance λ = hf – hi.
If the surface is terraced, then multiple partial monolayers spread simultaneously and λ
will be less than the length of the facet. The distance λ will also decrease as the number
of 2D nuclei on a terrace increases. The goal of this theoretical framework is to develop
an expression for facet growth rates (i.e. asymptotic growth rates) as a function of the
expected time for 2D monolayer nucleation, the flux of growth units to the step front, and
the jumping rates of adsorbed growth units. This rate expression can be used to determine
the regimes of nucleation-limited, diffusion-limited, and reaction-limited growth.

3.3 Mathematical Approach
We determine the expected time for net monolayer completion – the time required
for a facet to increase its average height by one monolayer – by summing the expected
time for nucleation and the expected time for partial monolayer spread of a distance λ.
The expected time for nucleation is treated as a known input, thus the primary calculation
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in this framework is the expected time for a step to become completely filled (henceforth
called step completion).
The expected time for step completion is a function of the number of growth units
in the step, the flux of growth units to the step front, and the activation energies for
jumping into and along the step. In the following sections, we outline our theoretical
framework by developing expressions for the expected times of growth unit arrival, onedimensional (1D) step nucleation, and growth unit incorporation into binding sites. The
latter process is divided into three separate mechanisms. The mechanism with the lowest
expected time for step completion is defined to be the operating mechanism for the
corresponding input parameters.

3.4 Expected Time of Growth Unit Arrival
Let the arrival of growth units at each site be modeled as a renewal process. Once
growth units arrive at the step front, they diffuse into the step by a single jump. If the
growth units are adsorbed on the surface, the rate at which they jump into the step is
characterized by the vibrational frequency of the growth unit and activation energy of the
jump. Growth units diffusing directly from solution into the step will have a different
prefactor and activation energy than those corresponding to jumping into the step from a
surface site. If the expected time for growth unit arrivals via diffusion, E(Tdiff), is small
compared to the expected time for jumps into the step, then the frequency of arrivals at
each site can be well approximated by the asymptotic rate of the renewal process, Rdiff:

𝑅𝑑𝑖𝑓𝑓 =

1
𝐸(𝑇𝑑𝑖𝑓𝑓 )
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Assuming that the expected time for growth unit arrival is constant along the step
front, the arrival rate of growth units summed over x sites is xRdiff, and the expected
arrival time is:
𝐸(𝑇𝑑𝑖𝑓𝑓 ) =
𝑥

1
𝑥𝑅𝑑𝑖𝑓𝑓

When the arrival time is slow on the scale of incorporation into the step, it can be
modeled as a rare event, which is well approximated by an exponential distribution. Such
distributions have the characteristic relationship:
𝑅𝑑𝑖𝑓𝑓 =

1
𝐸(𝑇𝑑𝑖𝑓𝑓 )

Which of course yields the same result for the expected arrival time over x sites:
𝐸(𝑇𝑑𝑖𝑓𝑓 ) =
𝑥

1
𝑥𝑅𝑑𝑖𝑓𝑓

Let F denote the flux of growth units per nm per second to the step front, and let
the length of a step unit, a||, be defined by the length, L, of the step and number, N, of
growth units in the step:
𝑢𝑛𝑖𝑡𝑠
𝐹 ≡ 𝑓𝑙𝑢𝑥 𝑖𝑛 (
)
𝑛𝑚 ∙ 𝑠
𝑎∥ =

𝐿
𝑁

The flux of growth units per step site per second is
𝐹𝑎∥ = 𝑓𝑙𝑢𝑥 𝑖𝑛 (

𝑢𝑛𝑖𝑡𝑠
)
𝑠𝑖𝑡𝑒 ∙ 𝑠

Thus we have the following relation that holds for arrival times that are either small or
large with respect to the expected time for jumping into the step:
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𝐸(𝑇𝑑𝑖𝑓𝑓 ) =

1
𝐹𝑎∥

𝐸(𝑇𝑑𝑖𝑓𝑓 ) =

1
𝑥𝐹𝑎∥

𝑥

In this theoretical framework, we assume for simplicity that the expected time for
growth unit arrival is well approximated by the reciprocal of the rate of growth unit
arrival throughout the entire range of input flux values considered.
We are particularly interested in seeded (nano)crystal syntheses that proceed via
reduction of a metal precursor by a weak reducing agent. Such syntheses are autocatalytic
wherein the seed surface plays an essential role in catalyzing the reduction of metal atom
precursors. In the present treatment, therefore, we will consider the rate of direct growth
unit diffusion from solution into binding sites as negligible, since they must first interact
with the surface before converting to the atomic form that is ultimately incorporated into
the crystal. Application of this theory to systems wherein the direct diffusion from
solution into binding sites is not negligible require modification of the equation for
E(Tdiff)x to incorporate solution-to-binding site flux.

3.5 Expected Time of 1D Nucleation
The binding of a growth unit into an empty step is herein considered to constitute
the process of one-dimensional (1D) nucleation. The term nucleation in this context
refers to the beginning of 1D growth (i.e. along the step), rather than the attainment of a
thermodynamic critical nucleus. Because a growth unit adsorbed to a step can detach
before bonding to additional growth units in the step, it is important to consider whether
or not the detachment rate should be used to modify the expected time for 1D nucleation.
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When the incorporation rate of a second growth unit is fast (e.g. more than an order of
magnitude larger) with respect to the detachment of the first growth unit, the detachment
rate can be neglected to a good approximation.
Let E(Tdiff)x denote the expected time for a growth unit to arrive at any one of x
sites one jump away from a step site. The expected time for 1D nucleation will be a
function of both E(Tdiff)x and the expected time for a growth unit to jump into a step site.
Because a single surface jump is characterized by a large number of attempts (vibrational
motion) and a low probability of success during each attempt, we can treat jumps into
step sites as Poisson processes. As such, they are exponentially distributed, and the
expected time of the process equals the reciprocal of the jump rate.
The Arrhenius rate, RArrh, of a surface diffusion process is given by:
𝐸𝑖𝑗

𝑅𝐴𝑟𝑟ℎ = 𝜈𝑖𝑗 𝑒 − 𝜅𝑇

Where 𝜈𝑖𝑗 is the component of vibrational frequency of the growth unit along the ijdirection, Eij is the activation energy for jumping from i to j, κ is Boltzmann’s constant,
and T is the absolute temperature. If the jump is defined to occur in a particular direction,
then an additional factor, pij, must be included to account for the probability of jumping
in the direction of interest:
𝐸𝑖𝑗

𝑅𝑖𝑗 = 𝑝𝑖𝑗 𝜈𝑖𝑗 𝑒 − 𝜅𝑇

For surface jumps, pij is well approximated as the reciprocal of the number of
lattice sites that an adatom can reach in a single jump (e.g. pij = 1/3 for {111} and 1/4 for
{100}, etc.}. The expected time for a single jump is therefore:
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𝐸(𝑇1 )𝑖𝑗 =

1
𝑅𝑖𝑗

𝐸(𝑇1 )𝑖𝑗 = (𝑝𝑖𝑗 𝜈𝑖𝑗 𝑒

−

𝐸𝑖𝑗 −1
𝜅𝑇 )

Let the subscripts L, U, K, and S denote the lower terrace, upper terrace, kink, and
non-kink step sites, respectively. The expected time, E(T1), for jumps from the lower and
upper terraces to the kink and non-kink step sites are given by:
𝐸(𝑇1 )𝐿𝐾 =

1
𝑅𝐿𝐾

𝐸(𝑇1 )𝑈𝐾 =

1
𝑅𝑈𝐾

𝐸(𝑇1 )𝐿𝑆 =

1
𝑅𝐿𝑆

𝐸(𝑇1 )𝑈𝑆 =

1
𝑅𝑈𝑆

Let Pj denote the probability that a growth unit arriving at the step front lands in
site j, and let 𝐸(𝑇𝑠𝑡𝑒𝑝 |𝑗) denote the expected time for a growth unit to jump from site j
into the adjacent step site, provided the growth unit arrives at site j. The expected time for
1D nucleation is given by:
𝑥

𝐸(𝑇1D ) = 𝐸(𝑇𝑑𝑖𝑓𝑓 ) + ∑ 𝑃𝑗 𝐸(𝑇𝑠𝑡𝑒𝑝 | 𝑗)
𝑥

𝑗=1

When the probability of arriving at each site j is equal and growth units arrive from both
the upper and lower terraces, this becomes:
1 1
1
𝐸(𝑇1D ) = 𝐸(𝑇𝑑𝑖𝑓𝑓 ) + (
+
)
𝑥
2 𝑅𝐿𝑆 𝑅𝑈𝑆
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Figure 3.1 | Growth Unit Incorporation at the Step Front. a, 1D nucleation at the edge
of a triangular partial monolayer. The filled and unfilled circles represent occupied and
unoccupied sites, respectively. b, Expanded view of the incomplete step in a. The sites
labeled “k” are kink binding sites and those labeled “s” are non-kink step sites. The
variables “m” and “n” are highlighted, which respectively denote the total number of sites
in a step and the number of sites in the largest unfilled fragment. c, Mechanism 1 – Step
adsorption and diffusion to kink. Growth units jump into the step (blue arrows) at random
locations and diffuse along the step (red arrows) until they bind at the kink site. The nonkink step sites are modeled as a continuous time Markov chain to determine the expected
time of step diffusion to the kink binding site. d, Mechanism 2 – Direct step
incorporation. In contrast to Mechanism 1, this Mechanism 2 does not involve step
diffusion. Mechanism 2 operates when the rate of step diffusion is slower than the rate of
additional growth unit arrivals into the step sites. e, Mechanism 3 – Direct kink
incorporation. Similar to Mechanism 2, Mechanism 3 does not involve step diffusion. In
contrast to mechanisms 1 and 2, growth by Mechanism 3 occurs exclusively by jumps
from the terrace to kink binding sites. This mechanism operates when the rate of step
diffusion is slower than the rate of additional growth unit arrivals and the activation
energy for jumping into kink sites is significantly lower than for jumping into non-kink
step sites.
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3.6 Expected Time of Incorporation – Step Adsorption and Diffusion
Let m denote the total number of step sites at the edge of a partial monolayer, as
illustrated in Figure 3.1a,b:
𝑚 ≡ 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑠𝑡𝑒𝑝 𝑠𝑖𝑡𝑒𝑠
The number of sites one jump from the step is a function of the facet index and step
structure. Herein, we assume without loss of generality that there are 2m sites one jump
away from step sites, corresponding to m sites on both the lower and upper terraces:
2𝑚 = 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑠𝑖𝑡𝑒𝑠 𝑜𝑛𝑒 𝑗𝑢𝑚𝑝 𝑎𝑤𝑎𝑦
Upon 1D nucleation, the step is fragmented into segments of length less than m on
either side of the incorporated growth unit (i.e. the 1D nucleus). Because step completion
proceeds independently on either side of the 1D nucleus, the expected time for step
completion equals the expected time for completion of the largest fragment. We denote
the number of sites in the largest fragment by n (Fig 3.1b). Given a step comprising m
available sites for 1D nucleation, if a growth unit adsorbs at site 𝑗 ∈ (1, 2, … , 𝑚), n is
defined as:
𝑛 = 𝑚𝑎𝑥𝑖𝑚𝑢𝑚(𝑚 − 𝑗, 𝑗 − 1)
The step fragment comprises one kink binding site – the site adjacent to the 1D
nucleus – and n-1 non-kink step sites. When the expected time for step diffusion to the
kink binding site is less than the expected time for an additional growth unit to jump into
the step we can model the step diffusion process by a continuous time Markov chain
(CTMC). In particular, we construct an n-1 × n-1 infinitesimal generator matrix,
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typically called a Q-matrix. The Q-matrix, taken here to be positive dominant, has the
form:

Q=
R1

- R1,2

0

0

0

0

0

0

- R2,1

R2

- R2,3

0

0

0

0

0

0

- R3,2

R3

- R3,4

0

0

0

0

0

0

- R4,3

R4

- R4,5

0

0

0

0

0

0

- R5,4

R5

- R5,6

0

0

0

0

0

0

- R6,5

R6

- R6,7

0

0

0

0

0

0

- R7,6

R7

- R7,8

0

0

0

0

0

0

- R8,7

R8

Where Rij is the rate of jumping from i to j, and Ri is the total rate of jumping out of site i.
Here we have arbitrarily chosen n-1 = 8 for illustrative purposes.
The expected time, E(Tbind), for a growth unit in a step to reach the binding site
from each initial step site is obtained by inverting the Q-matrix, and summing the entries
in each row:
1
𝒐𝒏𝒆𝒔(𝑛 − 1,1) = ( ⋮ )
1
𝑴 = 𝑸−1 𝒐𝒏𝒆𝒔(𝑛 − 1,1)
Entry M(j) gives the expected time of step diffusion to the binding site for a growth unit
beginning in the step site j jumps from the kink binding site. The complete list of
expected times to arrive at the binding site from any step site are given by the column
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vector 𝑬(𝑇𝑏𝑖𝑛𝑑 ), where the first entry corresponds to a growth unit that is already in the
binding site, the second entry corresponds to the position one jump away, and so on:

0
𝑀(1)
𝑬(𝑇𝑏𝑖𝑛𝑑 ) = [
]
⋮
𝑀(𝑛 − 1)
The column vector of expected times for jumping from the terrace into each step site is
given by:
1

+

1

𝑅𝐿0 𝑆0 𝑅𝑈0 𝑆0
1
1
1
+
𝑬(𝑇𝑠𝑡𝑒𝑝 ) = ( )
𝑅𝐿1 𝑆1 𝑅𝑈1 𝑆1
2𝑛
⋮
1
1
+
[𝑅𝐿𝑛−1 𝑆𝑛−1 𝑅𝑈𝑛−1 𝑆𝑛−1 ]
Where the coefficient 1/2n is the probability that an atom impinging upon the step front
arrives at the specific site Lj or Uj (e.g. if there are 2n = 18 sites one jump away from the
step, each has probability = 1/18 that an impinging adatom arrives at that specific site).
Here we have assumed that each site has equal likelihood of adatom arrival. For
convenience, we construct a column vector with n entries, rather than 2n, where each
entry equals the sum of the contribution from the corresponding upper terrace and lower
terrace sites. If the probability of growth unit arrival is different for lower terrace versus
upper terrace sites then each site must be given its own entry and corresponding
probability of arrival in the E(Tstep) column vector.
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We determine the expected time of the growth unit incorporation reaction,
𝐸(𝑇𝑟𝑥𝑛 ), by summing all entries in the two column vectors, 𝑬(𝑇𝑠𝑡𝑒𝑝 ) and 𝑬(𝑇𝑏𝑖𝑛𝑑 ).
1

+

1

𝑅𝐿0 𝑆0 𝑅𝑈0 𝑆0
0
1
1
1
𝑀(1)
+
𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑 ) = ( )
+[
]
𝑅𝐿1 𝑆1 𝑅𝑈1 𝑆1
⋮
2𝑛
⋮
𝑀(𝑛 − 1)
1
1
+
[𝑅𝐿𝑛−1 𝑆𝑛−1 𝑅𝑈𝑛−1 𝑆𝑛−1 ]

𝒐𝒏𝒆𝒔(1, 𝑛) = [1,1, … ,1]

𝐸(𝑇𝑟𝑥𝑛 ) = 𝒐𝒏𝒆𝒔(1, 𝑛)𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑 )

1
1
1
( ) {0 +
+
}
𝑛
2𝑅𝐿0 𝑆0 2𝑅𝑈0 𝑆0
1
1
1
(
)
{𝑀(1)
+
+
}
)
[1,1,
𝐸(𝑇𝑟𝑥𝑛 =
… ,1]
𝑛
2𝑅𝐿1 𝑆1 2𝑅𝑈1 𝑆1
⋮
1
1
1
( ) {𝑀(𝑛 − 1) +
+
}
2𝑅𝐿𝑛−1 𝑆𝑛−1 2𝑅𝑈𝑛−1 𝑆𝑛−1 ]
[ 𝑛
Given a flux of F atoms per nm per second to the step front, the expected time for
adatom arrival is:
𝐸(𝑇𝑑𝑖𝑓𝑓 )

2𝑛

=

1
2𝑛𝑎∥ 𝐹

The expected time for growth unit incorporation, E(Tinc), which corrects for the
detachment of atoms during growth, is given by:
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(𝑅𝐾𝐿 )−1 [𝐸(𝑇𝑑𝑖𝑓𝑓 )

+ 𝐸(𝑇𝑟𝑥𝑛 )]
2𝑛
𝐸(𝑇𝑖𝑛𝑐 ) = {
}
(𝑅𝐾𝐿 )−1 − [𝐸(𝑇𝑑𝑖𝑓𝑓 ) + 𝐸(𝑇𝑟𝑥𝑛 )]
2𝑛
The derivation of the correction factor is provided at the end of the theoretical
framework. The expected time for step fragment completion, E(Tfragment), is obtained
repeating the calculation of E(Tinc) after each new atom is added into the step until all
sites have been filled :
𝑛

𝐸(𝑇𝑓𝑟𝑎𝑔𝑚𝑒𝑛𝑡 ) = ∑ 𝐸(𝑇𝑑𝑖𝑓𝑓 )
𝑘=1

1
+ 𝒐𝒏𝒆𝒔(1, 𝑘) [ 𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑 )𝑘 ]
2𝑘
𝑘

Because the 1D nucleation event can occur at any one of the m available sites, we
must randomize the initial growth unit adsorption in order to arrive at the expected time
for step completion. The resulting equation gives the expected time for completion of an
entire row (i.e. entire step), E(Trow), according to the mechanism depicted in Figure 3.1c:

𝐸(𝑇𝑟𝑜𝑤 )𝑚𝑒𝑐ℎ.1 = (𝐸(𝑇𝑑𝑖𝑓𝑓 )
𝑚

2𝑚

+

1
1
+
)
2𝑅𝐿𝑆 2𝑅𝑈𝑆

𝑛

1
1
+ ∑ {∑ 𝐸(𝑇𝑑𝑖𝑓𝑓 ) + 𝒐𝒏𝒆𝒔(1, 𝑘) [ 𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑 )𝑘 ]}
2𝑘
𝑚
𝑘
𝑗=1 𝑘=1

𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑 )𝑘=1 =

𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑 )𝑘=2

1 1
1
(
+
)
2 𝑅𝐿𝐾 𝑅𝑈𝐾

1 1
1
(
+
)
4 𝑅𝐿𝐾 𝑅𝑈𝐾
=
1 1
1
2
(
+
+
)
[4 𝑅𝐿𝑆 𝑅𝑈𝑆 𝑅𝑆𝐾 ]
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𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑 )𝑘≥3

1 1
1
(
+
)
2 𝑅𝐿𝐾 𝑅𝑈𝐾
1 1
1
1
𝑀(1)
+
(
+
)
=( )
2
𝑅
𝑅
𝐿𝑆
𝑈𝑆
𝑘
⋮
1 1
1
𝑀(𝑘 − 1) + (
+
)
[
2 𝑅𝐿𝑆 𝑅𝑈𝑆 ]

Recall that n = maximum(m-j, j-1)

3.7 Expected Time of Incorporation – Direct Step Binding
When the arrival of growth units into the step becomes sufficiently fast, the
mechanism of incorporation no longer includes diffusion along the step (Fig 3.1d). The
threshold where the incorporation mechanism changes from step adsorption and diffusion
to direct step binding (i.e. incorporation without diffusion within the step) can be
approximated by comparing the expected time for growth units to jump into the step and
the expected time for growth units to diffuse to the kink. In particular, the mechanism
changes when the expected time for a growth unit to diffuse to a kink is greater than the
expected time for a second growth unit to jump into the step.
The expected time to complete a row of step atoms, E(Trow), via direct step
binding is determined by summing the expected times for consecutive arrival and step
adsorption events. For a step with m available binding sites prior to 1D nucleation we
have:
𝑚−1

𝐸(𝑇𝑟𝑜𝑤 )𝑚𝑒𝑐ℎ.2 = ∑ 𝐸(𝑇𝑑𝑖𝑓𝑓 )
𝑘=0

2(𝑚−𝑘)

1 1
1
+ (
+
)
2 𝑅𝐿𝑆 𝑅𝑈𝑆 𝑘
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Where the subscript k on the last term indicates that the expected time for jumping into
the step can change as the number of adsorbed growth units in the step changes. When
the activation energy for incorporation into the step does not depend strongly on the
number of adsorbed growth units then the following approximation can be used:
𝑚−1

𝐸(𝑇𝑟𝑜𝑤 )𝑚𝑒𝑐ℎ.2 = ∑ 𝐸(𝑇𝑑𝑖𝑓𝑓 )
𝑘=0

𝑚
1
1
+ ( )(
+
)
2(𝑚−𝑘)
2 𝑅𝐿𝑆 𝑅𝑈𝑆

Note that because the step does not complete symmetrically outward from the 1D
nucleation site it is not sufficient to consider only the completion of the largest step
fragment of n sites. Notice also that the detachment rate has been neglected because step
completion occurs very rapidly with respect to growth unit detachment.

3.8 Expected Time of Incorporation – Direct Kink Binding
As the expected time for growth unit arrival at the step front approaches zero,
incorporation into the step becomes reaction limited. When the activation energy for
direct incorporation into a kink site is significantly lower than that for direct
incorporation into a non-kink step site, the minimum expected time for step completion
will occur via direct kink binding. That is, after 1D nucleation, growth units will
exclusively incorporate into the step by jumping from the terraces into the kink binding
sites. Because this mechanism creates symmetric kink propagation from the initial 1D
nucleation site, the expected time for step completion equals the expected time for the
largest step fragment of n sites. Thus, the expected time equals the expected time for 1D
nucleation randomized over the m possible nucleation sites plus the expected time for n
consecutive kink binding events:
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𝐸(𝑇𝑟𝑜𝑤 )𝑚𝑒𝑐ℎ.3 = (𝐸(𝑇𝑑𝑖𝑓𝑓 ) +
𝑚

1
1
+
)
2𝑅𝐿𝑆 2𝑅𝑈𝑆

𝑚

1
1 1
1
+ ∑ {𝑛 [𝐸(𝑇𝑑𝑖𝑓𝑓 ) + (
+
)]}
2
𝑚
2 𝑅𝐿𝐾 𝑅𝑈𝐾
𝑗=1

𝑛 = 𝑚𝑎𝑥𝑖𝑚𝑢𝑚(𝑚 − 𝑗, 𝑗 − 1)

3.9 Expected Time of Step Completion
The expected time to complete a row of step atoms is a function of the
incorporation mechanism and flux of growth units to the step front, as described above.
Here we present the six step completion equations: the three growth mechanism from
above, each with an expression for a system wherein growth units arrive from the lower
and upper terraces and a system wherein growth units arrive exclusively from the lower
terrace. If the expected time for step diffusion to kink binding sites is less than the
expected time for a second growth unit to jump into the step, then mechanism 1 (i.e. step
adsorption and diffusion) is used. Otherwise, the expected time for step completion via
mechanisms 2 and 3 are both computed and the minimum expected time is selected. This
processes is repeated from the initial step – corresponding to the edge of the 2D critical
nucleus – to the final step, defined as the step that completes a net monolayer.
The six expressions considered are:
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Mechanism 1, Upper and Lower Terrace
𝐸(𝑇𝑟𝑜𝑤 )𝑚𝑒𝑐ℎ.1 = (𝐸(𝑇𝑑𝑖𝑓𝑓 )
𝑚

2𝑚

+

1
1
+
)
2𝑅𝐿𝑆 2𝑅𝑈𝑆

𝑛

1
1
+ ∑ {∑ 𝐸(𝑇𝑑𝑖𝑓𝑓 ) + 𝒐𝒏𝒆𝒔(1, 𝑘) [ 𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑 )𝑘 ]}
2𝑘
𝑚
𝑘
𝑗=1 𝑘=1

𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑 )𝑘=1 =

𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑 )𝑘=2

𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑 )𝑘≥3

1 1
1
(
+
)
2 𝑅𝐿𝐾 𝑅𝑈𝐾

1 1
1
(
+
)
4 𝑅𝐿𝐾 𝑅𝑈𝐾
=
1 1
1
2
(
+
+
)
[4 𝑅𝐿𝑆 𝑅𝑈𝑆 𝑅𝑆𝐾 ]

1 1
1
(
+
)
2 𝑅𝐿𝐾 𝑅𝑈𝐾
1 1
1
1
𝑀(1)
+
(
+
)
=( )
2
𝑅
𝑅
𝐿𝑆
𝑈𝑆
𝑘
⋮
1 1
1
𝑀(𝑘 − 1) + (
+
)
[
2 𝑅𝐿𝑆 𝑅𝑈𝑆 ]

Mechanism 1, Lower Terrace Only

𝐸(𝑇𝑟𝑜𝑤 )𝑚𝑒𝑐ℎ.1𝐿
= (𝐸(𝑇𝑑𝑖𝑓𝑓 ) +
𝑚

𝑚

1
)
𝑅𝐿𝑆

𝑛

1
+ ∑ {∑ 𝐸(𝑇𝑑𝑖𝑓𝑓 ) + 𝒐𝒏𝒆𝒔(1, 𝑘) [𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑 )𝑘 ]}
𝑘
𝑚
𝑗=1 𝑘=1

𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑 )𝑘=1 =

1
𝑅𝐿𝐾
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𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑 )𝑘=2

1
2𝑅𝐿𝐾
=
1 1
1
(
+
)
[2 𝑅𝐿𝑆 𝑅𝑆𝐾 ]
1
𝑅𝐿𝐾

1
𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑 )𝑘≥3 = ( )
𝑘

𝑀(1) +
⋮
[

1
𝑅𝐿𝑆

𝑀(𝑘 − 1) +

1
𝑅𝐿𝑆 ]

Mechanism 2, Upper and Lower Terrace

𝑚−1

𝐸(𝑇𝑟𝑜𝑤 )𝑚𝑒𝑐ℎ.2 = ∑ 𝐸(𝑇𝑑𝑖𝑓𝑓 )
𝑘=0

2(𝑚−𝑘)

𝑚
1
1
+ ( )(
+
)
2 𝑅𝐿𝑆 𝑅𝑈𝑆

Mechanism 2, Lower Terrace Only

𝑚−1

𝐸(𝑇𝑟𝑜𝑤 )𝑚𝑒𝑐ℎ.2𝐿 = ∑ 𝐸(𝑇𝑑𝑖𝑓𝑓 )(𝑚−𝑘) +
𝑘=0

𝑚
𝑅𝐿𝑆

Mechanism 3, Upper and Lower Terrace

𝐸(𝑇𝑟𝑜𝑤 )𝑚𝑒𝑐ℎ.3 = (𝐸(𝑇𝑑𝑖𝑓𝑓 ) +
𝑚

1
1
+
)
2𝑅𝐿𝑆 2𝑅𝑈𝑆

𝑚

1
1 1
1
+ ∑ {𝑛 [𝐸(𝑇𝑑𝑖𝑓𝑓 ) + (
+
)]}
2
𝑚
2 𝑅𝐿𝐾 𝑅𝑈𝐾
𝑗=1

𝑛 = 𝑚𝑎𝑥𝑖𝑚𝑢𝑚(𝑚 − 𝑗, 𝑗 − 1)
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Mechanism 3, Lower Terrace Only

𝑚

𝐸(𝑇𝑟𝑜𝑤 )𝑚𝑒𝑐ℎ.3𝐿

1
1
1
= (𝐸(𝑇𝑑𝑖𝑓𝑓 ) +
) + ∑ {𝑛 [𝐸(𝑇𝑑𝑖𝑓𝑓 ) +
]}
𝑚
1
𝑅𝐿𝑆
𝑚
𝑅𝐿𝐾
𝑗=1

𝑛 = 𝑚𝑎𝑥𝑖𝑚𝑢𝑚(𝑚 − 𝑗, 𝑗 − 1)

3.10 Formula for Step Size as a Function of Partial Monolayer Radius

In order to employ the expected time for step completion to determine the
expected time for layer completion, we must derive an expression for the number of step
sites as a function of the partial monolayer size. If we consider step flow via the
completion of consecutive single steps, then the geometry of the partial monolayer and
the symmetry of its growth (e.g. a triangle growing from three edges, a triangle growing
from one edge, etc.) will be the primary factors in developing an expression for the
number of step sites, m(h), as a function of the length, h, of the partial monolayer.
Because we are especially interested in growth originating from the corners of triangular
{111} facets (i.e. symmetry of growth on {111} nanorod facets), we will use the
expression for a triangular partial monolayer growing from one edge:

𝑚(ℎ + 1) = 𝑚(ℎ) + 1
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When alternative geometries and growth symmetries are used, the appropriate
expression is likely to change. The form of the recursion formula will only change by the
value of the constant for many relevant cases.

3.11 Expected Time of Net Monolayer Completion
Once the expected time for step completion and the formula for the number of
step sites as a function of partial monolayer size are known, the expected time of net
monolayer completion is straightforward to compute. Using the example of a triangular
partial monolayer spreading from one edge, we can see that the mth step requires m
growth units for completion. We can therefore determine the expected time for
monolayer completion by summing the expected time for step completion over the total
number of steps required to complete a net monolayer:

Mechanism 1, Upper and Lower Terrace
𝐸(𝑇𝑚𝑜𝑛𝑜𝑙𝑎𝑦𝑒𝑟 )𝑚𝑒𝑐ℎ.1
ℎ𝑓

= ∑ [𝐸(𝑇𝑑𝑖𝑓𝑓 )
𝑚=ℎ𝑖
𝑚

1 1
1
+ (
+
)
2𝑚
2 𝑅𝐿𝑆 𝑅𝑈𝑆

𝑛

1
+ ∑ {∑ 𝐸(𝑇𝑑𝑖𝑓𝑓 ) + 𝒐𝒏𝒆𝒔(1, 𝑘) [𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑 )𝑘 ]}]
2𝑘
𝑚
𝑗=1 𝑘=1

𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑 )𝑘=1 =

1 1
1
(
+
)
2 𝑅𝐿𝐾 𝑅𝑈𝐾
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𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑 )𝑘=2

𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑 )𝑘≥3

1 1
1
(
+
)
4 𝑅𝐿𝐾 𝑅𝑈𝐾
=
1 1
1
2
(
+
+
)
[4 𝑅𝐿𝑆 𝑅𝑈𝑆 𝑅𝑆𝐾 ]

1 1
1
(
+
)
2 𝑅𝐿𝐾 𝑅𝑈𝐾
1 1
1
1
= ( ) 𝑀(1) + 2 (𝑅𝐿𝑆 + 𝑅𝑈𝑆 )
𝑘
⋮
1 1
1
𝑀(𝑘 − 1) + (
+
)
[
2 𝑅𝐿𝑆 𝑅𝑈𝑆 ]

Mechanism 1, Lower Terrace Only
𝐸(𝑇𝑚𝑜𝑛𝑜𝑙𝑎𝑦𝑒𝑟 )𝑚𝑒𝑐ℎ.1𝐿
ℎ𝑓

= ∑ [(𝐸(𝑇𝑑𝑖𝑓𝑓 ) +
𝑚

𝑚=ℎ𝑖
𝑚

1
)
𝑅𝐿𝑆

𝑛

1
+ ∑ {∑ 𝐸(𝑇𝑑𝑖𝑓𝑓 ) + 𝒐𝒏𝒆𝒔(1, 𝑘) [𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑 )𝑘 ]}]
𝑘
𝑚
𝑗=1 𝑘=1

𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑 )𝑘=1 =

𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑 )𝑘=2

1
𝑅𝐿𝐾

1
2𝑅𝐿𝐾
=
1 1
1
(
+
)
[2 𝑅𝐿𝑆 𝑅𝑆𝐾 ]
1
𝑅𝐿𝐾

𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑 )𝑘≥3

1
=( )
𝑘

𝑀(1) +
⋮
[

1
𝑅𝐿𝑆

𝑀(𝑘 − 1) +

1
𝑅𝐿𝑆 ]
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Mechanism 2, Upper and Lower Terrace

ℎ𝑓

𝑚−1

𝐸(𝑇𝑚𝑜𝑛𝑜𝑙𝑎𝑦𝑒𝑟 )𝑚𝑒𝑐ℎ.2 = ∑ [ ∑ 𝐸(𝑇𝑑𝑖𝑓𝑓 )
𝑚=ℎ𝑖 𝑘=0

𝑚
1
1
+ ( )(
+
)]
2(𝑚−𝑘)
2 𝑅𝐿𝑆 𝑅𝑈𝑆

Mechanism 2, Lower Terrace Only

ℎ𝑓

𝑚−1

𝐸(𝑇𝑚𝑜𝑛𝑜𝑙𝑎𝑦𝑒𝑟 )𝑚𝑒𝑐ℎ.2𝐿 = ∑ [ ∑ 𝐸(𝑇𝑑𝑖𝑓𝑓 )(𝑚−𝑘) +
𝑚=ℎ𝑖 𝑘=0

𝑚
]
𝑅𝐿𝑆

Mechanism 3, Upper and Lower Terrace

𝐸(𝑇𝑚𝑜𝑛𝑜𝑙𝑎𝑦𝑒𝑟 )𝑚𝑒𝑐ℎ.3
ℎ𝑓

= ∑ [(𝐸(𝑇𝑑𝑖𝑓𝑓 )
𝑚=ℎ𝑖

2𝑚

+

1
1
+
)
2𝑅𝐿𝑆 2𝑅𝑈𝑆

𝑚

1
1 1
1
+ ∑ {𝑛 [𝐸(𝑇𝑑𝑖𝑓𝑓 ) + (
+
)]}]
2
𝑚
2 𝑅𝐿𝐾 𝑅𝑈𝐾
𝑗=1

𝑛 = 𝑚𝑎𝑥𝑖𝑚𝑢𝑚(𝑚 − 𝑗, 𝑗 − 1)
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Mechanism 3, Lower Terrace Only

𝐸(𝑇𝑚𝑜𝑛𝑜𝑙𝑎𝑦𝑒𝑟 )𝑚𝑒𝑐ℎ.3𝐿

ℎ𝑓

𝑚

𝑚=ℎ𝑖

𝑗=1

1
1
1
= ∑ [(𝐸(𝑇𝑑𝑖𝑓𝑓 ) +
) + ∑ {𝑛 [𝐸(𝑇𝑑𝑖𝑓𝑓 ) +
]}]
𝑚
1
𝑅𝐿𝑆
𝑚
𝑅𝐿𝐾

𝑛 = 𝑚𝑎𝑥𝑖𝑚𝑢𝑚(𝑚 − 𝑗, 𝑗 − 1)

3.12 Asymptotic Growth Rate Normal to Surface
Although the expected time for net monolayer completion has a clear meaning
and strong mathematical foundation, it is much more common to experimentally measure
and report crystal growth “rates”. Although the rate of a process has an intuitive
colloquial meaning, it is important to articulate exactly which rate is referenced when
attempting to provide a meaningful mathematical expression. Because there is no reason
to assume that the time for monolayer completion should be an exponentially distributed
random variable, it cannot be assumed that the “rate” of monolayer completion is defined
as the reciprocal of the expected time for monolayer completion. It is, however,
reasonable to consider the asymptotic rate of monolayer formation over growth of several
tens of nanometers. In this case, we can treat monolayer formation as a renewal process,
and thus the expected time for layer formation as constant. This requires that we assume
that the expected time for nucleation and the flux of growth units per step site per second
are constant throughout the timeframe of crystal growth. Note, however, that a seed
crystal growing from time t1 to t2 and another seed crystal growing from time t3 to t4 can

79

be subject to different nucleation rates and flux. The (asymptotic) rate of crystal growth,
Rhkl, normal to a facet with Miller indices hkl and monolayer height dhkl is defined as:

𝑅ℎ𝑘𝑙 =

𝑑ℎ𝑘𝑙
𝐸(𝑇𝑚𝑜𝑛𝑜𝑙𝑎𝑦𝑒𝑟 )ℎ𝑘𝑙

The units of Rhkl are nm per second, and the logarithm of this rate as a function of
nucleation rate and growth unit flux is used to generate the crystal growth contour plots
reported in the main text. The advantage of using this expression is that it can be
compared to experimental measurements and alternative rate expressions commonly
found in the literature. It should be noted, however, that working instead with the
expected time for monolayer formation provides the advantages of a slightly less
restricted mathematical foundation and distinct contributions from the expected times of
2D nucleation and partial monolayer spread.

3.13 Derivation of the Correction Factor for the Detachment of Growth Units
Suppose we want to know the expected time for a step fragment of n unfilled sites
to be completely filled, one site at a time. If the expected time for one atom to fill a
binding site is E(tatt), then the expected time, E(tn,att), for n binding events is:

𝐸(𝑡𝑛,𝑎𝑡𝑡 ) = 𝑛𝐸(𝑡𝑎𝑡𝑡 )
If detachment of atoms from binding sites did not occur, then E(tn) would be the
expected time for the step fragment comprising n atoms to be completed. In reality,
however, atoms detach from binding sites at a rate of Rdet. Because the detachment is a
Poisson process, the expected time for an atom to detach, E(tdet), is:
80

𝐸(𝑡𝑑𝑒𝑡 ) =

1
𝑅𝑑𝑒𝑡

From the expected times for incorporation and detachment of atoms at binding
sites, we can write the expected number of attachments, Natt, and detachments, Ndet, from
time t = 0 to τ:
𝑁𝑎𝑡𝑡 (𝜏) =

𝜏
𝐸(𝑡𝑎𝑡𝑡 )

𝑁𝑑𝑒𝑡 (𝜏) =

𝜏
𝐸(𝑡𝑑𝑒𝑡 )

The number of attachments minus the number of detachments gives the net
number of atoms incorporated, Ninc. The net number of atoms incorporated in time τ, is:
𝑁𝑖𝑛𝑐 (𝜏) = 𝑁𝑎𝑡𝑡 (𝜏) − 𝑁𝑑𝑒𝑡 (𝜏)
𝑁𝑖𝑛𝑐 (𝜏) =
𝑁𝑖𝑛𝑐 (𝜏) =

𝜏
𝜏
−
𝐸(𝑡𝑎𝑡𝑡 ) 𝐸(𝑡𝑑𝑒𝑡 )

𝜏[𝐸(𝑡𝑑𝑒𝑡 ) − 𝐸(𝑡𝑎𝑡𝑡 )]
𝐸(𝑡𝑎𝑡𝑡 )𝐸(𝑡𝑑𝑒𝑡 )

Setting τ = 1s gives the net number of atoms incorporated per second:
[𝐸(𝑡𝑑𝑒𝑡 ) − 𝐸(𝑡𝑎𝑡𝑡 )]
𝑎𝑡𝑜𝑚𝑠
𝑁𝑖𝑛𝑐 (
)=
𝑠
𝐸(𝑡𝑎𝑡𝑡 )𝐸(𝑡𝑑𝑒𝑡 )
In order to determine the expected time, in seconds, for an atom to be
incorporated, E(tinc), we take the reciprocal of Ninc:
𝐸(𝑡𝑖𝑛𝑐 ) =
𝐸(𝑡𝑖𝑛𝑐 ) =

1
𝑁𝑖𝑛𝑐

𝐸(𝑡𝑎𝑡𝑡 )𝐸(𝑡𝑑𝑒𝑡 )
[𝐸(𝑡𝑑𝑒𝑡 ) − 𝐸(𝑡𝑎𝑡𝑡 )]
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𝐸(𝑡𝑖𝑛𝑐 ) = {

𝐸(𝑡𝑑𝑒𝑡 )
} 𝐸(𝑡𝑎𝑡𝑡 )
[𝐸(𝑡𝑑𝑒𝑡 ) − 𝐸(𝑡𝑎𝑡𝑡 )]

The expected time, E(tn,inc), for n sites to be filled (i.e. Natt – Ndet = n), is therefore
given by:
𝐸(𝑡𝑛,𝑖𝑛𝑐 ) = 𝑛𝐸(𝑡𝑖𝑛𝑐 )
𝐸(𝑡𝑛,𝑖𝑛𝑐 ) = {

𝐸(𝑡𝑑𝑒𝑡 )
} 𝑛𝐸(𝑡𝑎𝑡𝑡 )
[𝐸(𝑡𝑑𝑒𝑡 ) − 𝐸(𝑡𝑎𝑡𝑡 )]

We see in the last expression, that the net time for n sites to be filled is equal to
the expected time of attachment, multiplied by the ratio:
1
𝐸(𝑡𝑑𝑒𝑡 )
𝑅𝑑𝑒𝑡
{
}={
}
1
[𝐸(𝑡𝑑𝑒𝑡 ) − 𝐸(𝑡𝑎𝑡𝑡 )]
[𝑅 − 𝐸(𝑡𝑎𝑡𝑡 )]
𝑑𝑒𝑡
Alternatively, we can derive this factor from the rates of attachment, detachment,
and the net rate of incorporation:
𝑅𝑖𝑛𝑐 = 𝑅𝑎𝑡𝑡 − 𝑅𝑑𝑒𝑡
If we assume that the incorporation of growth units is well modeled by a renewal
process wherein the asymptotic rate of attachment gives a good approximation to the
experimental rate of attachment, we can apply the theorem:
𝑁𝑎𝑡𝑡
1
=
𝑡→∞ 𝑡
𝐸(𝑡𝑎𝑡𝑡 )
lim

𝑅𝑎𝑡𝑡 =
𝑅𝑎𝑡𝑡 =
𝑅𝑖𝑛𝑐 =

𝑁𝑎𝑡𝑡
𝑡

1
𝐸(𝑡𝑎𝑡𝑡 )

1
− 𝑅𝑑𝑒𝑡
𝐸(𝑡𝑎𝑡𝑡 )
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Then the expected time for n sites to be filled is given by:
𝑅𝑖𝑛𝑐 𝐸(𝑡𝑛,𝑖𝑛𝑐 ) = 𝑛
𝐸(𝑡𝑛,𝑖𝑛𝑐 ) =
𝐸(𝑡𝑛,𝑖𝑛𝑐 ) =

𝐸(𝑡𝑛,𝑖𝑛𝑐 ) =

𝐸(𝑡𝑛,𝑖𝑛𝑐 ) =

𝑛
[

1
− 𝑅𝑑𝑒𝑡 ]
𝐸(𝑡𝑎𝑡𝑡 )
𝑛

[

1
1
−
]
𝐸(𝑡𝑎𝑡𝑡 ) 𝐸(𝑡𝑑𝑒𝑡 )

𝑛
𝐸(𝑡 ) − 𝐸(𝑡𝑎𝑡𝑡 )
[ 𝑑𝑒𝑡
]
𝐸(𝑡𝑎𝑡𝑡 )𝐸(𝑡𝑑𝑒𝑡 )

𝐸(𝑡𝑛,𝑖𝑛𝑐 ) =
𝐸(𝑡𝑛,𝑖𝑛𝑐 ) = [

𝑛
𝑅𝑖𝑛𝑐

𝐸(𝑡𝑎𝑡𝑡 )𝐸(𝑡𝑑𝑒𝑡 )𝑛
𝐸(𝑡𝑑𝑒𝑡 ) − 𝐸(𝑡𝑎𝑡𝑡 )

𝐸(𝑡𝑑𝑒𝑡 )
] 𝑛𝐸(𝑡𝑎𝑡𝑡 )
𝐸(𝑡𝑑𝑒𝑡 ) − 𝐸(𝑡𝑎𝑡𝑡 )

Which again defines the expected time for incorporation as the expected time of
attachment, multiplied by the ratio
1
𝐸(𝑡𝑑𝑒𝑡 )
𝑅𝑑𝑒𝑡
{
}={
}
1
[𝐸(𝑡𝑑𝑒𝑡 ) − 𝐸(𝑡𝑎𝑡𝑡 )]
[𝑅 − 𝐸(𝑡𝑎𝑡𝑡 )]
𝑑𝑒𝑡

3.14 Application of the Theoretical Framework to Shape-Controlled Syntheses
Shape-controlled syntheses of metal nanoparticles typically rely upon surfactants
or polymers as shape-directing agents, wherein shape control is thought to be a direct
consequence of these species adsorbed to specific facets (9, 17, 18). The degree and
symmetry of surface “blocking” is hypothesized to modulate the growth rates in each

83

crystallographic direction, thereby directing morphology. The motivation for the present
work was our contrasting observation that a high degree of shape control can be achieved
without auxiliary additives. Figure 3.2 shows several gold nanoparticle morphologies
generated from the same starting seed population by finely controlling the kinetics of
tetrachloroauric acid (HAuCl4) reduction by hydrogen peroxide (H2O2). Energy
dispersive x-ray scattering (EDS) of the nanoparticles demonstrated clean gold spectra,
indicating that morphology was not influenced by shape-directing contaminants (Fig.
3.3). Protocols for each synthesis are provided in the Supplementary Methods.
The established (nano)crystal growth theories do not quantitatively explain all of
our results (see Appendix 1). The existing theories can be broadly classified as
nucleation-limited, diffusion-limited, or reaction-limited, as defined by the rate-limiting
step – the nucleation of monolayers, the diffusion of growth units to binding sites, or the
incorporation reaction of growth units, respectively (7, 9, 12-14, 19). The failure of these
theories is that they do not correctly account for the rate-limiting step (RLS) of facet
growth as a function of reaction conditions. For example, if the flux of growth units to
binding sites is fast with respect to the nucleation rate, then a diffusion-limited theory
will be invalid and overestimate the facet growth rate. A general expression for the
design rules of shape-controlled growth will not be possible until the RLS of facet growth
can be determined as a function of experimental conditions.
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Figure 3.2 | Shape-controlled synthesis of gold nanoparticles without surfactants. a,
Selective formation of various morphologies from the same batch of 3.5 nm gold
nanoparticle seeds. Nanostars form under the fastest rates of HAuCl4 reduction, followed
by nanospheres, nanorods, and nanoplates as the reduction rate decreases. The size of all
shapes can be tuned by adjusting the HAuCl4:seeds ratio. b, Nanostars, nanospheres,
nanorods, and nanoplates synthesized under optimized conditions. While nanostars and
nanospheres form virtually quantitatively, the nanorods and nanoplates require postsynthetic purification. Scale bars for nanoplates in (a) are 500 nm; all other scale bars are
100 nm.
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Figure 3.3 | Energy Dispersive x-ray Spectra (EDS) of gold nanoparticles. EDS of
nanostars, nanospheres, nanorods, and nanoplates indicate that the various morphologies
have the same internal composition of pure gold (i.e. no inclusions or alloys), without
significant differences in surface chemistry.

Herein, we solve the problem of identifying the rate-limiting step of facet growth
from knowledge of the experimental rates. Our new theoretical framework uses literature
values of diffusion activation energies and atomic vibrational frequencies at different
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lattice sites to identify the ranges of nucleation rates and diffusional flux that correspond
to nucleation-limited, diffusion-limited, and reaction-limited growth (16, 20, 21). Crystal
growth is thus modeled as proceeding by three distinct steps: nucleation of a monolayer,
diffusion of growth units to a step front, and incorporation of growth units into binding
sites at the step front (Fig. 3.4).

Figure 3.4 | Illustration of theoretical considerations. a, Schematic of a crystal facet
during lateral growth. The surface is populated by terrace (yellow), step (red), and kink
(white) sites. Important structural terms include the kink density (number of kinks
divided by total number of step plus kink sites), ρhkl, the step separation, λhkl, and the
monolayer height, dhkl. b-d, The three primary rates influencing the crystal growth rate in
the orientation normal to a facet. b, The nucleation rate is the rate at which a critical
nucleus (blue) – an island of adatoms that will continue to grow rather than dissolve –
forms on a facet (yellow). c, The “diffusion” rate can refer to different processes in
different theories. Here, we define the rate of diffusion specifically as the flux of growth
units to the step front – the region of terrace sites that are one jump from step or kink
sites (highlighted in light yellow). This definition separates bulk and surface diffusion
from the incorporation reaction process. d, The incorporation “reaction” rate as defined in
our treatment is the net rate at which adatoms in the step front (highlighted in light
yellow) diffuse into kink binding sites (red). The delivery of growth units to kink sites is
therefore divided into two regimes in our theory: diffusion of growth units from the bulk
to the step front, and incorporation reaction from the step front into the kink binding
sites.
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Figure 3.5 shows the relationship between diffusional flux, nucleation rate, and
the rate-limiting step for growth of {111} and {100} facets as a function of adsorbed
chloride ions (see Appendix 2 for Matlab scripts). The relationship between nucleation
and flux rates and the rate-limiting growth process can be easily visualized in contour
plots. Nucleation-limited growth occurs at high values of flux and reaction rate (i.e.
incorporation rate); diffusion-limited growth occurs at high nucleation and reaction rates;
reaction-limited growth proceeds at high values of flux and nucleation rate. When the
activation energy for growth unit detachment is sufficiently small, the net flux of growth
units into binding sites is negative, and dissolution occurs. Interestingly, chloride is
shown to have a pronounced effect on the balance between nucleation-limited, diffusionlimited, and reaction-limited growth. The origin of this behavior is the catalytic effect of
chloride to decrease the activation energies of adatom diffusion into and out of binding
sites via the formation of AuCl complexes (21).
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Figure 3.5 | Crystal growth contour plots for {111} and {100} facets of gold
nanocrystals. Three distinct regimes can be identified wherein the total facet growth rate
is limited by the nucleation rate (N), growth unit diffusion rate (D), or incorporation
reaction rate (R). The presence of Cl-, common to gold nanocrystal syntheses, shifts the
location of the nucleation-limited, diffusion-limited, and reaction-limited regimes by
decreasing the activation energies of various surface diffusion processes. The contour
lines represent the logarithm of the growth rate, such that the depicted rates range from
100 to 108 nm/s. The Matlab program for generating contour plots is available in
Appendix 2.

The crystal growth contour plots can be put into context by considering the
experimental transition between lateral growth and secondary nucleation. Lateral growth
is characterized by the lateral advance (i.e. step flow) of partial monolayers across a
surface as growth units are incorporated at the edges (22, 23). Secondary nucleation
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occurs when the reduction rate becomes so great that growth units begin to nucleate into
new seeds, either free in solution or at the surface of existing nanoparticles (24). In our
synthesis, crystal growth switches from lateral growth to secondary nucleation as the
growth rate approaches 100 nm/s. Thus, the shape-controlled region of all morphologies
other than stars and spheres occurs below this rate (Fig. 3.6). The 100 nm/s contour
appears below the transition to reaction-limited growth, and becomes further removed
from the reaction-limited transition as the concentration of chloride in solution increases.
We therefore conclude within the accuracy of the published activation energies that gold
nanoparticle growth is not reaction-limited on {111} and {100} facets. This conclusion
validates the classical hypothesis that rate of growth unit exchange at surface steps is
sufficiently fast to be negligible for the {111} and {100} facets of gold nanoparticles
(12).
Experimental rate contours reveal whether or not growth is reaction-limited. The
presence of 200 nm long nanorods after 10 s of growth suggests a {111}-facet growth
rate of approximately 10 nm/s (i.e. 10 nm/s growth from {111} facets in opposite
directions). Because the reaction-limited regime begins at rates orders of magnitude
higher than 10 nm/s, growth must be either nucleation- or diffusion-limited.
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Figure 3.6 | Changes in crystal growth as a function of growth rate. The twelve TEM
images correspond to reaction conditions “1 – 12” given in the Supplementary Methods.
All reactions have the same concentration of seeds and HAuCl4, such that the only
synthetic variables are the amount of H2O2 and NaOH in solution. Panels 1 – 6 have 19.6
mM H2O2 and NaOH concentrations decreasing from 3.9 mM to 0.49 mM. Panels 7 – 12
have no NaOH, and H2O2 concentrations decreasing from 9.8 x 10-1 M to 4.9 x 10-8 M.
The reduction rate of HAuCl4 and average growth rate of nanoparticles decreases from
panel 1 to 12. The dominant type of crystal growth, as determined by the products
observed, changes as labeled from Secondary Nucleation and Growth in panel 1 to
Lateral Defect-Mediated with strong influences from screw-dislocations in panel 12.

We determine whether growth is nucleation-limited or diffusion-limited by
statistical analysis using our theoretical framework. We compared nucleation-limited and
diffusion-limited growth by modeling nucleation rate and flux, respectively, to be
normally distributed random variables with mean equal to the value that yields the
average experimental growth rate, and standard deviation equal to 1% of the mean. We
simulated the expected distribution of nanorod growth rates using a Monte Carlo method
to randomly sample each initial distribution 106 times (Figs. 3.7a,b). Three separate
regions are highlighted: dissolution (white), lateral growth (green), and secondary
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nucleation (blue). Nanorod formation occurs in the lateral growth regime with an average
rate highlighted by the blue dashed line.

Figure 3.7 | Growth mechanism analysis for gold nanorods. a, Simulated growth rate
distribution in the diffusion-limited regime. The diffusion-limited hypothesis yields a
distribution of growth rates not observed experimentally, and incorrectly predicts that
stars and rods form in the same synthesis (i.e. secondary nucleation and lateral growth).
b, Simulated growth rate distribution in nucleation-limited regime. The nucleationlimited hypothesis yields accurate predictions of distributions tightly centered about the
experimentally observed growth rate. c, Length and width versus number of atoms in
nanorods. The curves are the best theoretical fits for nucleation-limited growth starting
from a 4 nm seed (dashed line) and a 7.5 nm seed (solid line). The best fit to data occurs
for a seed that experiences symmetry-breaking at 7.5 nm which induces a nucleation rate
on {111} facets that is 76 times faster than the nucleation rate on {100} facets. d, Highresolution transmission electron micrographs (HRTEM) of gold nanorods. The end facets
exhibit re-entrant grooves, while the side facets are stepped, but relatively smooth by
comparison. The grooves are known to catalyze monolayer nucleation, which explains
the faster nucleation rate on the {111} facets. Matlab scripts for the Monte Carlo
growth rate simulations are provided in Appendix 2.
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Our theoretical framework indicates that gold nanorod growth in our surfactantfree synthesis occurs by a nucleation-limited mechanism. The nucleation-limited
hypothesis yields normally distributed growth rates entirely within the lateral regime,
tightly centered about the experimental growth rate. In contrast, the simulated distribution
of diffusion-limited growth demonstrates a very poor fit to experimental results, with
only 29% of seeds growing in the lateral regime. Realistic fluctuations in flux during
growth would therefore preclude nanorod formation if growth was diffusion-limited.
The growth of nanorods is initially symmetric but becomes highly anisotropic
after a symmetry-breaking event at 7.5 nm. Although the initial seed diameter is
approximately 4 nm, a plot of experimental nanorod dimensions versus the number of
atoms they comprise is best fit by a 7.5 nm diameter at the time of symmetry-breaking
and a 76:1 preference for growth of {111} facets over {100} facets (Fig. 3.7c).
Interestingly, there are no conditions wherein symmetry breaking at the initial seed size
of 4 nm gives good correlation to data. Indeed, no rod-like particles are experimentally
observed when the HAuCl4:seed ratio is decreased such that the average nanoparticle
diameter falls below 7 nm.
The anisotropic growth of nanorods is consistent with a nucleation-limited
mechanism driven by differences in surface structure. We performed selected area
electron diffraction (SAED) and HRTEM analyses of the nanorods and found that they
were multiply twinned (Fig. 3.8) with re-entrant grooves on the {111} end facets, but not
on the {100} side facets (Fig. 3.7d). The re-entrant grooves are known to increase
monolayer nucleation rates, which explains why the end facets grow faster than the sides
(13, 25). Eucentric sample tilting was often required to resolve the structures, but they
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were clearly and consistently observed. The need for high resolution imaging at the
proper orientation may explain the lack of previous reports for these structures on metal
nanorods.

Figure 3.8 | Evidence for five-fold structure of gold nanorods produced by the H2O2mediated synthesis. a, HRTEM of gold nanorod prepared by our approach. b, Electron
diffraction pattern of nanorod in (a) demonstrating a superposition of [100] and [112]
contributions. c, The electron beam is incident upon the nanorod as depicted in the
schematic. d, Selected Area Electron diffraction pattern of nanorod in (a). The point
labeled A corresponds to the [100] orientation and the point labeled B corresponds to the
[112] orientation. e, The view along [100] produces strong contrast confined near the
central axis of the rod, as expected from cross-section of the V1 tetrahedral subunit of the
five-fold twinned structure. Dashed outline is included for clarity. f, The view along
[112] produces strong contrast throughout the nanorod, as expected from the combined
V3 and V4 tetrahedral subunits. These results provide strong evidence of the five-fold
twin nanorod structure. Scale bar in (a) is 10 nm.
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Figure 3.9 | Electron diffraction of gold nanoplates. Electron diffraction analysis of the
nanoplates reveals a forbidden 1/3{224̅} reflection, indicating the presence of twin planes
parallel to the top and bottom {111} facets. The electron diffraction pattern shown here
corresponds to the nanoplate on the left. Several plates were analyzed and all
demonstrated the forbidden reflection.

Evidence for nucleation-limited growth of morphologies other than nanorods was
observed. SAED of nanoplates reveals the forbidden 1/3{224̅} reflection (Fig. 3.9)
characteristic of parallel twin boundaries known to create re-entrant grooves on the
nanoplate side facets (25, 26). When the HAuCl4 reduction rate falls below 8.2 × 10-8
M/s, heavily defected decahedra, icosahedra, plates, and irregularly twinned particles
constitute virtually all of the products. The re-entrant features are so pronounced on some
morphologies (e.g. plates, distorted decahedra, etc.) that they are observed on lowresolution TEM (Fig. 3.6). The lack of nanorods under these conditions appears to result
from multiply twinned seeds attaining structural defects other than {111}-facet re-entrant
grooves, such that the symmetry-breaking event for nanorod growth does not occur.
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Figure 3.10 | Tunability of nanostars. a, As the HAuCl4 reduction kinetics increase,
protrusions begin to grow outward from the nanoparticle core. The aspect ratio of the
protrusions increases until an optimum is reached, beyond which the aspect ratio
decreases and the number of protrusions increases. b, TEM image of characteristic
nanostars formed under the minimal reaction rate sufficient to produce stable nanostars in
high yield (1.0 mM/s). c, TEM image of characteristic nanostars formed under the fastest
reaction kinetics tested shows that the number of protrusions increases and their aspect
ratio decreases relative to the nanostars formed under slower kinetics. d-f, Nanostars
grown from different seed diameters. The average number of protrusions per particle
increases while maintaining the same total diameter as the seed size is increased from (d)
5 nm, to (e) 15 nm, to (f) 33 nm. Scale bars are 50 nm in b-c, and 100 nm in d-f.
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When the kinetics of HAuCl4 reduction exceed 1.4 × 10-4 M/s secondary
nucleation occurs, resulting in nanospheres and nanostars. Depending on the relative rates
of secondary nucleation and Ostwald-type ripening, the nanoparticles either grow by
dendritic branching (nanostars) or birth and spread of small protrusions (nanospheres).
Accordingly, the length of the nanostar branches can be tuned to a moderate degree
simply by controlling the HAuCl4 reduction kinetics and oxidation potential (Fig. 3.10ac). The average number of branches per particle could be controlled by the size of the
initial seed particles, with more branches observed as the seed size increased (Fig. 3.10df). The protrusion ripening process was accelerated by the presence of chlorine in the
synthesis (27). Consequently, removing the chlorine immediately after synthesis
stabilized the nanostar morphology (Fig. 3.11). Dialysis of the nanostars afforded
stability in excess of six months at room temperature. Alternatively, increasing the
concentration of halides led to improved symmetry of nanospheres.
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Figure 3.11 | Nanostar transformation and stabilization. a, Absorbance spectra of assynthesized gold nanostars that were not subjected to post-processing measured at the
indicated time points. b, Absorbance spectra of as-synthesized gold nanostars that were
immediately dialyzed to remove residual reagents measured at the indicated time points.
c, Localized surface plasmon resonance (LSPR) maximum plotted against time. No shift
was observed for the dialyzed gold nanostars, while the absorbance maximum of nondialyzed gold nanostars rapidly red-shifted over time approaching 540 nm (LSPR of
spherical gold nanoparticles). d, TEM images demonstrated spherical transformation of
the non-dialyzed gold nanostars over time, while the star-shape of the dialyzed gold
nanostars was preserved. Scale bars are 50 nm.
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Figure 3.12 | Crystal growth regimes for gold nanoparticles. a, The transition between
lateral growth and secondary nucleation was experimentally observed when growth rates
approached 100 nm/s. This rate is highlighted in red on the contour plot for chloride-free
media. As chloride is introduced, the 100 nm/s contour moves toward the nucleationlimited regime. Lateral growth of {100} and especially {111} gold facets tend to be
nucleation-limited under surfactant-free conditions. b, The five primary regimes of
crystal growth are placed into context based on the empirical findings in this study. The
HAuCl4 reduction rates approximate the transitions between different types of growth.
The transitions are not sharp, as they represent the conditions when the major product
(i.e. highest-yield) morphologies of the reaction change. For example, “lateral
asymmetric” nanorods can be observed as a minority product in the “lateral symmetric”
regime. Matlab scripts for generating contour plots from the theoretical framework
are provided in Appendix 2.
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Figure 3.13 | Kinetics of HAuCl4 reduction. The absorbance of Au(III) was monitored
by UV-visible spectroscopy at 300 nm. Representative syntheses were performed from
which aliquots were removed at the measured time points and added to an equal volume
of a 2 % polyvinylpyrrolidone (PVP; 10 kDa) quenching solution. All measurements,
including calibration curves, were performed on the same well plate.

Extended Data Figure 3.14 | Yield of product morphologies. a, Centrifugal split-flow
thin (C-SPLITT) separation was performed on a representative sample of nanoparticles
synthesized in the lateral growth regime. The unpurified sample exclusively contained
rods, plates, decahedra, and icosahedra, as observed by TEM. The eluent fractions were
analyzed by TEM and revealed that the particles eluted in the order rods, plates,
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decahedra, icosahedra. The experimental data was fit by assigning a Gaussian to each
peak, and the relative area of each Gaussian was used to determine the yield of the
corresponding shape. The fit shows that our products comprise 44.9% plate-like, 43.3%
five-fold twinned (i.e. rods plus decahedra), and 11.7% icosahedra. The starting seed
population has been identified to comprise 45% plate-like, 45% five-fold twinned, and
10% icosahedral seeds by high-resolution TEM analysis. The correspondence between
product crystallinity and seed crystallinity indicates that products are predominantly
formed via growth of single seeds.

The theoretical and experimental results reported herein can be summarized into
distinct regimes of gold nanocrystal growth, classified by the type of growth – lateral or
secondary nucleation – and subclassified by the major products observed (Fig. 3.12). For
reference, the reduction rates of HAuCl4 that approximate the transitions between
regimes are labeled in Figure 3.12 (see Fig. 3.13 for spectroscopic data). Because stars
and spheres form via a secondary nucleation mechanism there is no strong correlation
between the initial seed structure and the product structure. Lateral growth, however, is
very sensitive to the initial seed structures. Figure 3.14 demonstrates that the crystallinity
of products formed in the lateral asymmetric regime directly corresponds to the
crystallinity of the initial seeds, with the exception that re-entrant grooves become
introduced into the multiply-twinned seeds that grow into rods. In this regard, the yield of
a particular shape is fundamentally dependent on the yield of the corresponding seed,
such that high-yield surfactant-free syntheses can be simply achieved as soon as the
crystallinity of seeds becomes easily tunable (see Appendix 1).
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Figure 3.15 | Performance of surfactant-free nanoparticles in surface-dependent
applications. Surfactant-free nanoparticles outperform similar morphologies with
polymer or surfactant coatings. a, Catalytic efficiency for the conversion of resazurin to
resorufin with hydroxylamine using surfactant-free, PEG-SH, and CTAB-coated gold
nanostars. Error bars represent the standard deviation of triplicate data. b, Surfaceenhanced Raman scattering spectrum of 1,2-di(4-pyridyl)ethylene on surfactant-free,
PEG-SH, and CTAB-coated gold nanostars. Nanostars were chosen as the proof-ofconcept morphology tested because uniform samples could be obtained for all surface
coatings in high yields without requiring purification. The same trends are expected for
all shapes.
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Although the present findings highlight a gold nanoparticle synthesis free of
surfactants and polymers, it should be noted that this theoretical framework is broadly
applicable to more complex synthetic environments, provided the appropriate activation
energies and vibrational frequencies are computed. Accordingly, we anticipate that this
work will motivate new investigations into the activation energies of surface diffusion
processes for various materials under relevant experimental conditions. The concept of
shape-directing agents, though not discredited by this study, should be cautiously applied
given the alternative routes to a given morphology. The significantly enhanced
performance of these additive-free nanoparticles in surface-dependent applications such
as catalysis and surface-enhanced Raman scattering (Fig. 3.15) is expected to stimulate
further research into the control of seed crystallinity such that any geometry presented
herein can be directly synthesized in arbitrarily high yield (see Fig. 3.16).
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Extended Data Figure 3.16 | Summary of design considerations for surfactant-free
syntheses. Each product morphology forms from a corresponding seed. All types of
seeds (e.g. icosahedral, five-fold twinned, plate-like, etc.) can grow into spheres and stars
if the reduction rate of HAuCl4- is sufficiently fast. The polyhedral shapes can only be
formed in high yield if the corresponding seed is present in high yield. Nanorod
formation has the additional requirement that the seed posses re-entrant grooves
(highlighted in red on five-fold seed) on the {111} facets. The reduction rates and
additional comments give the experimental conditions necessary to synthesize each
shape.

3.15 Methods
Materials
Hydrogen peroxide (TraceSELECT; Sigma Aldrich) and all other chemicals were
ordered from Sigma-Aldrich with the highest purity available and used as received. In all
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cases 18.2 MΩ∙cm water was used. Slide-A-Lyzer 2K Dialysis Cassettes G2 were
ordered from Thermo Scientific and used in all dialysis experiments.

Gold Nanoparticle Characterization
HRTEM analyses, bright and dark field images from Fig. 3 and Extended Data
Figs. 4, and 5, and electron diffraction were performed on 200kV JEOL 2100F HighResolution Transmission Electron Microscopes from Brookhaven National Laboratory
and Hunter College. TEM bright field images from Fig. 1 and Extended Data Figs 3,6,
and 7 were acquired using a JEOL 1200 EX-II TEM at Memorial Sloan Kettering Cancer
Center. EDS was obtained with EDAX hardware and software from the JEOL 2100F
HRTEM at Hunter College. Nanoparticle concentrations were determined by nanoparticle
tracking analysis (Nanosight; Salisbury, United Kingdom). Nanoparticle separations were
performed by Postnova Analytics Inc. (Salt Lake City, UT, USA) using centrifugal splitflow thin fractionation (C-SPLITT).

Gold Nanoparticle Synthesis
3.5 nm gold seeds – 3.5 nm seeds were synthesized by a modification of the
standard NaBH4 method. Briefly, 100 μL of 25.4 mM HAuCl4 was added to 10 mL of
H2O, then 300 μL of 100 mM ice-cold NaBH4 was added to this solution under vigorous
stirring. The formation of seeds could be monitored by the immediate appearance of an
orange-brown color. These seeds were used in all reactions without further treatment. We
observed that dialysis of the seeds in a 2,000 Da molecular weight cut-off cassette to
remove unreacted ions did not prevent the formation of any morphologies, nor did the
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addition of citrate to the seed synthesis. Therefore, the influence of the capping agents
present on the seeds was treated as negligible in our syntheses. Dr. Stefan Harmsen and
Gianluca Arianna independently verified all synthetic methods.

Nanoplates – 150 μL of as-prepared 3 nm seeds were added to 9.85 mL of H2O. 150 μL
of 25.4 mM HAuCl4 was added to the mixture and the reaction was initiated by the
addition of 200 L of 0.3% (v/v) H2O2 under stirring.

Nanorods – 600 μL of as-prepared 3 nm seeds were added to 9.40 mL of H2O. 30 μL of
30% H2O2 was added to this mixture and the reaction was initiated by the addition of 300
μL of 25.4 mM HAuCl4 under vigorous stirring. The best results were obtained by adding
the HAuCl4 in increments of 30 μL every 2 - 3 seconds.

Nanospheres – 30 μL of as-prepared 3 nm seeds were added to 9.97 mL of ice-cold H2O.
150 L of 25.4 mM HAuCl4 was added to this mixture and the reaction was initiated by
adding a solution of 15 μL 1 M NaOH dissolved in 1 mL of 0.3% H2O2. The balance
between NaOH and seed concentration is very sensitive during sphere formation. When
the synthesis begins with the appearance of a blue color, less NaOH should be used.
When rods or other anisotropic polyhedra are observed in the products, more NaOH
should be used. Addition of chloride or bromide before reduction of HAuCl4 greatly
improves the symmetry of the spheres.
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Nanostars – 30 μL of as-prepared 3 nm seeds were added to 9.97 mL of ice-cold H2O.
150 L of 25.4 mM HAuCl4 was added to this mixture and the reaction was initiated by
adding a solution of 50 μL 1 M NaOH dissolved in 1 mL of 0.3% H2O2. Some syntheses
generate stars that transform more rapidly than others, but this can be controlled to an
extent by consideration of the oxidation potential generated during HAuCl4 reduction. In
general, the amount of NaOH added should be the minimal amount necessary to generate
stars, and increasing the pH beyond this point results in increasingly rapid transformation.

Procedure for removing residual chemical species

Washing – Immediately after the nanostars are synthesized they are diluted to 150% of
their original volume by the addition of ice-cold H2O. The solution is then split into two
separate centrifuge tubes and spun down for the minimal amount of time necessary to
collect the nanostars at the bottom of the tube at 8000 rpm (e.g. approximately 4
minutes). The supernatant is removed and a small volume of ice-cold H2O is added in
order to enable effective redispersion of the nanostars via ultrasonication. Finally, the
original reaction volume is obtained by dilution with ice-cold H2O.

Note: Repeating this process multiple times can result in aggregation; however it is
difficult to remove all residual reagent traces in one wash, thus shape-transformation is
not prevented indefinitely by this method.
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Dialysis – Immediately after the nanostars are synthesized they are added to a 2,000 Da
MWCO Slide-A-Lyzer dialysis cassette that is then placed into a large volume of H2O
and subjected to slow stirring. The dialysis water is replaced periodically until residual
chemical species are removed. Our investigations did not reveal the presence of any
impurities on the nanoparticle surface to suggest that cassette-derived particle stabilizing
effects (e.g. membrane polymer leaching) occurred.

Catalysis
The catalytic reduction of resazurin to resorufin mediated by hydroxylamine in
the presence versus absence of gold nanoparticles serves as an assay for their efficacy as
catalysts. 1 μL of 5 mM resazurin was added to 100 µL of 33 pM gold nanostars and 150
mM hydroxylamine in 10 mM pH = 7.3 MES buffer. At the desired time point, the
sample was centrifuged at 10,000 rpm for three minutes and 80 μL of the supernatant was
removed, then added to 200 μL of pH = 7.3 MES buffer in a clear-bottom 96 well plate.
The fluorescence intensity at an excitation wavelength of 571 nm and emission
wavelength of 584 nm was followed every ten minutes after reaction initiation. The
fluorescence intensity of the control reaction of resazurin and hydroxylamine in the
absence of gold nanostars remains virtually constant indicating that resazurin is not being
converted into resorufin (data not shown). All experiments were performed in triplicate
and measured under identical conditions.
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Surface-Enhanced Raman Scattering
Nanostars were evaluated as substrates for surface-enhanced Raman scattering
(SERS). 1 μL of 0.5 mM 1,2-Di(4-pyridyl)ethylene was added to 20 μL of 0.50 nM
aqueous nanostar samples and allowed to stir for 15 minutes at room temperature. SERS
spectra were then recorded by a Raman spectrometer (Renishaw, Gloucestershire, UK)
with 785 nm laser excitation at 3 mW/cm2 for 1 s. No aggregation was present in any of
the samples, insuring that the SERS intensity was not complicated by the presence of
aggregation-induced hotspots.

Monte Carlo Calculations:
Expected distributions of nanorod growth rates from nucleation-limited and
diffusion-limited hypotheses were generated in Matlab (see Appendix 2 for Matlab
Scripts). Nucleation rate and flux (i.e. diffusion rate) were modeled as normally
distributed random variables. The mean nucleation rate and flux were chosen to be the
values that that give the experimental growth rate (i.e. 10 nm/s from {111} facets) under
nucleation-limited and diffusion limited hypotheses, respectively. The standard deviation
was set to be 1% of the mean. The input distributions were randomly sampled 106 times
in order to generate the output facet growth rate distributions shown in Fig. 3a,b.
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CHAPTER 4
Encapsulation
4.0 Acknowledgement
Sections 4.8, 4.9, and 4.12 are adapted from our publication in Nano Letters (1).
Accordingly, the figures and text in those sections are the result of collaborative data
collection and writing with the co-authors.

4.1 Introduction
Encapsulation – the addition of an outer layer to envelop a substrate – is often
essential to the performance and longevity of a material for a given application (2-4). The
advantages of encapsulation are particularly notable on the nanoscale, where
functionality is strongly correlated with shape and composition (5-8). Encapsulant layers
can fix the shape and structure of a nanomaterial, shield an active surface or component
from environmental influences, separate compartments of a multicomponent
nanostructure, and provide new functionality (3, 9-11).
Encapsulation is a necessary step in the synthesis of surface-enhanced Raman
scattering (SERS) nanoprobes because it inhibits detachment of Raman-active molecules
and prevents unwanted environmental species from interfering with the substrate-analyte
(e.g. metal-molecule) interface (3, 12-14). Furthermore, the encapsulant layer of SERS
nanoparticles enables incorporation of functional additives (e.g. radiotracers, fluorescent
molecules, etc.) and surface moieties such as polymers or targeting agents (10, 15-17). In
this chapter, we focus on the use of silica as a functional encapsulant, particularly as it
pertains to the creation of multimodal SERS-based contrast agents.

113

4.2 Background
Nanoprobes constructed for biomedical applications must provide high signal-tonoise ratios, demonstrate satisfactory pharmacokinetic properties, and remain sufficiently
stable and non-toxic in vivo for the benefits of improved imaging or therapy to offset the
risk of unintended medical consequences (18-21). In the case of SERS nanoprobes, the
requirements of high signal-to-noise ratio and stability in vivo necessitate encapsulation
of the substrate-analyte (e.g., metal-molecule) interface (13). Common encapsulant
materials include Bovine serum albumin (BSA), polymers (e.g., thiolated poly(ethylene
glycol), polyvinylpyrrolidone, etc.), and silica (12). Although future SERS substrates
may be made of materials other than gold (e.g. semiconductors) and thus require different
approaches to encapsulation, the methods and results presented here will focus on the
current state-of-the art: gold nanoparticle cores encapsulated in silica shells (17, 22, 23).

4.3 The chemistry of silica
Silica is typically synthesized by the hydrolysis and condensation of a precursor
molecule (24-26). The most common approach is the sol-gel synthesis developed by
Stöber (24). In the Stöber method, tetraethyl orthosilicate (TEOS) is hydrolyzed under
basic conditions in a solvent of alcohol and water. The hydrolyzed monomers condense
into nanoparticles or gel-like networks depending upon the ratios of TEOS, base, alcohol,
and water (27). The reaction scheme is shown in Fig. 4.1.
The species and concentration of the silica precursor, the solvent composition,
and the pH of the solution control the rates of hydrolysis and condensation (24). Both
reactions proceed via nucleophilic attack in an SN2 mechanism (25, 27). Accordingly,
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polar protic solvents were initially expected to promote the fastest reaction rates because
they hydrogen bond with the leaving group, stabilizing the transition state of both
reactions (25, 28). While polar protic solvents do yield the fastest hydrolysis reactions,
investigations into the condensation rates revealed that the less polar solvents induced
faster condensation rates (29). A likely reason for this is that the solubility of hydrolyzed
moieties decreases as solvent polarity decreases, creating an increased driving force for
condensation (30).

Fig. 4.1 | Reaction scheme of Stöber process. The formation of silica from silane
precursors proceeds via hydrolysis and condensation.

Because silica formation is typically limited by the rate of hydrolysis, the
nucleation rate increases as the molecular weight of the alcohol decreases, although
anomalous effects have been reported (30). Reactions with the fastest nucleation rates
generate the greatest number of nanoparticles. Consequently, the final silica diameter
decreases as the molecular weight of the solvent alcohol decreases because the
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concentration of silica precursor is divided into a larger number of particles for the faster
nucleation rates.

4.4 Synthesis of silica nanoparticles
Narrowly dispersed populations of silica nanoparticles can be synthesized by the
Stöber process. A standard protocol for the formation of 125 nm silica nanoparticles is
provided in the methods section at the end of the chapter. The average nanoparticle
diameter can be easily tuned by changing either the water content or solvent alcohol (Fig.
4.2). Increasing the concentration of water increases the overall rate of hydrolysis and
condensation such that more particle growth occurs over time. When water is the limiting
reagent, increasing the amount of water will increase the final nanoparticle diameter
approximately linearly (Fig. 4.2A). Increasing the molecular weight of the solvent
alcohol while keeping the concentrations of all other reactants constant also increases the
average nanoparticle diameter. Decreasing the molecular weight of the solvent alcohol
increases the solvent polarity, which increases the nucleation rate. Accordingly, the
higher molecular weight alcohols nucleate fewer silica nanoparticles, but grow them to a
larger final diameter (Fig. 4.2B) as discussed in section 2.3.
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Fig. 4.2 | Silica diameter as a function of solvent. (A) Silica nanoparticles synthesized
according to the Stöber process in ethanol with varying water content. The average
nanoparticle diameter decreases as the percent by volume of water is decreased from 10
% to 2.5 %. (B) Silica nanoparticles synthesized in isopropanol (IPA), ethanol (EtOH),
equal parts ethanol and methanol by volume (EtOH/MeOH), and methanol (MeOH). The
average nanoparticle diameter decreases as the molecular weight of the alcohol decreases.

4.5 Silica formation from the perspective of nucleation theory
Studying the nucleation of silica from the perspective of classical or generalized
nucleation theory (chapter 2) reveals interesting insights into the process of silica
formation. Small-angle x-ray scattering (SAXS) coupled with 29Si-nuclear magnetic
resonance (NMR) experiments show that the nucleation of silica begins with the initial
build up of singly-hydrolyzed monomers (HO-Si(OCHCH2)3) during an induction period
wherein no nuclei form (29, 31). In line with the nucleation theories presented in chapter
2, the concentration of this hydrolyzed species (i.e. growth unit precursor) must reach a
critical supersaturation before silica nuclei begin to form. Once the size of the nuclei
exceed the critical radius, they grow spontaneously into larger silica nanoparticles.

117

In contrast to the classical picture of nucleation, however, silica nuclei form by a two-step
mechanism (29, 31). First, the partially hydrolyzed monomers react with other silica
precursor species (e.g., monomers and oligomers) via SN2 nucleophilic substitution to
generate open polymers (25, 27). Next, fractal-like growth increases the density of the
polymeric structures without notably increasing their overall radii, ultimately resulting
amorphous solid nanoparticles (29, 31).
The two-step nucleation mechanism of silica presents two primary routes to
controlling the nucleation rate. Because open polymers must form prior to nucleation,
reaction conditions that yield fast SN2 reactions – polar protic solvents with high
concentrations of nucleophiles – will exhibit fast nucleation rates. Thus, the first means
of controlling nucleation rate is to control the rate of hydrolysis reactions (see sections
4.3, 4.4). The second approach to nucleation rate control is to manipulate the
condensation process of the open polymer reacting with itself. When a substrate surface
sufficiently catalyzes this process, encapsulation of the substrate will occur preferentially
over nucleation free in solution (i.e., heterogeneous nucleation is favored over
homogeneous nucleation).

4.6 Silica encapsulation of metal nanoparticles
Encapsulating a substrate with silica is not as straightforward as simply
introducing the substrate into an established Stöber process (3, 9). In fact, the rapid
homogeneous nucleation of silica in the Stöber process presents a significant challenge
with respect to encapsulation. Because the homogeneous nucleation rate is so fast, it is
challenging to make the heterogeneous nucleation (i.e., surface nucleation) rate
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sufficiently favorable to induce encapsulation rather than free silica nanoparticle
formation (3). The silication of gold nanoparticles is particularly difficult to control
because gold is not a vitreophilic material (i.e., the binding energy between silica and
gold is low) (32).
Gold nanoparticle silication was originally achieved by a “surface primer”
method, wherein the gold surface is pretreated to become vitreophilic (32). First, the gold
surface is modified in aqueous solution with small molecules comprising either an amine
or thiol functional group bound to a trimethoxysilane moiety. The amine or thiol group
has high affinity for gold, while the trimethoxysilane moiety is reactive toward silica.
Next, sodium silicate is introduced to form a thin silica layer at the modified gold surface.
The nanoparticles are centrifuged and redispersed into a Stöber reaction mixture. When
the Stöber process is initiated (e.g., by the addition of NH4OH), hydrolysis and
condensation of silica precursors proceeds rapidly at the nanoparticle surface. Because
the nanoparticle surface has been primed with a thin layer of silica, surface nucleation is
not required for growth of the silica shell. Thus, encapsulation proceeds rather than free
silica formation because growth is not inhibited by a nucleation barrier at the surface.
Despite the low affinity of silica for gold, “primer-free” silication can be achieved
under judicious control of reaction conditions in the Stöber process (2, 12). In order to
explain the origin of preferential surface nucleation, we recall that the rate of a chemical
reaction increases exponentially as its activation energy decreases. The activation energy
is the difference between the average total energy of all reacting pairs of reactants minus
the average total energy of all pairs of reactants (i.e., reacting and non-reacting pairs)
(33). Thus, the activation energy can be decreased by increasing the average total free
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energy of all pairs of reactants. In other words, the surface nucleation rate will be fast if
the reactants have large enthalpies or small entropies at the substrate-solution interface.
The decrease in reactant pair entropy at gold nanoparticle surfaces promotes
encapsulation rather than free silica nucleation in solution. In particular, adsorbed
reactant molecules have their translational degrees of freedom decreased, and depending
upon their diffusion mean free paths may have substantially restricted motion relative to
their state free in solution. Conceptually, confined motion of reactants at the nanoparticle
surface increases the probability of collisions that generate products, even if the
adsorption energy is not particularly high (34). The confined motion at the substrate
surface will, therefore, catalyze condensation reactions of open polymer silica precursors
(section 4.5) with other reactants and with themselves (i.e., densification), generating
amorphous solid silica nuclei selectively at the surface.

4.7 Synthesis of SERS nanoprobes
In addition to the design considerations presented in the last section, the gold-dye
affinity and colloidal stability must be taken into account (12). In order to maximize the
number of dye molecules on the gold nanoparticle surface, either positively charged or
neutral species must be used (assuming a negatively charged gold nanoparticle surface)
(17). The coulombic repulsion between negatively charged surfaces and negatively
charged dyes precludes the formation of strong metal-molecule binding. When neutral
species are used, it is important that either nitrogen or sulfur atoms are available for
binding to the gold, such that the molecule remains adsorbed to the surface (17).
Additionally, molecules with large Raman cross-sections are necessary for high SERS
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intensity. The dyes that meet all of these requirements are typically resonant with the
incident laser and form J-aggregates or have degenerate vibrational modes that yield one
or two particularly intense peaks (17, 23, 35, 36).
Once the optimal dye has been selected, thorough optimization of the silica
encapsulation procedure must be done in order to prevent aggregation of the gold
nanoparticles (i.e., the cores) (12). Introducing a dye molecule, typically with one or
more counterions, raises the ionic strength of the solution, which decreases the electric
double layer responsible for colloidal stability. Furthermore, adsorption of positively
charged dye molecules decreases the magnitude of the zeta-potential at the gold surface.
In order to maximize the amount of molecules that can adsorb to the gold surface
without inducing aggregation, the destabilizing effect of counterions must be mitigated.
This is achieved by using the most chaotropic counterion species – defined by their
ability to disrupt the polar protic solvent molecules and stabilize the increasingly nonpolar nanoparticles (i.e., the magnitude of the zeta-potential decreases and the
hydrophobicity increases as more dye molecules adsorb to the surface) (17). The
chaotropic anions that we found best-promoted colloidal stability are perchlorate and
hexafluorophosphate.
The optimal reaction conditions for SERS nanoprobe synthesis are those that
narrowly avoid aggregation. Gold nanoparticles that are far from aggregation (i.e., highly
stable with respect to precipitation) necessarily have less than their maximum proportion
of adsorbed Raman dye molecules. Consequently, they do not exhibit their maximum
SERS. The amount of dye that should be added into a SERS nanoparticle synthesis is
determined by the relative rates of gold aggregation and silica encapsulation. If the
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silication procedure has an incubation time of 15 minutes before a shell begins to form,
then the amount of dye that induces precipitation of gold cores just after 15 minutes
should be used. Additionally, the initial reaction mixture should be split into two large
volumes – one containing the gold nanoparticles and the other containing the dye – so
that the local concentration of dye molecules is never sufficiently high to induce
precipitation.

Fig. 4.3 | Silica shell diameter as a function of water concentration. When water is the
limiting reagent of the silication experiment, the final shell thickness is proportional to
the water concentration. The scale bars are 100 nm.
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Figure 4.4 | SERRS-signal intensity of resonant cyanine and chalcogenopyrylium
dyes. (A) Structure of the resonant dye IR792 and chalcogenopyrylium dye CP3 from
reference 17. (B) SERRS intensity of an equimolar amount of IR792-based SERRSnanoprobes and CP3-based SERRS-nanoprobes that were synthesized with equimolar
amounts of the dyes. (C) Limits of detection of the IR792- and CP3-based SERRSnanoprobes were determined to be 1.0 fM and 100 attomolar, respectively. This figure is
adapted from our publication in Nature Communications (17). Data obtained by Dr.
Stefan Harmsen.

The optimized protocol for SERS nanoprobe synthesis is presented in the methods
section at the end of this chapter. The silica shell thickness is easily tuned by controlling
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the concentration of water (i.e., increasing water increases silica shell thickness) (Fig.
4.3). By developing resonant dyes with high affinity for gold nanoparticle surfaces, using
chaotropic counterions, and optimizing our encapsulation procedure, we have generated
SERRS nanoprobes with attomolar limits of detection (Fig 4.4) (17).

4.8 Silica as a multifunctional encapsulant
In addition to stabilizing the structure of a substrate and protecting it from
environmental factors, the materials properties of an encapsulant layer can afford
complimentary functionality to a substrate. In the context of SERS nanoparticles,
encapsulant materials that improve the depth at which the nanoparticles can be detected
below the tissue surface are particularly desirable. Accordingly, materials capable of
providing positron emission tomography (PET), single-photon emission computed
tomography (SPECT), or magnetic resonance imaging (MRI) contrast would prove to be
particularly attractive encapsulants for SERS nanoparticles (37-40).
PET, SPECT, and MRI contrast is typically achieved via surface functionalization
of small molecular chelating agents that bind radionuclides or gadolinium (41). This
approach presents several well-known disadvantages, particularly for PET and SPECT.
Since the coordination chemistry of different nuclides varies greatly, there is no
molecular chelator that can effectively bind many radionuclides interchangeably. Thus,
for a given radiotracer, selection of and particle modification with the proper chelator
may be very difficult or even impossible (42). Even when nuclides are stably chelated
during radiolabeling, introduction of the nanoparticle in vivo presents a new set of
challenges. Transchelation by endogenous proteins or detachment of the surface-bound
molecular chelators can strip the nanoparticles of their radiolabels, yielding images that
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do not reflect the true biodistribution (43). We note that iron oxide can alternatively be
used for MRI contrast, but its absorption in the near-infrared window precludes its use as
an encapsulant for SERS nanoparticles (44).

In response to the abovementioned concerns, several chelator-free approaches to
nanoparticle labeling have emerged and are the subject of a recent review (42). These
methods largely fall into three categories: inclusion of a trace amount of radioactive
precursor during a typical nanoparticle synthesis (e.g. including a small amount of 64Cu
during synthesis of CuS nanoparticles) (45), entrapment of radionuclides into sites
capable of binding specific species (e.g. addition of 18F to NaYF4 nanoparticles, 64Cu into
porphysomes, etc.) (46, 47), and cation exchange replacing one (cold) cation present in a
nanoparticle for a different radioactive cation (e.g. 153Sm replacing Lu3+ or Y3+ in
upconverting nanoparticles) (48). While these approaches eliminate the need for
molecular chelators during nanoparticle radiolabeling, they remain restricted to specific
nuclides, rather than being effective general platforms for many species.
A generalized method for producing nanoparticles that are capable of intrinsically
binding a wide variety of radionuclides without additional selective chelation molecules
would be highly desirable. It would provide a "one stop" nanoparticle that can be
radiolabeled for multiple applications without being individually modified with different
chelators each time. To this end, we first identified some important properties shared
between many common nuclides. The majority of medically relevant nuclides are
chelated by electron donors (e.g. oxygen, sulfur, or nitrogen atoms) arranged in a
symmetry that results in a stable coordination complex (49). In this regard, it is
reasonable to hypothesize that a chelator-free nanoparticle for intrinsic radiolabeling
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could be constructed by creating a nanoparticle with oxygen atoms arranged in a variety
of symmetries. A prototypical example of a material meeting these requirements is
amorphous silica, which has the benefits of well-established synthetic protocols and
widespread use in biomedical applications (24, 50). Silica nanoparticles are known to
bind heavy metal ions for environmental remediation (51, 52). Because silica
nanoparticles are inexpensive and certain formulations have been approved for clinical
trials by the United States Food and Drug Administration, they make for ideal substrates
in a kit-like protocol for producing intrinsically labeled nanoparticles (53).

4.9 Silica as a general substrate for chelation of oxophilic species
We investigated the ability of amorphous silica nanoparticles to bind a variety of
medically important radionuclides with a range of half-lives and emissions. In particular,
we explored the labeling efficiency of 68Ga, 64Cu, 89Zr, 90Y, 111In, and 177Lu under various
temperatures, pH, and incubation times (Fig. 4.5). 89Zr was further investigated using
silica nanoparticles that had been coated with polyethylene glycol. The 145 nm silica
nanoparticles were synthesized according to a modified Stöber process (24), washed three
times in ethanol and then resuspended in buffered solutions at either pH = 5.7, 7.3, or 8.8
(see methods). The silica nanoparticles maintained a constant size and did not aggregate
during this process (Fig. 4.6). The radiochemical yield was assessed both by instant thinlayer chromatography (iTLC) and centrifugal nanoparticle purification (Fig. 4.7).
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Fig. 4.5 | Scheme for intrinsic radiolabeling of silica nanoparticles. The nanoparticles
are incubated with free radionuclide at 70°C for 15 to 60 minutes depending on specific
radionuclide, then purified by centrifugation and resuspension.

Fig. 4.6 | Pre- and post-radiolabeling nanoparticle characterization. (A) Atomic force
microscopy (AFM) and transmission electron microscopy (TEM) characterization of
silica nanoparticles before radiolabeling. (B) AFM and TEM characterization of silica
nanoparticles after radiolabeling with 68Ga. The size and shape of the nanoparticles
remains unchanged. Scale bars are 100nm.
When the specific activity is 100 Ci/μmol, all nuclides tested demonstrate
radiochemical yields of >99% at pH = 7.3, 70°C, and incubation times less than or equal
to one hour. The radiochemical yield improves as temperature increases from 4°C to
70°C, but does not vary significantly as a function of pH in the range investigated (pH =
5.7 – 8.8). Buffer without silica nanoparticles was used as a control for each condition to
exclude the possibility of false-positive signals due to precipitate formation. Every
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nuclide except 177Lu shows >95% activity as free in solution, in agreement with previous
reports (54).

Fig. 4.7 | Radiolabeling and serum stability of silica nanoparticles. (A) Instant thinlayer chromatographs of radiolabeled silica nanoparticles. The red asterisk denotes the
origin, where the nanoparticles remain, and the black asterisk denotes the solvent front,
where the free activity would be located. Controls of buffer-only solutions (no particles)
were ran with each condition, with >95% signal at the free activity peak. (B) Percent
radionuclide bound to silica nanoparticles as a function of time and pH. The blue, red,
and green lines indicate radiolabeling at pH = 5.5, 7.3, and 8.8, respectively. (C) Percent
radionuclide bound to silica nanoparticles as a function of time and temperature. The
blue, red, and green lines indicate radiolabeling at 4°C, 37°C, and 70°C, respectively. (D)
Serum stability of silica nanoparticles radiolabeled at pH = 7.3 and 70°C, then incubated
in 50 % FBS at 37°C. The approach of using silica nanoparticles for oxophilic
radiolabeling was proposed by Matthew Wall. The data presented in this figure was
collected by Travis Shaffer (1).
Because 177Lu exhibits >10% signal associated with precipitate formation in the
buffer control, centrifugation and size exclusion filtration is necessary in the analysis of
177

Lu radiolabeling to ensure that false-positive signals from precipitates do not occur.

Separating the particles from the supernatant shows that virtually all radioactivity is
associated with the nanoparticles, independent of temperature. Competitive chelation
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studies with ethylenediaminetetraacetic acid (EDTA) demonstrate that only samples
incubated at 70°C robustly retain the various nuclides. This suggests that the dominant
influence of the temperature is in overcoming the activation energy required for stable
radionuclide binding, rather than enabling delivery of the radionuclides to binding sites
(i.e. the process is reaction limited, not diffusion limited). This finding is supported by
the observation that the silica nanoparticles are sufficiently porous to enable diffusion of
the radionuclides throughout the nanoparticle interior (Fig. 4.8).

Figure 4.8 | Pore size of silica nanoparticles. Atomic force microscopy of silica
nanoparticle samples reveals porous surfaces with many pore diameters in excess of 5
nm. Low magnification phase images (left) and high-magnification phase images (right)
were acquired in tapping mode as described in the methods. The porosity of these silica
nanoparticles is sufficient for diffusion of radionuclides into the nanoparticle interior,
making chelation feasible anywhere within the nanoparticle (i.e. not restricted to the
surface).

While heating the particles to 70°C precludes pre-labeling attachment of
temperature-sensitive targeting ligands such as antibodies, other targeting ligands that are
stable at this temperature such as smaller peptides and aptamers may be used. In Figure
4.9, we demonstrate that PEGylation of the silica nanoparticles does not preclude 89Zr
binding. Therefore, attachment of moieties incompatible with the reported labeling
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procedure can be facilitated by first radiolabeling silica nanoparticles coated with
functionalized polyethylene glycol, then performing straightforward post-radiolabeling
reactions. The nanoparticle size and zeta potential before and after radiolabeling are
given in Table 4.1.

Figure 4.9 | Intrinsic radiolabeling of 89Zr using PEGylated silica nanoparticles. The
surface of silica nanoparticles was modified by the addition of 2,000 Da polyethylene
glycol (PEG) according to the procedure reported in the methods. The red asterisk
represents the activity remaining at the origin of the ITLC strip and the black asterisk
represents the activity at the solvent front. Virtually all of the activity appears at the
origin (i.e. where the silica nanoparticles remain) in the PEGylated silica nanoparticle
sample, whereas the control sample containing free PEG without silica exhibits the
majority of activity at the solvent front. These results demonstrate that PEGylating silica
nanoparticles does not preclude intrinsic radiolabeling. Data collected by Travis Shaffer
(1).

Pre and post radiolabeling nanoparticle characteristics
Radionuclide Prelabeling
Postlabeling
Prelabeling
Postlabeling
mean diameter mean diameter zeta potential
zeta potential
(nm)
(nm)
(mV)
(mV)
68
Ga
144.1 (± 1.42) 142.5 (± 2.07) -45.2 (± 1.44)
-48.7 (± 4.23)
89
Zr
144.1 (± 1.42) 146.0 (± 6.86) -45.2 (± 1.44)
-47.7 (± 0.58)
90
Y
144.1 (± 1.42) 145.4 (± 0.30) -45.2 (± 1.44)
-47.4 (± 3.25)
177
Lu
144.1 (± 1.42) 141.6 (± 2.98) -45.2 (± 1.44)
-45.1 (± 3.16)
111
In
144.1 (± 1.42) 143.4 (± 0.85) -45.2 (± 1.44)
-42.1 (± 0.51)
64
Cu
144.1 (± 1.42) 145.0 (± 1.00) -45.2 (± 1.44)
-47.7 (± 3.34)
Table 4.1 | Pre- and post-labeling silica nanoparticle characterization. The size and
zeta-potential of silica nanoparticles is not significantly affected by intrinsic
radiolabeling. Silica nanoparticles synthesized by Matthew Wall. Radiolabeling and
characterization performed by Travis Shaffer (1).
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Having established protocols for achieving chelator-free high specific activities,
we examined the stability of the silica nanoparticles under physiological conditions. The
serum stability of each nuclide was investigated in 50% fetal bovine serum at 37°C over
time periods appropriate to each nuclide’s half-life. All nuclides were stably retained
within the silica nanoparticles except for 64Cu. In the case of copper, 50 % of the bound
nuclide leached into the serum after 4 h. Since the operating principle of intrinsic labeling
with silica nanoparticles is the affinity each nuclide has for the oxygen-rich matrix, it is
unsurprising that copper is most weakly retained because it is the least oxophilic of the
nuclides tested. In fact, the trend in serum stability of the intrinsically labeled silica
demonstrated excellent correlation with the oxophilicity (i.e. hardness) of the ions (55).
The marked decrease in the serum stability of 64Cu can be further attributed to proteins
present in the serum that actively chelate copper ions, resulting in pronounced
transchelation effects (56).
We investigated the stability and biodistribution of 68Ga- and 89Zr-labeled silica
nanoparticles in vivo. We were particularly interested in these nuclides because of their
increasing clinical importance in PET imaging, disparity in half-life, and excellent serum
stability (57, 58). Because nanoparticles are known to generally accumulate in the
reticuloendothelial system in amounts well exceeding 90 % of the injected dose (20),
short-lived nuclides like 68Ga are attractive in minimizing the cross-dose to healthy
organs while still enabling whole-body cancer imaging. Alternatively, because some
nanoparticle formulations remain in circulation for extended periods and most
nanoparticle clearance studies extend for weeks or longer, long-lived nuclides like 89Zr
are essential for investigating the biological response to nanoparticle administration.
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Fig. 4.10 | In vivo coronal PET maximum intensity projections (MIPs) of free and
silica-bound radiotracers in athymic nude mice. (A) MIPs of free (top) and silicabound (bottom) 68Ga at 1 h and 3 h post injection. (B) MIPs of free (top) and silica-bound
(bottom) 89Zr at 4 h, 12 h, and 24 h post injection. The intrinsically labeled silica
nanoparticles exhibit contrast in reticuloendothelial system, the known biodistribution of
silica nanoparticles, whereas the free nuclides demonstrate an entirely different
biodistribution. This stark contrast indicates that the silica nanoparticles remain
intrinsically labeled in vivo. Data collected by Travis Shaffer (1).
An additional benefit of studying 68Ga and 89Zr is that their biodistribution free in
circulation is easily distinguished from their biodistribution when bound to nanoparticles.
68

Ga and 89Zr will preferentially accumulate in the liver and spleen if they are bound to

nanoparticles (Fig. 4.10A), but not if they are free in circulation. Other radionuclides, like
64

Cu, can naturally accumulate in the liver such that a whole-body image or

biodistribution would be insufficient to determine whether or not the nuclide was bound
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to the nanoparticle. Male athymic nude mice (8-10 weeks old, n = 3) were injected with
250-350 μCi (9.25 – 12.95 MBq) of either free 68Ga or 89Zr while another set was injected
with 68Ga- or 89Zr-silica nanoparticles (10 nM) in 100 µL of 10 mM pH =7.3 2-(Nmorpholino)ethanesulfonic acid solution via the lateral tail vein. The nanoparticle-bound
nuclides demonstrated the known biodistribution of silica nanoparticles and remained
localized in the liver and spleen for the entire period investigated (3 h for 68Ga, 24 h for
89

Zr, n = 3 for each) (Fig. 4.10B) (59). The stark contrast between the free and

nanoparticle-bound biodistributions demonstrates that the silica stably retain the nuclides
in vivo (Fig. 4.11).

Figure 4.11 | Biodistribution of 68Ga- and 89Zr-radiolabeled silica nanoparticles 4
hours and 24 hours post-injection, respectively. Both biodistributions are consistent
with the known uptake of silica nanoparticles. The minimally elevated levels of 89Zr
activity in the bone (< 1 % ID/g) suggest that some radionuclide leaching may be
occurring in vivo, but the total amount of bone uptake is less than reported for other
radiolabeled nanoparticles (54). These biodistributions are consistent with the
observations from the PET images reported in Fig. 4.10. Data collected by Travis Shaffer
(1).

Because silica serves as a robust platform for binding radionuclides and retaining
them in vivo, the nanoprobes generated by this kit-like radiolabeling protocol should be
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immediately useful in the many known biomedical applications of nanoparticles. As a
proof of concept, we attempted to use these nanoparticles for lymph node imaging – a
clinically important application where nanoparticles demonstrate great promise (60). We
injected either free 89Zr or nanoparticle-bound 89Zr (n=3 per condition, 3.7-5.5MBq, 2030μL) into the footpad of male athymic nude mice (see methods) and performed wholebody PET-CT scans. In all cases, the nanoparticle-bound radionuclides enabled robust
detection of local lymph nodes while the free radionuclide controls did not (Figure 4.12).

Fig. 4.12 | In vivo PET-CT (left) and PET-only (right) lymph node tracking after
injection in the right rear paw of athymic nude mice. (A) Silica nanoparticles
intrinsically labeled with 89Zr 48 h post injection. (B) Free 89Zr 48 h post injection.
Images at earlier time points demonstrated the same trend, where the free 89Zr did not
accumulate in lymph nodes, while the intrinsically labeled silica nanoparticles
progressively moved through the lymphatic system. Data collected by Travis Shaffer (1).
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4.10 Chelator-free radiolabeling of SERRS nanoprobes
The in vivo stability demonstrated by silica nanoparticles validates their use in wellestablished and future biomedical applications (19, 61), and it is conceivable that other
particles could be encapsulated with silica for facile and highly efficient radiolabeling
(18). The radiolabeling procedure outline in section 2.8 may, therefore, be directly
applicable to SERRS nanoparticles comprising a silica encapsulant. The added
functionality of whole-body imaging would enable pre-operative staging and
intraoperative guidance from a single nanoparticle construct.
When designing a multimodal probe, it is necessary to realize that combining the
strengths of each modality does not necessarily mitigate their weaknesses. In particular,
the high sensitivity of optical nanoparticles, especially SERRS nanoprobes, is among
their greatest advantages, but when a low-sensitivity whole-body modality like SPECT or
even MRI is necessary for initial detection, the nanoparticle’s limit of detection becomes
problematic. In this regard, positron-emitting radionuclides are the ideal compliment to
optical nanoprobes, because Positron Emission Tomography (PET) tends to be the most
sensitive whole-body imaging modality. Additionally, PET offers the potential for
pharmacokinetic and biodistribution studies, which are essential for the development of
clinically translatable imaging agents and therapeutics.
Although the radiolabeling of SERS nanoprobes has been previously reported, the
labeling method was limited by the requirement of a molecular chelator, and no imaging
was performed to validate the probe as a contrast agent. Here we show that the general
method of chelator-free radiolabeling can be applied such that reliance on molecular
chelators becomes unnecessary. 68Ga and 64Cu are chosen proof-of-principle
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radionuclides because their half-lives are long enough to provide contrast throughout the
circulation lifetime of SERS nanoparticles, but short enough to minimize the radioactive
cross-dose to healthy tissues.
We directly applied the 68Ga protocol used for silica nanoparticles (see methods
section) in an attempt to radiolabel the SERS nanoparticles. In contrast to the findings of
section 2.8, the silica encapsulant of SERS nanoparticles became very porous and even
disintegrated entirely for some nanoparticles (Fig. 4.13). The decreased stability of a
silica shell compared to a silica nanoparticle is likely caused by the different conditions
under which they are synthesized. In order to generate silica shells around the gold
nanoparticles, the rate of hydrolysis must be kept low so that heterogeneous nucleation
occurs more rapidly than free silica formation in solution. As discussed in section 2.3,
decreasing the rate of hydrolysis also decreases the rate of condensation, leading to more
broken bonds within the amorphous silica structure and greater susceptibility to
degradation. Strategies must be developed, therefore, to make the radiolabeling procedure
less harsh.
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Fig. 4.13 | Degradation of silica shells upon non-optimized 68Ga radiolabeling. TEM
reveals that the silica shells become extremely porous and unstable after the 68Ga
radiolabeling procedure that had been optimized for silica nanoparticles. Scale bar is 100
nm.

Given that the rate of silica dissolution is catalyzed by the presence of sodium
ions, we hypothesized that a radiolabeling procedure free of sodium would be less
detrimental to the silica shells. Rather than eluting the 68Ga generator with potassium
hydroxide (KOH) and neutralizing the eluent with acid (e.g., hydrochloric acid, glacial
acetic acid, etc.) as is done in the standard procedure, we eluted the generator with
hydrochloric acid (HCl) and neutralized the eluent with ammonium hydroxide (NH4OH).
We incubated the SERRS nanoparticles with the 68Ga solution for 5 minutes at room
temperature and observed greater than 95 % of the radioactivity associated with the
nanoparticles. The silica shells were observed to be intact after radiolabeling, and the
nanoparticles remained SERRS active (Fig. 4.14).
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Fig. 4.14 | Characterization of optimized PET-SERRS nanoprobes. (A) TEM of PETSERRS nanoparticles after radiolabeling with the optimized 68Ga protocol. (B) SERRS
spectrum of PET-SERRS nanoparticles. (C) Instant thin layer chromatogram of PETSERRS nanoparticles 5 minutes after addition of 68Ga at room temperature. The data in
(C) was collected by Travis Shaffer.

4.11 In vivo applications of PET-SERRS nanoprobes
The whole-body imaging capabilities of PET and high-sensitivity intraoperative
contrast provided by SERRS (i.e. SERS with a resonant Raman reporter) are a promising
combination for in vivo imaging. In particular, PET imaging enables pre-operative
identification of regions of interest, while SERRS imaging facilitates high-resolution
delineation of diseased tissue in vivo. In this section, we investigate the utility of the
PET-labeled SERRS nanoparticles (PET-SERRS nanoparticles) in several proof-of-
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concept studies including lymph node (LN) tracking, intraoperative guidance for LN
resection, and cancer imaging after intravenous (I.V.) injection.
We began our in vivo evaluation of PET-SERRS nanoparticles by attempting to
image lymph nodes near the periphery of an orthotopic 4T1 breast cancer tumor. The
success of radiolabeled silica for imaging lymph nodes in vivo was established in section
4.8, but the ability of a silica shell to retain radionuclides in vivo has not yet been
demonstrated. PET-SERRS nanoparticles were injected subcutaneously at the tumor
periphery and into the tumor itself. PET imaging 4 h post-injection revealed that much of
the signal remained concentrated near the tumor, suggesting that most of the PET-SERRS
nanoparticles had not migrated from the injection sites. Interestingly, the cervical LN
could be visualized with strong contrast at the 4 h time point (Fig. 4.15A). Although the
axillary LN is the sentinel node for murine breast tissue, the size and location of the
implanted tumor completely obstruct the axillary LN from imaging. The cervical LN
drains multiple regions, including the upper extremities, so the accumulation of PETSERRS nanoparticles in the cervical LN occurs because one or more peripheral injection
sites falls in the region it drains (62, 63). Although direct visualization of the breast’s
sentinel LN was obstructed, the cervical LN imaging illustrates that LN tracking can be
achieved in vivo with PET-SERRS nanoparticles.

139

Figure 4.15 | Lymph node tracking with PET-SERRS nanoparticles. (A) PET-CT
image 4 h after the 68Ga-labeled PET-SERRS nanoparticles were injected around the
periphery of an orthotopic 4T1 breast tumor. (B) SERRS spectrum of PET-SERRS
nanoparticles can be tracked in vivo with a handheld Raman detector. The cervical LN
exhibits the characteristic peaks of the PET-SERRS nanoparticle, which are not present
in outside of the LN. Accordingly, a quick handheld scan can be performed to guide
location and resection of the LN. (C) After resection, the handheld detector is used to
confirm that the SERRS spectrum is only detected in the excised tissue, such that clean
margins exist in the resection bed. The data in (A) was collected by Travis Shaffer.

Intraoperative imaging of the cervical LN confirmed the presence of SERRS
nanoparticles. The characteristic spectrum of the PET-SERRS nanoparticles was
detectable with a handheld Raman detector, and could be raster scanned by a fixed
Raman imaging system to generate a map of relative SERRS intensity The SERRS map
demonstrated excellent co-localization with the pre-operative PET imaging signal,
confirming that the PET-SERRS nanoparticles remained intact after subcutaneous
injection and migration through lymphatic channels (Fig. 4.15B,C). We used a handheld
Raman detector to guide surgical resection of the cervical LN, first by locating it in vivo,
and then by confirming that all contrast-enhanced tissue had been removed. Postoperative SERRS imaging was performed to corroborate the handheld results, and indeed
showed that the lymph node had been completely resected (Fig. 4.16).
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Figure 4.16 | SERRS map of excised LN and resection bed. (A) Photograph and
SERRS map of the same excised tissue shown in the top of Fig. 4.15C shows that the LN
is completely contained within the resected specimen. (B) Photograph and SERRS map
of the same resection bed shown in the bottom of Fig. 4.15C shows that no detectable
SERRS signal remains, indicating clean resection margins.

Because the PET-SERRS nanoparticles naturally accumulate in the
reticuloendothelial system (RES), we hypothesized that they would be well suited for
imaging liver cancer. In particular, the rapid uptake of nanoparticles in healthy liver
tissue and comparatively low uptake of nanoparticles in cancerous tissue was expected to
yield sufficient contrast to delineate tumors in vivo (64). Because the cancerous regions
should contain fewer PET-SERRS nanoparticles than the surrounding liver tissue, the
presence of cancer was expected to yield filling defects (i.e., regions of little to no
contrast surrounded by regions of high contrast). We tested these hypotheses in mice that
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had been genetically engineered to develop hepatocellular carcinomas (HCC). 150 μL of
10 nM PET-SERRS nanoparticles (labeled with 68Ga) were intravenously injected via tail
vein and PET scans were performed 3 h post-injection (Fig. 4.17A). The PET contrast
exhibited several distinct filling defects throughout the liver, as hypothesized, suggesting
the presence of tumors.

Figure 4.17 | Pre-operative staging and intraoperative imaging of liver cancer using
PET-SERRS nanoparticles. (A) PET contrast provided by PET-SERRS nanoparticles
reveals clear filling defects. (B) Intraoperative photograph of liver from the mouse
imaged in (A). Solid tumors are visible by naked eye due to their large size and light
discolorations. The location of the tumors match the areas of filling defects on the PET
scan. (C) Maximum intensity projection (MIP) of the PET signal correlates with the
healthy regions of the liver, revealing the presence of cancer where filling defects occur.
(D) SERRS image of the tumor-bearing liver reveals high-resolution map of the healthy
liver, providing intraoperative contrast. The correlation between PET signal and SERRS
signal indicates that the nanoparticles remain intact and active in vivo. (E) Overlay of
photograph and SERRS map shows that the filling defects in the SERRS signal
correspond to cancer. The images in (A) and (C) were provided by Travis Shaffer.
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We then surgically exposed the livers of the cancer-bearing mice and performed
high-resolution SERRS scans in a simulated intraoperative setting. Even without SERRS
contrast, some large tumors with sizes and locations corresponding to filling defects of
the PET scan were clearly visible. The SERRS map demonstrated pronounced filling
defects where tumors were present, and correlated strongly with the pre-operative PET
signal (Fig. 4.17D-E). The co-registration of PET and SERRS signals in the liver indicate
that the PET-SERRS nanoparticles remain intact after I.V. injection and circulation.
Although future work is required to optimize the delivery of PET-SERRS nanoparticles
to regions of interest outside of the RES, the results presented in this section confirm that
both modalities remain sufficiently stable in vivo to justify further investigation into their
use as whole-body, combined pre- and intra-operative multimodal nanoimaging agents.
Furthermore, this work validates the use of silica encapsulation as a means to render
nanoparticle substrates capable of binding oxophilic radionuclides without requiring
molecular chelation chemistry.

4.12 Methods
Silica Nanoparticle Synthesis
Silica Nanoparticles were synthesized according to a modified Stöber method.
Briefly, 3.75 mL of ultrapure H2O was added to 25 mL of ethanol and 1.25 mL tetraethyl
orthosilicate. The reaction was initiated by the addition of 0.625 mL of 28% ammonium
hydroxide and washed three times in ethanol after the nanoparticles had reached the
desired size.
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Silica Nanoparticle Characterization
The hydrodynamic diameter of the silica nanoparticles pre- and post-labeling was
determined by dynamic light scattering (DLS) (Nano-ZS, Malvern, Westborough, MA).
The same instrument was used in nanoparticle surface charge measurement (ζ potential)
in ultrapure water (>18.2 MΩ cm–1 at 25 °C, Milli-Q, Millipore, Billerica, MA). The
silica nanoparticle concentration was measured with an NS500 instrument (NanoSight,
Duxbury, MA).
68

Ga-Silica Nanoparticle Radiolabeling of Silica Nanoparticles
68

Ga (t1/2=68 minutes) was eluted from a 68Ge-68Ga generator (ANSTO, Australia)

as previously described(65), with 8-9mCi activity per elution. After elution in 500 µL of
0.5 M potassium hydroxide, the 68Ga hydroxide solution was neutralized with
concentrated hydrochloric acid, immediately added to silica nanoparticle solutions (10
nM, in 100µL of 10mM buffer) and incubated at the temperature and pH of interest on a
thermomixer at 500 rpm. MES buffer was used for pH = 5.5 and 7.3 solutions, while
HEPES buffer was used for pH = 8.8 solutions. 1µL samples were taken for radioactive
instant thin layer chromatography (rITLC) at various time points over the course of 1
hour using silica-gel impregnated ITLC paper (Varian), and analyzed with a Bioscan AR2000 radio-TLC plate reader. For 68Ga, 0.1 M citric acid was used as the elution solvent,
while 50 mM EDTA (pH = 5) was used for all other nuclides. The solution was
centrifuged at 10000 rpm for 5 minutes, the supernatant removed and counted, and the
product re-dispersed in 10 mM MES in order to achieve purification.
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89

Zr-Silica Nanoparticle Radiolabeling
89

Zr (t1/2=78.4 h) was produced at Memorial Sloan Kettering Cancer Center on a

TR19/9 cyclotron (Ebco Industries Inc.) via the 89Y(p,n)89Zr reaction and purified to yield
89

Zr-oxalate as previously described(66). 89Zr-oxalate was neutralized with 1.0 M sodium

carbonate and added to silica nanoparticle solutions as described for the 68Ga-silica
nanoparticle radiolabeling.
90

Y-Silica Nanoparticle Radiolabeling
90

Y (t1/2=64 h) was obtained as yttrium (Y-90) chloride in 0.05 N HCl at an

activity concentration of 25 mCi/mL (Nordion). 90Y was added to silica nanoparticle
solutions as described for 68Ga-silica nanoparticle radiolabeling.
111

In-Silica Nanoparticle Radiolabeling
111

In (t1/2=2.8 days) was obtained as Indium (In-111) chloride in 0.05 N HCl at an

activity concentration of 25 mCi/mL (Nordion). 111In was added to silica nanoparticle
solutions as described for 68Ga-silica nanoparticle radiolabeling.
64

Cu-Silica Nanoparticle Radiolabeling
64

Cu (t1/2=12.7 h) was obtained from Washington University, St. Louis, where it

was produced on a CS-15 cyclotron (Cyclotron Corp.) by the 64Ni(p,n)64Cu reaction and
purified to yield 64Cu chloride with a specific activity of 7.4–14.8 GBq/μg. 64Cu was
added to silica nanoparticle solutions as described for 68Ga-silica nanoparticle
radiolabeling.
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177

Lu-Silica Nanoparticle Radiolabeling
177

Lu (t1/2=6.71 days) was obtained as Lutetium (Lu-177) chloride in 0.05 N HCl

at an activity concentration effective specific activity of 29.27 Ci/mg (PerkinElmer).
177

Lu was added to silica nanoparticle solutions as described for 68Ga-silica nanoparticle

radiolabeling. Because 177Lu in the buffer control showed activity at the origin for ITLC
analysis (i.e., some radioactivity did not travel with the solvent front), the amount of
177

Lu bound to the silica nanoparticles was determined both by centrifugal nanoparticle

pelleting and 100kD spin filtration cutoff filters.
Serum Stability Studies
Serum stability experiments at were performed at 37 °C in mixture of 50 % fetal
bovine serum (FBS, Gemini Bio-products) and 50% MES (total volume 150 μL) on an
Eppendorf thermomixer at 550 rpm. Both ITLC and size exclusion filtration analysis
were completed at the reported time points. The values given in Figure 2 are those
measured by ITLC, which showed more free activity for every nuclide and were therefore
considered more robust than size exclusion filtration.
In Vivo Experiments
All animal experiments were done in accordance with protocols approved by the
Institutional Animal Care and Use Committee of Memorial Sloan Kettering Cancer
Center and followed National Institutes of Health guidelines for animal welfare.
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Positron Emission Tomography
Male Nude athymic mice (8-10 weeks old, n = 3) were injected with 250-350 μCi
(9.25-12.95 MBq) radiolabeled Silica nanoparticles (10 nmol Silica nanoparticle) in 100
µL MES solution via the lateral tail vein. At predetermined time points (1h, 4h, and 24h)
animals were anesthetized with isoflurane (Baxter Healthcare, Deerfield, IL) and oxygen
gas mixture (2% for induction, 1% for maintenance) and scans were then performed
using an Inveon PET/CT scanner (Siemens Healthcare Global). Whole body PET static
scans were performed recording a minimum of 50 million coincident events, with
duration of 10-20 min. The energy and coincidence timing windows were 350−750 keV
and 6 ns, respectively. The image data were normalized to correct for non-uniformity of
response of the PET, dead-time count losses, positron branching ratio, and physical decay
to the time of injection, but no attenuation, scatter, or partial-volume averaging correction
was applied. Images were analyzed using ASIPro VMTM software (Concorde Microsystems).

Computed Tomography
Whole body standard low magnification CT scans were performed with the X-ray
tube setup at a voltage of 80 kV and current of 500 µA. The CT scan was acquired using
120 rotational steps for a total of 220 degrees yielding and estimated scan time of 120 s
with an exposure of 145 ms per frame.
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PET/CT Lymph Node Studies with 89Zr-Silica Nanoparticles
For in vivo silica nanoparticle-radiometal lymph node imaging studies, 3 mice
were injected in the footpad with 89Zr in saline and 3 mice were injected with 100-200
µCi of 89Zr-silica nanoparticle (10 mM MES, 20µL, 3.7-7.4 MBq) for a total of 6 mice.
All mice were induced with 2.5% isoflurane and maintained on 2-2.5% isoflurane in
preparation for the scans. Whole body scans were performed using Inveon Multimodality
(MM) CT scanner (Siemens) and Inveon dedicated PET scanner for a total of 15-45 min.

SERRS Nanoprobe Synthesis
Gold nanoparticles were synthesized through addition of 7.5 ml 1% (w/v) sodium
citrate to 1000 ml boiling 0.25 mM HAuCl4. The as-synthesized gold nanoparticles were
concentrated by centrifugation (10 min, 7500 x g, 4 °C) and dialyzed overnight (3.5 kDa
MWCO; 5L 18.2 MΩ.cm). The dialyzed gold nanoparticles (140 μL; 2.0 nM) were added
to 1000 μL absolute ethanol in the presence of 50 μL 99.999% tetraethoxyorthosilicate
(Sigma Aldrich), 20 μL 28% (v/v) ammonium hydroxide (Sigma Aldrich) and 2 μL
Raman reporter molecule (e.g. IR-780, IR-792, chalcogenopyrylium dye etc.) (1-25 mM)
in N,N-dimethylformamide. After shaking (375 rpm) for 25 min at ambient conditions in
a plastic container, the SERRS-Nanoprobes were collected by centrifugation, washed
with ethanol, and redispersed in water to yield 2.0 nM SERRS-Nanoprobes.

SERRS Nanoprobe Radiolabeling Protocols
68

Ga radiolabeling:
68

Ga (t1/2=68 m) was eluted from a 68Ge-68Ga generator (ANSTO, Australia) as

previously described1, with 555-740 MBq (15-20 mCi) activity per elution. 68Ga was
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eluted as either a direct elution in 0.4 N HCl, or as purified elution in 0.5 M potassium
hydroxide. The 68Ga HCl solution was neutralized with 28% ammonium hydroxide while
the 68Ga hydroxide solution was neutralized with concentrated hydrochloric acid. Upon
neutralization, 37 MBq (1.0 mCi) of 68Ga was immediately added to silicate gold
nanoparticle solutions (10 nM, in 100 μL of 10 mM pH = 7.3 MES buffer) and incubated
at 70 °C on a thermomixer at 500rpm for 30-60 minutes. Purification was completed by
centrifugation at 10,000 rpm for 120 seconds followed by resuspension.

64

Cu radiolabeling:
64

Cu (t1/2=12.7 h) was obtained from Washington University, St. Louis, as 64Cu

chloride in 0.05 N HCl with a specific activity of 7.4–14.8 GBq/μg. 1-2 μL (7.4-14.8
MBq, 200-400 μCi) was added to 100 μL silicated gold nanoparticles and radiochemistry
was completed as described for 68Ga.

Determination of Radiochemical Yield in PET-SERRS Experiments
Radiochemical yield (% of activity bound to particles) was determined via either
ITLC or through centrifugal pelleting of nanoparticles. For ITLC, 1 μL samples were
taken using silica-gel impregnated ITLC paper (Varian), and analyzed with a Bioscan
AR-2000 radio-TLC plate reader. For 68Ga, 0.1 M citric acid was used as the elution
solvent, while 50 mM EDTA (pH = 5) was used for 64Cu. Free activity moves with the
mobile phase, while nanoparticle bound radioactivity stays at the origin.
The centrifugal pelleting approach to determining radiochemical yield proceeded by
pelleting of radiolabeled nanoparticles, removal of supernatant, re-dispersion of the pellet
in10 mM MES measurement of its radioactivity.
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APPENDIX 1
Supplementary Discussion of Crystal Growth
A1.1 “Surface blocking” diffusion-limited and reaction-limited mechanisms
The concept of surface blocking is so intuitive that it has become perhaps the
most common explanation for the evolution of crystal shapes, yet the actual mechanism
by which growth is inhibited is rarely articulated. The foundational claim is that auxiliary
chemicals, termed shape-directing agents, bind with sufficient selectivity to a particular
family of crystallographic planes to modify their growth rates (1-3). This explanation
assumes first that the structure or reactivity of crystal facets are significantly different
such that some will interact strongly with auxiliary species and others will not. While this
is certainly the case for come crystals, such as those comprised of polar growth units, the
application of this hypothesis to low index facets of noble metals has, understandably,
been met with skepticism (4).
We have used the most common claims from highly cited articles and reviews to
articulate the physical processes promoting anisotropic growth in the presence of shapedirecting agents (1-3). The primary difference between the two theories is the mechanism
by which the shape-directing agents inhibit facet growth. We classify the two theories as
reaction-limited and diffusion-limited surface blocking.
Reaction-limited surface blocking occurs when a chemical other than the crystal
growth unit inhibits the incorporation of growth units to binding sites. The prototypical
example of this process is surfactant adsorption to binding sites. In order for growth units
to become incorporated into the crystal the surfactants must first be displaced. The
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greater the surfactant coverage and the stronger the surfactant-crystal bond, the slower
the incorporation rate of growth units (5).
Diffusion-limited surface blocking occurs when the adsorbed chemicals inhibit
delivery of growth units to the step front, but not necessarily the binding of the growth
unit once the step front is reached. Examples of this process include steric and
electrostatic repulsion preventing growth units from reaching the surface of a particular
facet (3, 6). The presence of adsorbed shape-directing agents can also inhibit surface
diffusion of adsorbed growth units. In short, diffusion-limited surface blocking inhibits
arrival of growth units at binding sites and reaction-limited surface blocking inhibits the
incorporation of growth units once they have reached binding sites.
Because we observe some highly anisotropic nanoparticles dominated by {111}
facets and other highly anisotropic nanoparticles dominated by{100} facets in the same
synthesis, we conclude that shape-directing agents cannot be the sole explanation for the
crystal habit in our experiments. It is not reasonable to explain the appearance of platelike particles with major {111} facets as the result of selective adsorption of shapedirecting agents when rod-like particles comprised primarily of {100} facets form in the
same solution (4). This is especially unlikely in our synthesis because of the dearth of
auxiliary chemicals available to act as shape-directing agents. It is also important to note
that surface reconstructions are likely during growth via reduction of metal salt
precursors by weak reducing agents (7). When {100} facets undergo hexagonal
reconstruction they become virtually identical to {111} facets. Although this
phenomenon receives very little consideration in the nanocrystal community, it must be
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addressed if differences in surface reactivity are essential to proposed growth
mechanisms.

A1.2 Structure-related nucleation-, diffusion-, and reaction-limited mechanisms
Although growth mechanisms based upon surface structure are uncommon in
nanocrystal research, with the exception of plate formation, there are several structure
related mechanisms proposed in classic crystal growth and silver halide literature (8-12).
The theories can be classified as nucleation-limited, diffusion-limited, or reaction-limited
based upon the rate-limiting step of growth proposed in the mechanism. Structure-based
mechanisms are attractive considerations for syntheses such as ours that do not rely
employ auxiliary species. However, they tend to suffer from a lack of quantitative
validation.
The fundamental hypothesis of surface structure based theories holds that
structural differences, particularly in the form of defects, alters growth rates of crystal
facets. Growth occurs preferentially on facets with defects in nucleation-limited theories
because the rate of monolayer nucleation is faster at defects than at pristine sites (4, 11).
Diffusion-limited and reaction-limited arguments are most common when it is assumed
that all facets have perpetual step defects, like screw dislocations, such that monolayer
nucleation is unnecessary (8). Under these conditions, growth is diffusion-limited when
growth unit arrival is rate-limiting, and reaction limited when growth unit incorporation
into binding sites is rate-limiting. It is common, as in the classic Burton-Cabrera-Frank
theory, to assume that growth is diffusion limited in the presence of perpetual step defects
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unless the growth unit itself must rearrange at the binding site to become incorporated
(e.g. urea crystals) (12).
Given the defect symmetries confirmed by selected area electron diffraction and
high-resolution transmission electron microscopy, surface structure hypotheses
qualitatively fit our experimental observations. We cannot discern from these theories
whether growth is nucleation-limited, diffusion-limited, or reaction-limited because
quantitative explanations are not available. This is especially problematic when it comes
to engineering shape control because the design rules for tuning growth rates depends on
the rate-limiting mechanism (see sections on shape control during nucleation-limited,
diffusion-limited and reaction-limited growth).

A1.3 Surface energy minimization mechanism
The surface energy minimization theory as an explanation for crystal habit is
closely associated with the concept of shape-directing agents (2, 13-15). Although the
hypothesis does not provide a mechanism by which any given shape is achieved, it is
clearly driven by thermodynamic considerations. When applied to the study of shape
evolution, it is typically hypothesized that shape-directing agents selectively bind crystal
facets and modify their surface energy. The crystal habit evolves until the Wulff shape is
achieved (13, 15, 16). We reject this explanation as representative of our experiments
because selective binding of shape-directing agents is not a reasonable assumption given
the product morphologies observed. Moreover, if {111} facets are sufficiently stable to
generate highly anisotropic platelets a minimum energy configuration, then nanorods
would not form because the {100} would have to be energetically unfavorable.

A1-4

A1.4 Shape control during nucleation-limited growth
In nucleation-limited growth, facet growth rates are determined by the rate at
which critical nuclei form (17). Controlling the relative growth rates in each
crystallographic direction, therefore, is a matter of controlling the rate of nucleation on
the corresponding facets. The rate of nucleation increases in the order of passivated
surfaces, defect-free unpassivated surfaces, surfaces with stacking-faults, surfaces with
cross-twinning, surfaces with twin lamellae, and surfaces with screw-dislocations or other
perpetual step sources. Either inducing defects on the facets where rapid growth is
desired, or passivating facets where slow growth is desired can therefore enable shape
control.
In practice, seed crystallinities can be identified that have surface defects in the
required crystallographic orientations for growth of a particular morphology. Shape
controlled syntheses in nucleation-limited regimes can therefore be achieved by
identifying the appropriate seed crystallinity, synthesizing seeds with that crystallinity in
the highest yield possible, and identifying the appropriate reaction kinetics to tune the
relative facet growth rates according to the prescribed dimensions. The preference for
growth of a defect-containing facet with respect to a defect-free facet tends to increase as
reaction kinetics decrease because the nucleation becomes highly improbable on pristine
facets at slow reaction kinetics (8).
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A1.5 Shape control based in diffusion-limited growth
In the diffusion-limited regime, the rate of growth in a crystallographic direction
is dependent on the flux of growth units to binding sites on the corresponding facet. The
total flux to step sites is a combination of volume and surface diffusion rates. Preferential
facet growth in this regime can thus be achieved by steering mass transport via surface
passivation, especially with charged species that induce electric-field directed delivery of
growth units (6). It should be noted, however, that the shape, step density and defect
symmetry of nanocrystals creates charge separation at the surface without the
requirement of charged adsorbates (18, 19). The density of surface charges can be further
tailored by the redox potential of the solution (20).
The relationship between crystal surfaces with accurate electronic structure and
preferential volume diffusion of growth units has received very little attention, but has
important consequences in symmetry breaking and anisotropic growth of metal
nanoparticles. Indeed, shape-controlled syntheses employing weak reducing agents to
reduce precursor metal complexes generate growth units that diffuse as charged
complexes. Preferential deposition of these negatively charged metal halide complexes is
likely to occur at positively charged surfaces, such as facets with small step separations,
high defect densities or large proportions of edge atoms, because electron smoothing
creates positively charged regions at convex corners. Preferential accumulation of
negatively charged growth units should be especially high at facet edges and corners
because of the combined influences of electron smoothing and the Berg effect (21).
After symmetry breaking has occurred, shear forces due to rapid stirring and
crystal alignment with flow can impart additional preference of volume diffusion. In fact,
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the very act of preferential facet growth is expected to create a cooperative phenomenon
of preferential volume diffusion to the faster growing facets because the reservoir of
growth units is depleted near the fast-growing sites, creating a diffusion field pointing in
their direction (22, 23).

A1.6 Shape control in reaction-limited growth
In the reaction-limited regime, the rate of growth in a crystallographic direction is
dependent on the net rate of growth unit incorporation into binding sites on the
corresponding facet. Preferential growth in a given direction can therefore be achieved by
decreasing the activation energy for diffusing into binding sites or increasing the
activation energy for detachment from binding sites. Introducing complexing agents,
varying temperature, and changing the redox potential of the solution can modulate these
activation energies. Reaction-limited growth is likely to be associated with chemical
additives adsorbed at binding sites, and thus is not expected to be a significant
consideration in additive-free syntheses such as the one presented here.

A1.7 The shape-directing role of chemical additives
Arguably the most widely accepted explanation for the mechanism of shape
control during (nano)crystal growth is the assumed presence of selectively bound
chemical species modulating the growth rates of distinct facet types (2). The prototypical
example in gold nanoparticle syntheses is the shape-directing surfactant
cetyltrimethylammonium bromide, which is thought to demonstrate preferential binding
of {100} and higher index facets over {111} facets (3). Although the selective adsorption
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is widely agreed upon as the origin of anisotropic growth, the specific mechanism is
rarely articulated. Instead, the fast-growing {111} facets are characterized as “more
reactive”, or less “blocked” than the slower growing {100} and {110} facets (2, 3). The
former terminology implies a reaction-limited hypothesis, whereas the latter suggests a
diffusion-limited mechanism, however the reader can only speculate without concrete
propositions.
The simplicity and generality of the selective chemical adsorption mechanism has
an intuitive appeal that facilitates widespread adoption, but is deceptively complicated.
What is the rate-limiting step? Do the adsorbates control shape by modulating nucleation
rates, directing flux of growth units, modifying the rate of incorporation into binding
sites, or something different all together? The answer to these questions likely varies
from one chemical species to another, and is beyond the scope of the present work.
However, we can address the analogous, perhaps more fundamental question of the
intrinsic differences in nucleation rate, diffusion rate, and incorporation rate characteristic
to different facets without chemical modification (see chapter 2). With this knowledge,
we can expound upon the origins of preferential growth in different crystallographic
directions as a function of reaction conditions, and hypothesize the likely effects of
preferential adsorption.

A1.8 The shape-directing role of halides
In addition to surfactants, polymers, and organic molecules, halides have been
proposed to serve as shape-directing agents in metal nanoparticle syntheses (24-26).
Because halides are typically present in the precursor metal complexes used in
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nanoparticle syntheses, this proposition is particularly important to consider. Although
there exists convincing evidence that the concentration and identity of halides affects
metal nanoparticle morphology, it should be recognized that the influence of halides
extends beyond surface passivation, and that the strength of the halide-metal interaction
varies significantly between species (26).
The main arguments for halides as shape-directing agents at the nanoparticlesolution interface are related to surface blocking. Studies of the seeded growth of Pd
nanocubes suggest that adlayers of Br- inhibit nucleation of monolayers, and surface
diffusion to binding sites on Pd {100} facets (24). However, the concentration of halides
in typical syntheses free of halide additives is on the order of 1000 times lower than
presented in the referenced work, so caution should be taken when applying these
conclusions to other metal nanoparticle syntheses, especially when the metal-halide pair
has a weaker interaction than Pd and Br-.
In the absence of a halide adlayer (i.e. monolayer of adsorbed halides), surface
halides can actually catalyze the diffusion of growth units to binding sites. The only
available computational study on the effect of Cl on Au surface diffusion shows that the
formation of AuCl surface complexes lowers the activation energies for surface diffusion
and kink incorporation – increasing the growth rate of such surfaces (27). The activation
energy for kink disincorporation is also lowered, however, so the ripening rate of adatom
islands similarly increases.
The role of halides is significant, yet quite complex, and more extensive
computational studies will be required to sort out the relationships between halide
concentrations and the formation, and structure, of halide-metal surface complexes for
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different facet symmetries. The results of these computational studies could be used as
inputs for the theoretical framework presented herein to determine the influence of halide
concentration on growth mechanisms and rates. For example, the activation energies for
surface jumping at relevant sites along the step front (see chapter 2) can be calculated and
directly input into our equations for facet growth rate.
In the present study, we used the activation energies for chloride-modified surface
diffusion processes as the upper limit for the effect of halide adsorption and investigated
the expected changes in facet growth rates. Because many shape-controlled syntheses of
gold nanoparticles, including the one presented here, are mediated by weak reducing
agents that deposit growth units as gold-halide species onto the nanoparticle surface, we
anticipate that these considerations will become increasingly important in computational
investigations.

A1.9 The role of defects on the rate of monolayer nucleation
The monolayer nucleation rate – the rate of critical 2D nucleus formation –
increases in the presence of surface defects (4, 11). The increased coordination number
for adatoms at defect sites increases their residence time in those locations, which
increases the probability of collision with other adatoms. Moreover, the higher
coordination of the defect decreases the size of the critical nucleus with respect to a
defect-free terrace. This occurs because the number of nearest neighbor bonds per atom is
greater for an adatom island at a defect than the same island on a pristine terrace, hence
the decrease in free energy is greater per growth unit added. Additional, less commonly
discussed phenomena, are also present at defect sites that favorably modulate nucleation
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rate, such as local changes in electrostatic potential due to electron smoothing at the
defect (18).

A1.10 Reaction kinetics versus probabilities of defect formation
For any crystal in solution, there exist non-zero probabilities for the formation of
various defects. The rate of defect formation will depend on the vibrational frequencies
and activation energies that characterize the number of attempts at defect formation per
unit time and probability of a successful attempt, respectively. The number of attempts at
defect formation increases linearly over time in accordance with the constant vibration of
growth units in the crystal. Hence, the number of observed defects in a crystal will
increase over time until an equilibrium concentration of defects is reached. This implies,
therefore, that as the net crystal growth rate approaches zero from positive infinity, the
observed number of crystal defects tends to increase, for a given activation energy of
defect formation.
Because the activation energy for a structural transition, such as defect formation,
tends to decrease as the number of atoms in a crystal decreases, slow reaction rates that
increase the time nanoparticles exist at small sizes should generate higher proportions of
defected seeds. It is important to note that defect formation requires the movement of
both surface and volume (i.e. interior) atoms. Therefore nanocrystals in reaction
conditions that catalyze removal, diffusion, and deposition of atoms will have a much
greater probability of defect formation than the same nanocrystals in pure solvent.
Defect-catalyzing reaction conditions include the presence of complexing ligands,
oxidants, and weakly reducing conditions – which result in charge accumulation at the
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nanoparticle surface and increased atom mobility. It is also important to note that these
conditions decrease colloidal stability and thereby increase the average number of
nanoparticle aggregation events which can be a dominant mechanism of creating defected
seed crystals (5).

A1.11 The role of perpetual steps on the mechanism of crystal growth
When defects such as screw dislocations that provide perpetual step sources are
present, the time for monolayer nucleation equals zero, and the facet growth rate is
dependent on the rate of growth unit diffusion to binding sites and the subsequent
incorporation reaction. Because these rates are typically faster than the rate of nucleation
for gold (nano)crystals, facets with screw dislocations will grow faster than facets that do
not possess perpetual step sources (8). The rate-limiting step for the growth of facets with
perpetual step sources will therefore be either diffusion of growth units to step sites or
incorporation of growth units into binding sites.

A1.12 Problems with the classical rate equations for diffusion
Classical diffusion flux equations are determined by applying continuity relations
to Fick’s laws (8). The relevance of these equations has been the subject of much
investigation, and it is known that they break down as the rate of adatom island formation
increases (28). This is a particularly significant point of criticism, because (nano)crystal
growth appears to only become diffusion-limited in the regime of fast monolayer
nucleation. More fundamentally, the continuity equations typically employed do not
represent proper definitions of thermodynamic driving forces, because the logarithmic
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definition of supersaturation must be replaced by linear definitions in order for analytical
solutions to exist. For example, a proper application of the Teorell definition of diffusion
leads to continuity equations of the form c1ΨeΨ = ∇2 Ψ which have no known analytical
solution. In general, the obtainable analytical expressions for surface diffusion are so
restricted by assumptions, particularly on the nanoscale, that these calculations are best
left to computational investigations, such as multiscale ReaxFF studies. Consequently,
caution should be exercised when extending the present work to incorporate diffusion
equations. In fact, this is the reason we left the flux as an input parameter, rather than
restricting the theoretical framework to a particular set of assumptions regarding growth
unit diffusion.

A1.13 Design considerations for the nucleation of seeds
The proportion of seeds with a particular type of defect can be modulated to some
degree by control of the capping ligands, solvent, reaction kinetics, and temperature
during synthesis (25, 29). For example, it was recently shown for Pd that by increasing
the reduction kinetics during nucleation, the dominant crystal types switch from single
and parallel twin planes (i.e. plate-like) to icosahedral to single crystalline (i.e. defectfree) (29). The increased concentration of defect-containing particles formed under slow
reaction conditions is expected due to the increased probability of seed aggregation and
the higher surface charge density (20). Conceptually, it stands to reason that more defectcontaining particles would form under slow reaction kinetics because monolayer
nucleation will only be favored at defect sites, thus the seeds with defects consume the
available growth units. Defect-free seed populations can also be obtained by using
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oxidants and complexing agents to selectively dissolve defect-containing seeds (30). It is
important to note that uncovering the relationship between the structural properties of
seeds and the reaction conditions employed in their formation is a burgeoning field of
research, and there is still much to be learned.
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APPENDIX 2
Matlab Scripts
A2.1 Matlab script for crystal growth contour plots
%% Input: Crystal Growth Contour Plot
%Temperature in Kelvin
T = 300;
%number of atoms in first step after nucleation
m_i = 3;
%number of atoms in step fragment
m = 10;
%Facet index (do not include brackets. Write 111 or 100)
facet = 111;
%Chloride coverage (between 0 and 1)
Cl = 0.0;
%% Input: Activation Energies, Vib. Frequencies
%{111} With Chloride EAM
%Activation Energies in eV
E_LLc111 = 0.080;
E_LSc111 = 0.075;
E_LKc111 = 0.052;
E_SSc111 = 0.243;
E_SKc111 = 0.223;
E_KSc111 = 0.356;
E_SLc111 = 0.320;
E_KLc111 = 0.282;
E_USc111 = 0.203;
E_UKc111 = 0.142;
d_hkl_111 = 0.353;
%{111} Without Chloride EAM
%Activation Energies in eV
E_LLp111 = 0.102;
E_LSp111 = 0.096;
E_LKp111 = 0.067;
E_SSp111 = 0.311;
E_SKp111 = 0.286;
E_KSp111 = 0.456;
E_SLp111 = 0.410;
E_KLp111 = 0.420;
E_USp111 = 0.260;
E_UKp111 = 0.181;
%{100} With Chloride EAM
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%Activation Energies in eV
E_LLc100 = 0.383;
E_LSc100 = 0.361;
E_LKc100 = 0.252;
E_SSc100 = 0.236;
E_SKc100 = 0.217;
E_KSc100 = 0.355;
E_SLc100 = 0.533;
E_KLc100 = 0.468;
E_USc100 = 0.413;
E_UKc100 = 0.288;
d_hkl_100 = 0.408;
%{100} Without Chloride EAM
%Activation Energies in eV
E_LLp100 = 0.490;
E_LSp100 = 0.462;
E_LKp100 = 0.322;
E_SSp100 = 0.302;
E_SKp100 = 0.278;
E_KSp100 = 0.455;
E_SLp100 = 0.682;
E_KLp100 = 0.698;
E_USp100 = 0.528;
E_UKp100 = 0.368;
%Vibrational Frequencies in 1/s
v_LL = 1.76E+12;
v_LS = 1.42E+12;
v_LK = 1.43E+12;
v_SS = 1.41E+12;
v_SK = 1.45E+12;
v_KS = 1.45E+12;
v_SL = 1.91E+12;
v_KL = 1.75E+12;
v_US = 1.42E+12;
v_UK = 1.43E+12;
%% Activation Energies
%Facet-dependent activation energies
if facet == 111
E_LLc = E_LLc111;
E_LSc = E_LSc111;
E_LKc = E_LKc111;
E_SSc = E_SSc111;
E_SKc = E_SKc111;
E_KSc = E_KSc111;
E_SLc = E_SLc111;
E_KLc = E_KLc111;
E_USc = E_USc111;
E_UKc = E_UKc111;
E_LLp = E_LLp111;
E_LSp = E_LSp111;
E_LKp = E_LKp111;
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E_SSp = E_SSp111;
E_SKp = E_SKp111;
E_KSp = E_KSp111;
E_SLp = E_SLp111;
E_KLp = E_KLp111;
E_USp = E_USp111;
E_UKp = E_UKp111;
else
E_LLc = E_LLc100;
E_LSc = E_LSc100;
E_LKc = E_LKc100;
E_SSc = E_SSc100;
E_SKc = E_SKc100;
E_KSc = E_KSc100;
E_SLc = E_SLc100;
E_KLc = E_KLc100;
E_USc = E_USc100;
E_UKc = E_UKc100;
E_LLp = E_LLp100;
E_LSp = E_LSp100;
E_LKp = E_LKp100;
E_SSp = E_SSp100;
E_SKp = E_SKp100;
E_KSp = E_KSp100;
E_SLp = E_SLp100;
E_KLp = E_KLp100;
E_USp = E_USp100;
E_UKp = E_UKp100;
end
E_LL = Cl*E_LLc+(1-Cl)*E_LLp;
E_LS = Cl*E_LSc+(1-Cl)*E_LSp;
E_LK = Cl*E_LKc+(1-Cl)*E_LKp;
E_SS = Cl*E_SSc+(1-Cl)*E_SSp;
E_SK = Cl*E_SKc+(1-Cl)*E_SKp;
E_KS = Cl*E_KSc+(1-Cl)*E_KSp;
E_SL = Cl*E_SLc+(1-Cl)*E_SLp;
E_KL = Cl*E_KLc+(1-Cl)*E_KLp;
E_US = Cl*E_USc+(1-Cl)*E_USp;
E_UK = Cl*E_UKc+(1-Cl)*E_UKp;
%% Input: Contour Plot Display
interval = 350;
%a = min flux, b = max flux
a = 10^0;
b = 10^15;
%f = min Nuc. Rate, g = Nuc. Rate
f = 10^0;
g = 10^15;
%nc = number of contours.
nc = 25;
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%% Data: Diffusion Rates and Physical Constants
format longG
%Boltzmann's Constant in eV/K
k_B = 8.6173324E-5;
%Thermal Energy
kT = k_B*T;
%Monolayer Height
if facet == 111
d_hkl = d_hkl_111;
else
d_hkl = d_hkl_100;
end
d_hkl;
%% Date: Diffusion Rates
preR_LL = v_LL*exp(-E_LL/kT);
preR_LS = v_LS*exp(-E_LS/kT);
preR_LK = v_LK*exp(-E_LK/kT);
preR_SS = v_SS*exp(-E_SS/kT);
preR_SK = v_SK*exp(-E_SK/kT);
preR_KS = v_KS*exp(-E_KS/kT);
preR_SL = v_SL*exp(-E_SL/kT);
preR_KL = v_KL*exp(-E_KL/kT);
preR_US = v_US*exp(-E_US/kT);
preR_UK = v_UK*exp(-E_UK/kT);
%Facet-dependent diffusion rates
if facet == 111
pij_LL = (1/3)*preR_LL;
pij_LS = preR_LS/(preR_LS+2*preR_LL);
pij_LK = preR_LK/(preR_LK+2*preR_LL);
pij_SS = (1/2);
pij_SK = preR_SK/(preR_SK+preR_SS);
pij_KS = 0;
pij_SL = preR_SL/(preR_SL+2*preR_SS);
pij_KL = 1;
pij_US = preR_US/(preR_US+2*preR_LL);
pij_UK = preR_UK/(preR_UK+2*preR_LL);
else
pij_LL = (1/4)*preR_LL;
pij_LS = preR_LS/(preR_LS+3*preR_LL);
pij_LK = preR_LK/(preR_LK+preR_LS+2*preR_LL);
pij_SS = (1/2);
pij_SK = preR_SK/(preR_SK+preR_SS);
pij_KS = 0;
pij_SL = preR_SL/(preR_SL+2*preR_SS);
pij_KL = 1;
pij_US = preR_US/(preR_US+3*preR_LL);
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pij_UK = preR_UK/(preR_UK+3*preR_LL);
end
R_LL = preR_LL*pij_LL;
R_LS = preR_LS*pij_LS;
R_LK = preR_LK*pij_LK;
R_SS = preR_SS*pij_SS;
R_SK = preR_SK*pij_SK;
R_KS = preR_KS*pij_KS;
R_SL = preR_SL*pij_SL;
R_KL = preR_KL*pij_KL;
R_US = preR_US*pij_US;
R_UK = preR_UK*pij_UK;

%Flux is the flux of growth units to the step front in atoms nm^-1 s^-1
syms Flux
D_Au = 0.288;
flux_step = D_Au*Flux;
%E_T0 is the expectation time for growth units to arrive at the step front
E_T0 = flux_step^(-1);
%% Data: Arrival Time
loga = log10(a);
logb = log10(b);
logf = log10(f);
logg = log10(g);
FL = ones(1,interval+1);
for j = (1:interval+1)
k = 10^(loga+(j-1)*(logb-loga)/interval);
FL(j) = subs(flux_step,Flux,k);
end
MATFL = ones(m,interval+1);
for l = (1:m)
MATFL(l,:) = l*FL;
end
MATFL;
ET0_L = 1./MATFL;
ET0_LU = ET0_L/2;
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%% Data: Incorporation Generator
Markov_incorporation = ones(m,1);
MarkovLU_incorporation = ones(m,1);
for n = (3:m)
ProbjL = 1/n;
ProbjLU = 1/(2*n);
timejL = 1/R_LS;
timejU = 1/R_US;
%Q is the infinitesimal generator
pkA = ones(n-1);
pkB = eye(n-1);
pkC = tril(pkA,-2);
pkD = triu(pkA,2);
pkE = pkA-pkB-pkC-pkD;
pkF = -R_SS*pkE;
pkG = pkB*(2*R_SS);
Q = pkF+pkG;
Q(1,1) = R_SK+R_SS;
Q(n-1,n-1) = R_SS;
Qone = ones(n-1,1);
E_partMarkov = Q\Qone;
T1T2mark = ones(n-1,1);
for q = (1:n-1)
T1T2mark(q) = ProbjL*(timejL+E_partMarkov(q));
end
T1T2mark0 = ProbjL*(1/R_LK);
T1T2_Markov = [T1T2mark0;T1T2mark];
T1T2one = ones(1,n);
T1T2L = T1T2one*T1T2_Markov;
Markov_incorporation(n) = T1T2L;
E_partMarkovLU = Q\Qone;
T1T2markLU = ones(n-1,1);
for h = (1:n-1)

A2-6

T1T2markLU(h) = ProbjLU*(timejL+timejU+2*E_partMarkovLU(h));
end
T1T2LUmark0 = ProbjLU*(1/R_LK+1/R_UK);
T1T2LU_Markov = [T1T2LUmark0;T1T2markLU];
T1T2LUone = ones(1,n);
T1T2LU = T1T2LUone*T1T2LU_Markov;
MarkovLU_incorporation(n) = T1T2LU;
end
Markov_incorporation(1) = 1/R_LK;
Markov_incorporation(2) = (1/2)*(1/R_LK)+(1/2)*((1/R_LS)+(1/R_SK));
MarkovLU_incorporation(1) = (1/2)*((1/R_LK)+(1/R_UK));
MarkovLU_incorporation(2) =
(1/4)*((1/R_LK)+(1/R_UK))+(1/4)*((1/R_LS)+2*(1/R_SK)+(1/R_US));
Markov_incorporation;
MarkovLU_incorporation;

%% Data: Expected Time to Complete Step by CTMC
Time_MarkovL = ones(m,interval+1);
Time_MarkovLU = ones(m,interval+1);
for v = (1:m)
Time_MarkovL(v,:) = ET0_L(v,:)+Markov_incorporation(v);
Time_MarkovLU(v,:) = ET0_LU(v,:)+MarkovLU_incorporation(v);
end

Time_MarkovL;
Time_MarkovLU;
CORXNL= ones(m,interval+1);
CORXNLU= ones(m,interval+1);
for v = (1:m)
CORXNL(v,:) = (1/R_KL)./((1/R_KL)-Time_MarkovL(v,:));
CORXNLU(v,:) = (1/R_KL)./((1/R_KL)-Time_MarkovLU(v,:));
end

T_markL = ones(m,interval+1);
T_markLU = ones(m,interval+1);
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for v = (1:m)
T_markL(v,:) = CORXNL(v,:).*Time_MarkovL(v,:);
T_markLU(v,:) = CORXNLU(v,:).*Time_MarkovLU(v,:);
end
numL = numel(T_markL);
for d = (1:numL)
if T_markL(d)<0
T_markL(d)=NaN;
end
if T_markLU(d)<0
T_markLU(d)=NaN;
end
end
T_markL;
T_markLU;
Time_Markov_L = cumsum(T_markL);
Time_Markov_LU = cumsum(T_markLU);
%% Data: Expected Time for 1D Nucleation
T1DL = ET0_L + 1/R_LS;
T1DLU = ET0_LU + 0.5/R_LS + 0.5/R_US;
CTMCL = ones(1+m-m_i,interval+1);
CTMCLU = ones(1+m-m_i,interval+1);
for p = (m_i:m)
E_T_M1 = ones(p,interval+1);
E_T_M2 = ones(p,interval+1);
for i = (1:p)
E_T_M1(i,:) = (1/p)*Time_Markov_L(max(i-1,p-i),:);
E_T_M2(i,:) = (1/p)*Time_Markov_LU(max(i-1,p-i),:);
end
jumpinL = T1DL(p,:);
jumpinLU = T1DLU(p,:);
E_T_ML = sum(E_T_M1);
E_T_MLU = sum(E_T_M2);
EML = E_T_ML + jumpinL;
EMLU = E_T_MLU + jumpinLU;
CTMCL(1+p-m_i,:) = EML;
CTMCLU(1+p-m_i,:) = EMLU;
end
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CTMCL;
CTMCLU;
%% Plot: Log Expectation Time versus Step Length versus Log Flux

set(gcf,'Colormap',jet)
contourf(log10(FL),(m_i:m),log10(CTMCL),25)
set(gca,'FontSize',28)
title('Log(Step Time) vs. Log(Flux)','Fontsize',28)
xhandle=xlabel('Log(Flux)');
yhandle=ylabel('n');
set(xhandle,'Fontsize',28)
set(xhandle,'Fontname','Helvetica')
set(yhandle,'Fontsize',28)
set(yhandle,'Fontname','Helvetica')
colormap(jet)
cb=colorbar;
set(cb,'fontsize',28, 'Fontname','Helvetica');
%% Data: Kink Propagation
kinkL = ones(1+m-m_i,interval+1);
kinkLU = ones(1+m-m_i,interval+1);
kinkarrival = ones(m,interval+1);
kinkarrivalLU = ones(m,interval+1);
for x = (1:m)
kinkarrival(x,:) = 1./FL;
kinkarrivalLU(x,:) = 1./(2*FL);
end
kinkcum = cumsum(kinkarrival);
kinkcumLU = cumsum(kinkarrivalLU);
for y = (1:m)
kinkL(y,:) = y/R_LK+kinkcum(y,:);
kinkLU(y,:) = y*(0.5/R_LK+0.5/R_UK)+kinkcumLU(y,:);
end
kinkL;
kinkLU;
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KPL = ones(1+m-m_i,interval+1);
KPLU = ones(1+m-m_i,interval+1);
for p = (m_i:m)
E_T_KPL = ones(p,interval+1);
E_T_KPLU = ones(p,interval+1);
for i = (1:p)
E_T_KPL(i,:) = (1/p)*kinkL(max(i-1,p-i),:);
E_T_KPLU(i,:) = (1/p)*kinkLU(max(i-1,p-i),:);
end
KPL1 = sum(E_T_KPL);
KPLU1 = sum(E_T_KPLU);
tkL = T1DL(p,:);
tkLU = T1DLU(p,:);
KPL(1+p-m_i,:) = KPL1+tkL;
KPLU(1+p-m_i,:) = KPLU1+tkLU;
end
KPL;
KPLU;
%% Data: Filters
Markov_Filter = ones(m,interval+1);
Markov_Filter_LU = ones(m,interval+1);
Kink_Filter = ones(m,interval+1);
Kink_Filter_LU = ones(m,interval+1);
for i = (1:interval+1)
Markov_Filter(:,i) = T1DL(:,i)-Markov_incorporation;
Markov_Filter_LU(:,i) = T1DLU(:,i)-MarkovLU_incorporation;
end
for j = (1:m*(interval+1))
if Markov_Filter(j)<=0
Markov_Filter(j) = 0;
else Markov_Filter(j) = 1;
end
if Markov_Filter_LU(j)<=0
Markov_Filter_LU(j) = 0;
else Markov_Filter_LU(j) = 1;
end
end
for i = (1:interval+1)
Kink_Filter(:,i) = T1DL(:,i)-Markov_incorporation;
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Kink_Filter_LU(:,i) = T1DLU(:,i)-MarkovLU_incorporation;
end
for j = (1:m*(interval+1))
if Kink_Filter(j)<=0
Kink_Filter(j) = 0;
else Kink_Filter(j) = 1;
end
if Kink_Filter_LU(j)<=0
Kink_Filter_LU(j) = 0;
else Kink_Filter_LU(j) = 1;
end
end
Markov_Filter;
Non_Markov_Filter = 1-Markov_Filter;
Markov_Filter_LU;
Non_Markov_Filter_LU = 1-Markov_Filter_LU;
%% Data: Time for Direct Step Adsorption
Direct_Step_L = ones(1+m-m_i,interval+1);
Direct_Step_LU = ones(1+m-m_i,interval+1);
premat_step_L = cumsum(ET0_L);
premat_step_LU = cumsum(ET0_LU);
for s = (m_i:m)
Direct_Step_L(1+s-m_i,:) = premat_step_L(s,:)+s/R_LS;
Direct_Step_LU(1+s-m_i,:) = premat_step_LU(s,:)+s/R_LS;
end
Direct_Step_L;
Direct_Step_LU;
%% Data: Minimum Time Direct Incorporation
MinDirectL = min(Direct_Step_L,KPL);
MinDirectLU = min(Direct_Step_LU,KPLU);
%% Collection of Important Matrices and Vectors
% Flux vector. 1 x int+1
FL;
% Expected Time for atom to arrive at step. n x int+1
ET0_L;
ET0_LU;
% Expected Time for 1D nucleation. n x int+1
T1DL;
T1DLU;
% Expected Time for atom to diffuse via CTMC to kink. n x 1
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Markov_incorporation;
MarkovLU_incorporation;
% Growth Mechanism Filters
Markov_Filter;
Non_Markov_Filter;
Markov_Filter_LU;
Non_Markov_Filter_LU;
% Expected Time to complete step via direct step incorporation. n x int+1
Direct_Step_L;
Direct_Step_LU;

% Expected Time to complete step via direct kink propagation. n x int+1
KPL;
KPLU;
% Expected Time to complete step via CTMC mechanism. n x int+1
CTMCL;
CTMCLU;
% (minimum) Expected Time for direct incorporation. n x int+1
MinDirectL;
MinDirectLU;
%% Data: Filtered Results
MF = ones(1+m-m_i,interval+1);
MFLU = ones(1+m-m_i,interval+1);
for f = (m_i:m)
MF(1+f-m_i,:) = Markov_Filter(f,:);
end
MF;
nMF = 1-MF;
for g = (m_i:m)
MFLU(1+g-m_i,:) = Markov_Filter_LU(g,:);
end
MFLU;
nMFLU = 1-MFLU;
Filtered_CTMCL = MF.*CTMCL;
Filtered_MINDIR = nMF.*MinDirectL;
Filtered_CTMCLU = MFLU.*CTMCLU;
Filtered_MINDIRU = nMFLU.*MinDirectLU;

% Expected times for step completion
TIME_L = Filtered_CTMCL+Filtered_MINDIR;
TIME_LU = Filtered_CTMCLU+Filtered_MINDIRU;
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%Time for monolayer spread
T_Spread_L = sum(TIME_L)';
T_Spread_LU = sum(TIME_LU)';
%% Plot: Log Expectation Time versus Log Flux
plot(log10(FL),log10(T_Spread_L),'o')
set(gca,'FontSize',28)
title('Log(Step Time) vs. Log(Flux)','Fontsize',28)
xhandle=xlabel('Log(Flux)');
yhandle=ylabel('Log(Step Time)');
set(xhandle,'Fontsize',28)
set(xhandle,'Fontname','Helvetica')
set(yhandle,'Fontsize',28)
set(yhandle,'Fontname','Helvetica')
hold on
plot(log10(FL),log10(T_Spread_LU),'o','markeredgecolor','r')
hold off
legend('Lower Terrace Only','Lower and Upper Terraces','location','southwest')
set(legend,'Fontsize', 16)

%% Data: Crystal Growth Contour Plot
NL = ones(1,interval+1);
NR = ones(1,interval+1);
for j = (1:interval+1)
k = 10^(logf+(j-1)*(logg-logf)/interval);
NR(j) = k;
NL(j) = 1/k;
end
NR;
NL;
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Markov_ContourL1 = ones(interval+1,interval+1);
Markov_ContourLU1 = ones(interval+1,interval+1);
for l = (1:interval+1)
Markov_ContourL1(l,:) = NL+T_Spread_L(l);
Markov_ContourLU1(l,:) = NL+T_Spread_LU(l);
end
Markov_ContourL1;
Markov_ContourLU1;
Markov_ContourL = Markov_ContourL1/d_hkl;
Markov_ContourLU = Markov_ContourLU1/d_hkl;
%% Plot: Crystal Growth Contour Plot
logy = log10(FL./D_Au);

% for unfilled contour plot use the following:
%contour(log10(NR),logy,log10(1./Markov_ContourL),nc,'linewidth',2)
% for filled contour plot use the following:
contourf(log10(NR),logy,log10(1./Markov_ContourL),nc)
set(gca,'FontSize',28)
title('Log(Rhkl)','Fontsize',28)
xhandle=xlabel('Log(Nucleation Rate)');
yhandle=ylabel('Log(Flux)');
set(xhandle,'Fontsize',28)
set(xhandle,'Fontname','Helvetica')
set(yhandle,'Fontsize',28)
set(yhandle,'Fontname','Helvetica')
set(gca,'XTick',(0:3:15),'FontSize',28)
set(gca,'YTick',(0:3:15),'FontSize',28)
colormap(jet)
cb=colorbar;
set(cb,'fontsize',0.1, 'Fontname','Helvetica');
set(gca,'CLim',[0,8])
set(cb,'YTick',(0:1:8),'FontSize',28)
maxv = max(max(log10(1./Markov_ContourL)));
minv = min(min(log10(1./Markov_ContourL)));
range = (maxv-minv)/(nc+1);
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v = (minv:range:maxv-range);
hold on
contour(log10(NR),logy,log10(1./Markov_ContourL),maxv-range,'k','linewidth',3.5)
hold off
ratematrix = log10(1./Markov_ContourL);
size(ratematrix);
ndtrans1 = ones(interval+1,interval+1);
for a = (1:interval)
ndtrans1(:,a) = ratematrix(:,a+1)-ratematrix(:,a);
end
ndtrans1(:,interval+1) = zeros(interval+1,1);
ndtrans2 = ones(interval+1,interval+1);
for a = (1:interval)
ndtrans2(a,:) = ratematrix(a+1,:)-ratematrix(a,:);
end
ndtrans2(interval+1,:) = zeros(1,interval+1);
ndtransA = ndtrans1 - ndtrans2;
ndtransB = ndtrans2 - ndtrans1;
ndtransC = ndtransA.*ndtransB;
[M,I] = max(ndtransC);
I;
testmat = zeros(interval+1);
for b = (1:interval+1)
testmat(I(b),b) = 1;
end
testmat;
testq = maxv-range;
maxmat = testmat.*ratematrix;
[row,col] = find(maxmat>=testq);
lrc = length(row);
maxmat2 = maxmat;
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for t = (1:lrc)
maxmat2(row(t),col(t)) = 0;
end
maxmat3 = maxmat2;
for s = (1:(interval+1)^2)
if maxmat2(s) == 0;
maxmat3(s) = NaN;
end
end
maxmat3;
testline = max(maxmat3);
N = isnan(testline);
NN = 1-N;
LN = nnz(NN);
rrr = ones(LN,1);
ccc = ones(LN,1);
for r = (1:LN)
[rrr(r),ccc(r)] = find(maxmat3 == testline(r));
end
rrr;
ccc;
xxx = log10(NR);
yyy = logy;
xvec = ones(1,LN);
for x = (1:LN)
xvec(x) = xxx(x);
end
xvec;
yvec = ones(1,LN);
for y = (1:LN)
yvec(y) = yyy(rrr(y));
end
yvec;
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hold on
plot(xvec,yvec,'k','linewidth',3.5)
hold off
J = isnan(ratematrix(:,1));
JJ = 1-J;
LJ = nnz(JJ);
Jinit = interval+2 - LJ;
minline = ones(interval+1,1);
for j = (1:interval+1)
minline(j) = yyy(Jinit);
end
hold on
plot(log10(NR),minline,'k','linewidth',3.5)
hold off
hold on

%% Plot: Experimental Rate Contour
% z = [log10(experimental growth rate),log10(experimental growth rate)]
z = [2,2];
%%
%contour(log10(NR),logy,log10(1./Markov_ContourL),z,'w','linewidth',3.5)
hold off
set(gcf,'Color','w')

A2.2 Matlab script for diffusion-limited growth rate distribution
%% Input: Diffusion-Limited Simulation
%Temperature in Kelvin
T = 300;
%number of atoms in first step after nucleation
m_i = 3;
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%number of atoms in final step of net monolayer
m = 10;
%Facet index (do not include brackets. Write 111 or 100)
facet = 111;
%Chloride coverage (between 0 and 1)
Cl = 0;
%% Monte Carlo
% Variables
mu=534950; % mean
sd=5349.50; % sigma
%% Input: Activation Energies, Vib. Frequencies
%{111} With Chloride EAM
%Activation Energies in eV
E_LLc111 = 0.080;
E_LSc111 = 0.075;
E_LKc111 = 0.052;
E_SSc111 = 0.243;
E_SKc111 = 0.223;
E_KSc111 = 0.356;
E_SLc111 = 0.320;
E_KLc111 = 0.282;
E_USc111 = 0.203;
E_UKc111 = 0.142;
d_hkl_111 = 0.353;
%{111} Without Chloride EAM
%Activation Energies in eV
E_LLp111 = 0.102;
E_LSp111 = 0.096;
E_LKp111 = 0.067;
E_SSp111 = 0.311;
E_SKp111 = 0.286;
E_KSp111 = 0.456;
E_SLp111 = 0.410;
E_KLp111 = 0.420;
E_USp111 = 0.260;
E_UKp111 = 0.181;
%{100} With Chloride EAM
%Activation Energies in eV
E_LLc100 = 0.383;
E_LSc100 = 0.361;
E_LKc100 = 0.252;
E_SSc100 = 0.236;
E_SKc100 = 0.217;
E_KSc100 = 0.355;
E_SLc100 = 0.533;
E_KLc100 = 0.468;
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E_USc100 = 0.413;
E_UKc100 = 0.288;
d_hkl_100 = 0.408;
%{100} Without Chloride EAM
%Activation Energies in eV
E_LLp100 = 0.490;
E_LSp100 = 0.462;
E_LKp100 = 0.322;
E_SSp100 = 0.302;
E_SKp100 = 0.278;
E_KSp100 = 0.455;
E_SLp100 = 0.682;
E_KLp100 = 0.698;
E_USp100 = 0.528;
E_UKp100 = 0.368;
%Vibrational Frequencies in 1/s
v_LL = 1.76E+12;
v_LS = 1.42E+12;
v_LK = 1.43E+12;
v_SS = 1.41E+12;
v_SK = 1.45E+12;
v_KS = 1.45E+12;
v_SL = 1.91E+12;
v_KL = 1.75E+12;
v_US = 1.42E+12;
v_UK = 1.43E+12;
%% Activation energies
%Facet identity
if facet == 111
E_LLc = E_LLc111;
E_LSc = E_LSc111;
E_LKc = E_LKc111;
E_SSc = E_SSc111;
E_SKc = E_SKc111;
E_KSc = E_KSc111;
E_SLc = E_SLc111;
E_KLc = E_KLc111;
E_USc = E_USc111;
E_UKc = E_UKc111;
E_LLp = E_LLp111;
E_LSp = E_LSp111;
E_LKp = E_LKp111;
E_SSp = E_SSp111;
E_SKp = E_SKp111;
E_KSp = E_KSp111;
E_SLp = E_SLp111;
E_KLp = E_KLp111;
E_USp = E_USp111;
E_UKp = E_UKp111;
else
E_LLc = E_LLc100;
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E_LSc = E_LSc100;
E_LKc = E_LKc100;
E_SSc = E_SSc100;
E_SKc = E_SKc100;
E_KSc = E_KSc100;
E_SLc = E_SLc100;
E_KLc = E_KLc100;
E_USc = E_USc100;
E_UKc = E_UKc100;
E_LLp = E_LLp100;
E_LSp = E_LSp100;
E_LKp = E_LKp100;
E_SSp = E_SSp100;
E_SKp = E_SKp100;
E_KSp = E_KSp100;
E_SLp = E_SLp100;
E_KLp = E_KLp100;
E_USp = E_USp100;
E_UKp = E_UKp100;
end
E_LL = Cl*E_LLc+(1-Cl)*E_LLp;
E_LS = Cl*E_LSc+(1-Cl)*E_LSp;
E_LK = Cl*E_LKc+(1-Cl)*E_LKp;
E_SS = Cl*E_SSc+(1-Cl)*E_SSp;
E_SK = Cl*E_SKc+(1-Cl)*E_SKp;
E_KS = Cl*E_KSc+(1-Cl)*E_KSp;
E_SL = Cl*E_SLc+(1-Cl)*E_SLp;
E_KL = Cl*E_KLc+(1-Cl)*E_KLp;
E_US = Cl*E_USc+(1-Cl)*E_USp;
E_UK = Cl*E_UKc+(1-Cl)*E_UKp;
%% Input: Growth Phase Diagram Display
interval = 400;
%a = min flux, b = max flux
a = mu-5*sd;
b = mu+5*sd;
%f = min Nuc. Rate, g = Nuc. Rate
f = 10^0;
g = 10^15;
%nc = number of contours.
nc = 25;
%% Data: Diffusion Rates and Physical Constants
format longG
%Boltzmann's Constant in eV/K
k_B = 8.6173324E-5;
%Thermal Energy
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kT = k_B*T;
%Monolayer Height
if facet == 111
d_hkl = d_hkl_111;
else
d_hkl = d_hkl_100;
end
d_hkl;
%Diffusion Rates in Jumps/s
R_LL = v_LL*exp(-E_LL/kT);
R_LS = v_LS*exp(-E_LS/kT);
R_LK = v_LK*exp(-E_LK/kT);
R_SS = v_SS*exp(-E_SS/kT);
R_SK = v_SK*exp(-E_SK/kT);
R_KS = v_KS*exp(-E_KS/kT);
R_SL = v_SL*exp(-E_SL/kT);
R_KL = v_KL*exp(-E_KL/kT);
R_US = v_US*exp(-E_US/kT);
R_UK = v_UK*exp(-E_UK/kT);
%Flux is the flux of growth units to the step front in atoms nm^-1 s^-1
D_Au = 0.288;
%% Data: Arrival Time
%Construct grid.
loga = log10(a);
logb = log10(b);
logf = log10(f);
logg = log10(g);
FL=linspace(0.288*(mu-5*sd),0.288*(mu+5*sd),interval+1);
MATFL = ones(m,interval+1);
for l = (1:m)
MATFL(l,:) = l*FL;
end
MATFL;
ET0_L = 1./MATFL;
ET0_LU = ET0_L/2;
%% Data: Incorporation Generator
Markov_incorporation = ones(m,1);
MarkovLU_incorporation = ones(m,1);
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for n = (3:m)
ProbjL = 1/n;
ProbjLU = 1/(2*n);
timejL = 1/R_LS;
timejU = 1/R_US;
%Q is the infinitesimal generator
pkA = ones(n-1);
pkB = eye(n-1);
pkC = tril(pkA,-2);
pkD = triu(pkA,2);
pkE = pkA-pkB-pkC-pkD;
pkF = -R_SS*pkE;
pkG = pkB*(2*R_SS);
Q = pkF+pkG;
Q(1,1) = R_SK+R_SS;
Q(n-1,n-1) = R_SS;
Qone = ones(n-1,1);
E_partMarkov = Q\Qone;
T1T2mark = ones(n-1,1);
for q = (1:n-1)
T1T2mark(q) = ProbjL*(timejL+E_partMarkov(q));
end
T1T2mark0 = ProbjL*(1/R_LK);
T1T2_Markov = [T1T2mark0;T1T2mark];
T1T2one = ones(1,n);
T1T2L = T1T2one*T1T2_Markov;
Markov_incorporation(n) = T1T2L;
E_partMarkovLU = Q\Qone;
T1T2markLU = ones(n-1,1);
for h = (1:n-1)
T1T2markLU(h) = ProbjLU*(timejL+timejU+2*E_partMarkovLU(h));
end
T1T2LUmark0 = ProbjLU*(1/R_LK+1/R_UK);
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T1T2LU_Markov = [T1T2LUmark0;T1T2markLU];
T1T2LUone = ones(1,n);
T1T2LU = T1T2LUone*T1T2LU_Markov;
MarkovLU_incorporation(n) = T1T2LU;
end
Markov_incorporation(1) = 1/R_LK;
Markov_incorporation(2) = (1/2)*(1/R_LK)+(1/2)*((1/R_LS)+(1/R_SK));
MarkovLU_incorporation(1) = (1/2)*((1/R_LK)+(1/R_UK));
MarkovLU_incorporation(2) =
(1/4)*((1/R_LK)+(1/R_UK))+(1/4)*((1/R_LS)+2*(1/R_SK)+(1/R_US));
Markov_incorporation;
MarkovLU_incorporation;
%% Data: Time to Complete Step by CTMC
Time_MarkovL = ones(m,interval+1);
Time_MarkovLU = ones(m,interval+1);
for v = (1:m)
Time_MarkovL(v,:) = ET0_L(v,:)+Markov_incorporation(v);
Time_MarkovLU(v,:) = ET0_LU(v,:)+MarkovLU_incorporation(v);
end

Time_MarkovL;
Time_MarkovLU;
CORXNL= ones(m,interval+1);
CORXNLU= ones(m,interval+1);
for v = (1:m)
CORXNL(v,:) = (1/R_KL)./((1/R_KL)-Time_MarkovL(v,:));
CORXNLU(v,:) = (1/R_KL)./((1/R_KL)-Time_MarkovLU(v,:));
end

T_markL = ones(m,interval+1);
T_markLU = ones(m,interval+1);
for v = (1:m)
T_markL(v,:) = CORXNL(v,:).*Time_MarkovL(v,:);
T_markLU(v,:) = CORXNLU(v,:).*Time_MarkovLU(v,:);
end
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numL = numel(T_markL);
for d = (1:numL)
if T_markL(d)<0
T_markL(d)=NaN;
end
if T_markLU(d)<0
T_markLU(d)=NaN;
end
end
T_markL;
T_markLU;
Time_Markov_L = cumsum(T_markL);
Time_Markov_LU = cumsum(T_markLU);
%% Data: Expected Time for 1D Nucleation
T1DL = ET0_L + 1/R_LS;
T1DLU = ET0_LU + 0.5/R_LS + 0.5/R_US;
CTMCL = ones(1+m-m_i,interval+1);
CTMCLU = ones(1+m-m_i,interval+1);
for p = (m_i:m)
E_T_M1 = ones(p,interval+1);
E_T_M2 = ones(p,interval+1);
for i = (1:p)
E_T_M1(i,:) = (1/p)*Time_Markov_L(max(i-1,p-i),:);
E_T_M2(i,:) = (1/p)*Time_Markov_LU(max(i-1,p-i),:);
end
jumpinL = T1DL(p,:);
jumpinLU = T1DLU(p,:);
E_T_ML = sum(E_T_M1);
E_T_MLU = sum(E_T_M2);
EML = E_T_ML + jumpinL;
EMLU = E_T_MLU + jumpinLU;
CTMCL(1+p-m_i,:) = EML;
CTMCLU(1+p-m_i,:) = EMLU;
end
CTMCL;
CTMCLU;
%% Data: Kink Propagation
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kinkL = ones(1+m-m_i,interval+1);
kinkLU = ones(1+m-m_i,interval+1);
kinkarrival = ones(m,interval+1);
kinkarrivalLU = ones(m,interval+1);
for x = (1:m)
kinkarrival(x,:) = 1./FL;
kinkarrivalLU(x,:) = 1./(2*FL);
end
kinkcum = cumsum(kinkarrival);
kinkcumLU = cumsum(kinkarrivalLU);
for y = (1:m)
kinkL(y,:) = y/R_LK+kinkcum(y,:);
kinkLU(y,:) = y*(0.5/R_LK+0.5/R_UK)+kinkcumLU(y,:);
end
kinkL;
kinkLU;

KPL = ones(1+m-m_i,interval+1);
KPLU = ones(1+m-m_i,interval+1);
for p = (m_i:m)
E_T_KPL = ones(p,interval+1);
E_T_KPLU = ones(p,interval+1);
for i = (1:p)
E_T_KPL(i,:) = (1/p)*kinkL(max(i-1,p-i),:);
E_T_KPLU(i,:) = (1/p)*kinkLU(max(i-1,p-i),:);
end
KPL1 = sum(E_T_KPL);
KPLU1 = sum(E_T_KPLU);
tkL = T1DL(p,:);
tkLU = T1DLU(p,:);
KPL(1+p-m_i,:) = KPL1+tkL;
KPLU(1+p-m_i,:) = KPLU1+tkLU;
end
KPL;
KPLU;
%% Data: Filters
Markov_Filter = ones(m,interval+1);
Markov_Filter_LU = ones(m,interval+1);
Kink_Filter = ones(m,interval+1);
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Kink_Filter_LU = ones(m,interval+1);
for i = (1:interval+1)
Markov_Filter(:,i) = T1DL(:,i)-Markov_incorporation;
Markov_Filter_LU(:,i) = T1DLU(:,i)-MarkovLU_incorporation;
end
for j = (1:m*(interval+1))
if Markov_Filter(j)<=0
Markov_Filter(j) = 0;
else Markov_Filter(j) = 1;
end
if Markov_Filter_LU(j)<=0
Markov_Filter_LU(j) = 0;
else Markov_Filter_LU(j) = 1;
end
end
for i = (1:interval+1)
Kink_Filter(:,i) = T1DL(:,i)-Markov_incorporation;
Kink_Filter_LU(:,i) = T1DLU(:,i)-MarkovLU_incorporation;
end
for j = (1:m*(interval+1))
if Kink_Filter(j)<=0
Kink_Filter(j) = 0;
else Kink_Filter(j) = 1;
end
if Kink_Filter_LU(j)<=0
Kink_Filter_LU(j) = 0;
else Kink_Filter_LU(j) = 1;
end
end
Markov_Filter;
Non_Markov_Filter = 1-Markov_Filter;
Markov_Filter_LU;
Non_Markov_Filter_LU = 1-Markov_Filter_LU;
%% Data: Time for direct step adsorption
Direct_Step_L = ones(1+m-m_i,interval+1);
Direct_Step_LU = ones(1+m-m_i,interval+1);
premat_step_L = cumsum(ET0_L);
premat_step_LU = cumsum(ET0_LU);
for s = (m_i:m)
Direct_Step_L(1+s-m_i,:) = premat_step_L(s,:)+s/R_LS;
Direct_Step_LU(1+s-m_i,:) = premat_step_LU(s,:)+s/R_LS;
end
Direct_Step_L;
Direct_Step_LU;
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%% Data: Minimum Time Direct Incorporation
MinDirectL = min(Direct_Step_L,KPL);
MinDirectLU = min(Direct_Step_LU,KPLU);
%% Collection of Important Matrices and Vectors
% Flux vector. 1 x int+1
FL;
% Expected Time for atom to arrive at step. n x int+1
ET0_L;
ET0_LU;
% Expected Time for 1D nucleation. n x int+1
T1DL;
T1DLU;
% Expected Time for atom to diffuse via CTMC to kink. n x 1
Markov_incorporation;
MarkovLU_incorporation;
% Growth Mechanism Filters
Markov_Filter;
Non_Markov_Filter;
Markov_Filter_LU;
Non_Markov_Filter_LU;
% Expected Time to complete step via direct step incorporation. n x int+1
Direct_Step_L;
Direct_Step_LU;

% Expected Time to complete step via direct kink propagation. n x int+1
KPL;
KPLU;
% Expected Time to complete step via CTMC mechanism. n x int+1
CTMCL;
CTMCLU;
% (minimum) Expected Time for direct incorporation. n x int+1
MinDirectL;
MinDirectLU;
%% Data: Filtered Results
MF = ones(1+m-m_i,interval+1);
MFLU = ones(1+m-m_i,interval+1);
for f = (m_i:m)
MF(1+f-m_i,:) = Markov_Filter(f,:);
end
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MF;
nMF = 1-MF;
for g = (m_i:m)
MFLU(1+g-m_i,:) = Markov_Filter_LU(g,:);
end
MFLU;
nMFLU = 1-MFLU;
Filtered_CTMCL = MF.*CTMCL;
Filtered_MINDIR = nMF.*MinDirectL;
Filtered_CTMCLU = MFLU.*CTMCLU;
Filtered_MINDIRU = nMFLU.*MinDirectLU;

% Expected times for step completion
TIME_L = Filtered_CTMCL+Filtered_MINDIR;
TIME_LU = Filtered_CTMCLU+Filtered_MINDIRU;
%Time for monolayer spread
T_Spread_L = sum(TIME_L)';
T_Spread_LU = sum(TIME_LU)';
%% Data: Growth Phase Diagram
NL = ones(1,interval+1);
NR = ones(1,interval+1);
for j = (1:interval+1)
k = 10^(logf+(j-1)*(logg-logf)/interval);
NR(j) = k;
NL(j) = 1/k;
end
NR;
NL;
Markov_ContourL1 = ones(interval+1,interval+1);
Markov_ContourLU1 = ones(interval+1,interval+1);
for l = (1:interval+1)
Markov_ContourL1(l,:) = NL+T_Spread_L(l);
Markov_ContourLU1(l,:) = NL+T_Spread_LU(l);
end
Markov_ContourL1;
Markov_ContourLU1;
Markov_ContourL = Markov_ContourL1/d_hkl;
Markov_ContourLU = Markov_ContourLU1/d_hkl;
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RATE_L = 1./Markov_ContourL;
RATE_LU = 1./Markov_ContourLU;
%% Histograms
N=10^6; % # times
% Solve for the analytical sampling equation and run N times
x=zeros(length(N));
x2=zeros(length(N));
y=zeros(length(N));
y2=zeros(length(N));
for i=1:N
r1=rand;
r2=rand;
r3=rand;
r4=rand;
x(i)=sqrt(-2*(0.288*sd)^2*log(r1))*sin(2*pi*r2);
x(i)=x(i)+0.288*mu;
%x2(i)=sqrt(-2*s2^2*log(r3))*sin(2*pi*r4);
%x2(i)=x2(i)+mu2;
end
bin = histc(x,FL)';
%%
rcol = RATE_L(:,interval+1);
blue = find(RATE_L(:,interval+1)>=100);
numel(blue)
%%
red = sum(isnan(RATE_L(:,interval+1)));
lg = (min(blue)-1)-(max(red)+1)+1;
lb = max(blue)-min(blue)+1;
green = ones(lg,1);
for g = (max(red)+1:min(blue)-1)
green(g-red)=rcol(g);
end
greenx = ones(lg,1);
for g = (max(red)+1:min(blue)-1)
greenx(g-red)=bin(g);
end
sumg = sum(greenx);
percentgreen = sumg/1000000; %percent lateral growth
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%%
green;
blu = ones(lb,1);
for b = (min(blue):max(blue))
blu(b-(min(blue))+1)=rcol(b);
end
blu;
bing = ones(lg,1);
for g = (max(red)+1:min(blue)-1)
bing(g-red)=bin(g);
end
bing;
binb = ones(lb,1);
for b = (min(blue):max(blue))
binb(b-(min(blue))+1)=bin(b);
end
binb;
%%
mu3 = 10;
sd3 = 100;
intblu = blu(2)-blu(1);
maxred = min(green)-intblu;
minred = mu3-max(blu);
redel = 1+ceil((maxred-minred)/intblu);
reds = ones(redel,1);
for r = (1:redel)
reds(r) = maxred-(r-1)*intblu;
end
redvals = flipud(reds);
xpdf = [redvals;green;blu];
ypdf = normpdf(xpdf,mu3,sd3);
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datax = [green;red];
datay = [bing;binb];
negdatay = zeros(length(datay)-27,1);
for d = (1:length(datay)-31)
negdatay(d) = datay(d+3);
end
negdatax = flipud(negdatay);
datastitch = [negdatax;bing;binb];
gaussEqn = 'a*exp(-((x-b)/c)^2)+d';
startPoints = [1 10 10 0.6];
gauss = fit(xpdf,datastitch,gaussEqn,'Start',startPoints);
figure(1)
bar(green,bing,1,'FaceColor',[0 0.85 0.15],'EdgeColor',[0 0.85 0.15])
xlim([-600 600])
ylim([0 12000])
hold on
bar(blu,binb,1,'FaceColor',[0 0.5 1],'EdgeColor',[0 0.5 1])
hold on
plot(gauss,'--r')
xlabel('Rhkl','FontSize',28)
ylabel('Frequency','FontSize',28)
set(gca,'FontSize',0.1)
set(gca,'XTick',(-600:200:600),'FontSize',28)
set(gca,'YTick',(0:2000:12000),'FontSize',28)
set(gcf,'color',[1 1 1])
hold off
hold off

A2.3 Matlab script for nucleation-limited growth rate distribution
%% Input: Crystal Growth Contour Plot
%Temperature in Kelvin
T = 300;
%number of atoms in first step after nucleation
m_i = 3;
%number of atoms in step fragment
m = 10;
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%Facet index (do not include brackets. Write 111 or 100)
facet = 111;
%Chloride coverage (between 0 and 1)
Cl = 0;
%% Monte Carlo
% Variables
mu2=28.5; % mean 2
sd2=0.285; % sigma 2
%% Input: Activation Energies, Vib. Frequencies
%{111} With Chloride EAM
%Activation Energies in eV
E_LLc111 = 0.080;
E_LSc111 = 0.075;
E_LKc111 = 0.052;
E_SSc111 = 0.243;
E_SKc111 = 0.223;
E_KSc111 = 0.356;
E_SLc111 = 0.320;
E_KLc111 = 0.282;
E_USc111 = 0.203;
E_UKc111 = 0.142;
d_hkl_111 = 0.353;
%{111} Without Chloride EAM
%Activation Energies in eV
E_LLp111 = 0.102;
E_LSp111 = 0.096;
E_LKp111 = 0.067;
E_SSp111 = 0.311;
E_SKp111 = 0.286;
E_KSp111 = 0.456;
E_SLp111 = 0.410;
E_KLp111 = 0.420;
E_USp111 = 0.260;
E_UKp111 = 0.181;
%{100} With Chloride EAM
%Activation Energies in eV
E_LLc100 = 0.383;
E_LSc100 = 0.361;
E_LKc100 = 0.252;
E_SSc100 = 0.236;
E_SKc100 = 0.217;
E_KSc100 = 0.355;
E_SLc100 = 0.533;
E_KLc100 = 0.468;
E_USc100 = 0.413;
E_UKc100 = 0.288;
d_hkl_100 = 0.408;
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%{100} Without Chloride EAM
%Activation Energies in eV
E_LLp100 = 0.490;
E_LSp100 = 0.462;
E_LKp100 = 0.322;
E_SSp100 = 0.302;
E_SKp100 = 0.278;
E_KSp100 = 0.455;
E_SLp100 = 0.682;
E_KLp100 = 0.698;
E_USp100 = 0.528;
E_UKp100 = 0.368;
%Vibrational Frequencies in 1/s
v_LL = 1.76E+12;
v_LS = 1.42E+12;
v_LK = 1.43E+12;
v_SS = 1.41E+12;
v_SK = 1.45E+12;
v_KS = 1.45E+12;
v_SL = 1.91E+12;
v_KL = 1.75E+12;
v_US = 1.42E+12;
v_UK = 1.43E+12;
%% Activation energies
%Facet identity
if facet == 111
E_LLc = E_LLc111;
E_LSc = E_LSc111;
E_LKc = E_LKc111;
E_SSc = E_SSc111;
E_SKc = E_SKc111;
E_KSc = E_KSc111;
E_SLc = E_SLc111;
E_KLc = E_KLc111;
E_USc = E_USc111;
E_UKc = E_UKc111;
E_LLp = E_LLp111;
E_LSp = E_LSp111;
E_LKp = E_LKp111;
E_SSp = E_SSp111;
E_SKp = E_SKp111;
E_KSp = E_KSp111;
E_SLp = E_SLp111;
E_KLp = E_KLp111;
E_USp = E_USp111;
E_UKp = E_UKp111;
else
E_LLc = E_LLc100;
E_LSc = E_LSc100;
E_LKc = E_LKc100;
E_SSc = E_SSc100;

A2-33

E_SKc = E_SKc100;
E_KSc = E_KSc100;
E_SLc = E_SLc100;
E_KLc = E_KLc100;
E_USc = E_USc100;
E_UKc = E_UKc100;
E_LLp = E_LLp100;
E_LSp = E_LSp100;
E_LKp = E_LKp100;
E_SSp = E_SSp100;
E_SKp = E_SKp100;
E_KSp = E_KSp100;
E_SLp = E_SLp100;
E_KLp = E_KLp100;
E_USp = E_USp100;
E_UKp = E_UKp100;
end
E_LL = Cl*E_LLc+(1-Cl)*E_LLp;
E_LS = Cl*E_LSc+(1-Cl)*E_LSp;
E_LK = Cl*E_LKc+(1-Cl)*E_LKp;
E_SS = Cl*E_SSc+(1-Cl)*E_SSp;
E_SK = Cl*E_SKc+(1-Cl)*E_SKp;
E_KS = Cl*E_KSc+(1-Cl)*E_KSp;
E_SL = Cl*E_SLc+(1-Cl)*E_SLp;
E_KL = Cl*E_KLc+(1-Cl)*E_KLp;
E_US = Cl*E_USc+(1-Cl)*E_USp;
E_UK = Cl*E_UKc+(1-Cl)*E_UKp;
%% Input: Growth Phase Diagram Display
interval = 350;
%a = min flux, b = max flux
a = 10^0;
b = 10^15;
%f = min Nuc. Rate, g = Nuc. Rate
f = mu-5*sd;
g = mu+5*sd;
%nc = number of contours.
nc = 25;

%% Data: Diffusion Rates and Physical Constants
format longG
%Boltzmann's Constant in eV/K
k_B = 8.6173324E-5;
%Thermal Energy
kT = k_B*T;
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%Monolayer Height
if facet == 111
d_hkl = d_hkl_111;
else
d_hkl = d_hkl_100;
end
d_hkl;
%Diffusion Rates in Jumps/s
R_LL = v_LL*exp(-E_LL/kT);
R_LS = v_LS*exp(-E_LS/kT);
R_LK = v_LK*exp(-E_LK/kT);
R_SS = v_SS*exp(-E_SS/kT);
R_SK = v_SK*exp(-E_SK/kT);
R_KS = v_KS*exp(-E_KS/kT);
R_SL = v_SL*exp(-E_SL/kT);
R_KL = v_KL*exp(-E_KL/kT);
R_US = v_US*exp(-E_US/kT);
R_UK = v_UK*exp(-E_UK/kT);
%Flux is the flux of growth units to the step front in atoms nm^-1 s^-1
syms Flux
D_Au = 0.288;
flux_step = D_Au*Flux;
%E_T0 is the expectation time for growth units to arrive at the step front
E_T0 = flux_step^(-1);
%% Data: Arrival Time
%Construct grid.
loga = log10(a);
logb = log10(b);
logf = log10(f);
logg = log10(g);
FL = ones(1,interval+1);
for j = (1:interval+1)
k = 10^(loga+(j-1)*(logb-loga)/interval);
FL(j) = subs(flux_step,Flux,k);
end
MATFL = ones(m,interval+1);
for l = (1:m)
MATFL(l,:) = l*FL;
end
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MATFL;
ET0_L = 1./MATFL;
ET0_LU = ET0_L/2;
%% Data: Incorporation Generator
Markov_incorporation = ones(m,1);
MarkovLU_incorporation = ones(m,1);
for n = (3:m)
ProbjL = 1/n;
ProbjLU = 1/(2*n);
timejL = 1/R_LS;
timejU = 1/R_US;
%Q is the infinitesimal generator
pkA = ones(n-1);
pkB = eye(n-1);
pkC = tril(pkA,-2);
pkD = triu(pkA,2);
pkE = pkA-pkB-pkC-pkD;
pkF = -R_SS*pkE;
pkG = pkB*(2*R_SS);
Q = pkF+pkG;
Q(1,1) = R_SK+R_SS;
Q(n-1,n-1) = R_SS;
Qone = ones(n-1,1);
E_partMarkov = Q\Qone;
T1T2mark = ones(n-1,1);
for q = (1:n-1)
T1T2mark(q) = ProbjL*(timejL+E_partMarkov(q));
end
T1T2mark0 = ProbjL*(1/R_LK);
T1T2_Markov = [T1T2mark0;T1T2mark];
T1T2one = ones(1,n);
T1T2L = T1T2one*T1T2_Markov;
Markov_incorporation(n) = T1T2L;
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E_partMarkovLU = Q\Qone;
T1T2markLU = ones(n-1,1);
for h = (1:n-1)
T1T2markLU(h) = ProbjLU*(timejL+timejU+2*E_partMarkovLU(h));
end
T1T2LUmark0 = ProbjLU*(1/R_LK+1/R_UK);
T1T2LU_Markov = [T1T2LUmark0;T1T2markLU];
T1T2LUone = ones(1,n);
T1T2LU = T1T2LUone*T1T2LU_Markov;
MarkovLU_incorporation(n) = T1T2LU;
end
Markov_incorporation(1) = 1/R_LK;
Markov_incorporation(2) = (1/2)*(1/R_LK)+(1/2)*((1/R_LS)+(1/R_SK));
MarkovLU_incorporation(1) = (1/2)*((1/R_LK)+(1/R_UK));
MarkovLU_incorporation(2) =
(1/4)*((1/R_LK)+(1/R_UK))+(1/4)*((1/R_LS)+2*(1/R_SK)+(1/R_US));
Markov_incorporation;
MarkovLU_incorporation;

%% Data: Time to Complete Step by CTMC
Time_MarkovL = ones(m,interval+1);
Time_MarkovLU = ones(m,interval+1);
for v = (1:m)
Time_MarkovL(v,:) = ET0_L(v,:)+Markov_incorporation(v);
Time_MarkovLU(v,:) = ET0_LU(v,:)+MarkovLU_incorporation(v);
end

Time_MarkovL;
Time_MarkovLU;
CORXNL= ones(m,interval+1);
CORXNLU= ones(m,interval+1);
for v = (1:m)
CORXNL(v,:) = (1/R_KL)./((1/R_KL)-Time_MarkovL(v,:));
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CORXNLU(v,:) = (1/R_KL)./((1/R_KL)-Time_MarkovLU(v,:));
end

T_markL = ones(m,interval+1);
T_markLU = ones(m,interval+1);
for v = (1:m)
T_markL(v,:) = CORXNL(v,:).*Time_MarkovL(v,:);
T_markLU(v,:) = CORXNLU(v,:).*Time_MarkovLU(v,:);
end
numL = numel(T_markL);
for d = (1:numL)
if T_markL(d)<0
T_markL(d)=NaN;
end
if T_markLU(d)<0
T_markLU(d)=NaN;
end
end
T_markL;
T_markLU;
Time_Markov_L = cumsum(T_markL);
Time_Markov_LU = cumsum(T_markLU);
%% Data: Expected Time for 1D Nucleation
T1DL = ET0_L + 1/R_LS;
T1DLU = ET0_LU + 0.5/R_LS + 0.5/R_US;
CTMCL = ones(1+m-m_i,interval+1);
CTMCLU = ones(1+m-m_i,interval+1);
for p = (m_i:m)
E_T_M1 = ones(p,interval+1);
E_T_M2 = ones(p,interval+1);
for i = (1:p)
E_T_M1(i,:) = (1/p)*Time_Markov_L(max(i-1,p-i),:);
E_T_M2(i,:) = (1/p)*Time_Markov_LU(max(i-1,p-i),:);
end
jumpinL = T1DL(p,:);
jumpinLU = T1DLU(p,:);
E_T_ML = sum(E_T_M1);
E_T_MLU = sum(E_T_M2);
EML = E_T_ML + jumpinL;
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EMLU = E_T_MLU + jumpinLU;
CTMCL(1+p-m_i,:) = EML;
CTMCLU(1+p-m_i,:) = EMLU;
end
CTMCL;
CTMCLU;
%% Data: Kink Propagation
kinkL = ones(1+m-m_i,interval+1);
kinkLU = ones(1+m-m_i,interval+1);
kinkarrival = ones(m,interval+1);
kinkarrivalLU = ones(m,interval+1);
for x = (1:m)
kinkarrival(x,:) = 1./FL;
kinkarrivalLU(x,:) = 1./(2*FL);
end
kinkcum = cumsum(kinkarrival);
kinkcumLU = cumsum(kinkarrivalLU);
for y = (1:m)
kinkL(y,:) = y/R_LK+kinkcum(y,:);
kinkLU(y,:) = y*(0.5/R_LK+0.5/R_UK)+kinkcumLU(y,:);
end
kinkL;
kinkLU;

KPL = ones(1+m-m_i,interval+1);
KPLU = ones(1+m-m_i,interval+1);
for p = (m_i:m)
E_T_KPL = ones(p,interval+1);
E_T_KPLU = ones(p,interval+1);
for i = (1:p)
E_T_KPL(i,:) = (1/p)*kinkL(max(i-1,p-i),:);
E_T_KPLU(i,:) = (1/p)*kinkLU(max(i-1,p-i),:);
end
KPL1 = sum(E_T_KPL);
KPLU1 = sum(E_T_KPLU);
tkL = T1DL(p,:);
tkLU = T1DLU(p,:);
KPL(1+p-m_i,:) = KPL1+tkL;
KPLU(1+p-m_i,:) = KPLU1+tkLU;
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end
KPL;
KPLU;
%% Data: Filters
Markov_Filter = ones(m,interval+1);
Markov_Filter_LU = ones(m,interval+1);
Kink_Filter = ones(m,interval+1);
Kink_Filter_LU = ones(m,interval+1);
for i = (1:interval+1)
Markov_Filter(:,i) = T1DL(:,i)-Markov_incorporation;
Markov_Filter_LU(:,i) = T1DLU(:,i)-MarkovLU_incorporation;
end
for j = (1:m*(interval+1))
if Markov_Filter(j)<=0
Markov_Filter(j) = 0;
else Markov_Filter(j) = 1;
end
if Markov_Filter_LU(j)<=0
Markov_Filter_LU(j) = 0;
else Markov_Filter_LU(j) = 1;
end
end
for i = (1:interval+1)
Kink_Filter(:,i) = T1DL(:,i)-Markov_incorporation;
Kink_Filter_LU(:,i) = T1DLU(:,i)-MarkovLU_incorporation;
end
for j = (1:m*(interval+1))
if Kink_Filter(j)<=0
Kink_Filter(j) = 0;
else Kink_Filter(j) = 1;
end
if Kink_Filter_LU(j)<=0
Kink_Filter_LU(j) = 0;
else Kink_Filter_LU(j) = 1;
end
end
Markov_Filter;
Non_Markov_Filter = 1-Markov_Filter;
Markov_Filter_LU;
Non_Markov_Filter_LU = 1-Markov_Filter_LU;
%% Data: Time for direct step adsorption
Direct_Step_L = ones(1+m-m_i,interval+1);
Direct_Step_LU = ones(1+m-m_i,interval+1);
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premat_step_L = cumsum(ET0_L);
premat_step_LU = cumsum(ET0_LU);
for s = (m_i:m)
Direct_Step_L(1+s-m_i,:) = premat_step_L(s,:)+s/R_LS;
Direct_Step_LU(1+s-m_i,:) = premat_step_LU(s,:)+s/R_LS;
end
Direct_Step_L;
Direct_Step_LU;
%% Data: Minimum Time Direct Incorporation
MinDirectL = min(Direct_Step_L,KPL);
MinDirectLU = min(Direct_Step_LU,KPLU);
%% Collection of Important Matrices and Vectors
% Flux vector. 1 x int+1
FL;
% Expected Time for atom to arrive at step. n x int+1
ET0_L;
ET0_LU;
% Expected Time for 1D nucleation. n x int+1
T1DL;
T1DLU;
% Expected Time for atom to diffuse via CTMC to kink. n x 1
Markov_incorporation;
MarkovLU_incorporation;
% Growth Mechanism Filters
Markov_Filter;
Non_Markov_Filter;
Markov_Filter_LU;
Non_Markov_Filter_LU;
% Expected Time to complete step via direct step incorporation. n x int+1
Direct_Step_L;
Direct_Step_LU;

% Expected Time to complete step via direct kink propagation. n x int+1
KPL;
KPLU;
% Expected Time to complete step via CTMC mechanism. n x int+1
CTMCL;
CTMCLU;
% (minimum) Expected Time for direct incorporation. n x int+1
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MinDirectL;
MinDirectLU;
%% Data: Filtered Results
MF = ones(1+m-m_i,interval+1);
MFLU = ones(1+m-m_i,interval+1);
for f = (m_i:m)
MF(1+f-m_i,:) = Markov_Filter(f,:);
end
MF;
nMF = 1-MF;
for g = (m_i:m)
MFLU(1+g-m_i,:) = Markov_Filter_LU(g,:);
end
MFLU;
nMFLU = 1-MFLU;
Filtered_CTMCL = MF.*CTMCL;
Filtered_MINDIR = nMF.*MinDirectL;
Filtered_CTMCLU = MFLU.*CTMCLU;
Filtered_MINDIRU = nMFLU.*MinDirectLU;

% Expected times for step completion
TIME_L = Filtered_CTMCL+Filtered_MINDIR;
TIME_LU = Filtered_CTMCLU+Filtered_MINDIRU;
%Time for monolayer spread
T_Spread_L = sum(TIME_L)';
T_Spread_LU = sum(TIME_LU)';
%% Plot: Growth Phase Diagram
NR =linspace(mu-5*sd,mu+5*sd,interval+1);
NL =1./NR;
Markov_ContourL1 = ones(interval+1,interval+1);
Markov_ContourLU1 = ones(interval+1,interval+1);
for l = (1:interval+1)
Markov_ContourL1(l,:) = NL+T_Spread_L(l);
Markov_ContourLU1(l,:) = NL+T_Spread_LU(l);
end
Markov_ContourL1;
Markov_ContourLU1;
Markov_ContourL = Markov_ContourL1/d_hkl;
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Markov_ContourLU = Markov_ContourLU1/d_hkl;

%% Histograms
N=10^6; % # times
% Solve for the analytical sampling equation and run N times
x=zeros(length(N));
x2=zeros(length(N));
y=zeros(length(N));
y2=zeros(length(N));
for i=1:N
r1=rand;
r2=rand;
r3=rand;
r4=rand;
x(i)=sqrt(-2*sd^2*log(r1))*sin(2*pi*r2);
x(i)=x(i)+mu;
end
NR;
bin = histc(x,NR);
figure(1)
hist(x,linspace(mu-5*sd,mu+5*sd,interval+1))
xlabel('x')
ylabel('Frequency')
hold on
RATE_L = 1./Markov_ContourL;
rcol = RATE_L(interval+1,:);
sum(bin)

%% Plot: Nucleation-Limited Growth Rate Distribution
bing = zeros(1,length(rcol));
for b = (1:length(rcol))
bing(b) = bin(b);
end
green = bing';
xpdf = rcol';
gaussEqn = 'a*exp(-((x-b)/c)^2)+d';
startPoints = [15000 10 0.1 0.1];
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gauss = fit(xpdf,green,gaussEqn,'Start',startPoints);
bar(xpdf,green,1,'FaceColor',[0 0.85 0.15],'EdgeColor',[0 0.85 0.15])

xlim([5 15])
ylim([0 12000])
hold on
plot(gauss,'--r')
xlabel('Rhkl','FontSize',28)
ylabel('Frequency','FontSize',28)
set(gca,'FontSize',0.1)
set(gca,'XTick',(0:1:15),'FontSize',28)
set(gca,'YTick',(0:2000:12000),'FontSize',28)
set(gcf,'Color','w')
hold off
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